,PatientID.x,Sample,SampleType,NonSynMut,log10mut,NACnt,log10na,PreTreat_Exome,OnTreat_Exome,TCR_Data,RNASeq_Pre,RNASeq_On,Cohort,Subtype,SubtypeEZ,NACnt2,NAFrac,oncosnp_Purity,oncosnp_Ploidy,facets_Purity,facets_Ploidy,dipLogR,CnvCnt,CVAL,SampleId,facets_CNVs,facets_CNA_Genome,median_vaf,max_vaf,EST.StromalScore,EST.ImmuneScore,EST.ESTIMATEScore,EST.TumorPurity,B.cells.naive,B.cells.memory,Plasma.cells,T.cells.CD8,T.cells.CD4.naive,T.cells.CD4.memory.resting,T.cells.CD4.memory.activated,T.cells.follicular.helper,T.cells.regulatory..Tregs.,T.cells.gamma.delta,NK.cells.resting,NK.cells.activated,Monocytes,Macrophages.M0,Macrophages.M1,Macrophages.M2,Dendritic.cells.resting,Dendritic.cells.activated,Mast.cells.resting,Mast.cells.activated,Eosinophils,Neutrophils,CIB.Tcell,CIB.Bcell,CIB.NK,CIB.Mac,CIB.Mast,CIB.Misc,sample_name,fraction_productive_of_cells,fraction_productive_of_cells_mass_estimate,max_productive_frequency,max_frequency,productive_templates,productive_rearrangements,total_productive_reads,productive_entropy,productive_clonality,sample_amount_ng,sample_cells,sample_cells_mass_estimate,total_templates,total_rearrangements,total_reads,sample_entropy,sample_clonality,fraction_productive,sample_tags,TCR_TIL,TCR.id,TCR.type,TCR.fraction_TILs,TCR.Num_CDR3,TCR.CLcdr3_Pre,TCR.NumCDR3perVJ_Median,TCR.Hcdr3PerVJ_Median,TCR.D90,ids,ccf,clusters,clusters_2muts,thresh95,thresh90,thresh85,ccf95,ccf90,ccf85,pyclone_muts,logclust,thresh95.muts,thresh90.muts,thresh85.muts,ccf95.muts,ccf90.muts,ccf85.muts,USUBJID.x,SSUBJID.x,SUBJID.x,STUDYID.x,SITEID.x,SEX.x,AGE.x,RACE,ETHNIC,COUNTRY.x,TRTGRP.x,RFSTDN.x,RFENDN.x,OFFTXDN,LTNIVDT.x,DTDDN,LALDT,FSTDT,RPRPDN.x,FPGDT.x,BOR.x,myBOR,BRPCT,DFLG,PFS_SOR,OS_SOR,DURRES,DURRESWK,TTR_SOR,TTR,TTRWK,OS,OSWK,IBOR.x,LTEDT,MPCT,ORDT,ORDY,PDDT,PFS,PFSWK,REPFL,MPCT_ALL,BRAFST,BRAFSP,LTDT100,myBOR_ord,myBOR2,myBOR3,OS_event,PFS_event,PtId,tmpId,USUBJID.y,AGE.y,SEX.y,RFSTDN.y,RFENDN.y,TRTGRP.y,CONSDN,LTNIVDT.y,LTIPIDT,RPRPDN.y,IBOR.y,FPGDT.y,BOR.y,PRIOR.IO.THERAPY,DXDGDN,DXDGDY,DXCLASSC.x,mySTAGE,PtID.subtype,SSUBJID.y,STUDYID.y,COUNTRY.y,SITEID.y,SUBJID.y,DXCLASSC.y,myDZSubtype,X.1,CURTRT,SampleTypeIHC,Perc.FOXP3.of.CD3,IHORRES.IHC.ASSAY.DATE.OF.ASSESSMENT,PDL1.1plus.pos,PDL1.2plus.pos,PDL1.3plus.pos,PDL1.overall.res,PDL1.tumor.pos,PDL1.immune.pos,PDL1.tumor.immune.cells,PDL1.predom.mem.immune.cells,Num_CD4,Num_CD3,Num_FOXP,Num_PD1,Perc.CD3.of.Total.Assay1,Perc.CD4.of.Total,Perc.CD3.of.Total.Assay2,Perc.CD8.of.Total,Perc.CD3.of.Total.Assay3,Perc.CD3.of.Total.Assay4,Perc.PD1.of.Total,Perc.FOXP3.of.Total,Perc.CD4.of.CD3,Perc.CD8.of.CD3,Perc.PD1.of.CD3,IHORRES.IHC.ASSAY.COMMENT1.1,IHORRES.IHC.ASSAY.REASON.PD.L1.OVERALL.INDETERMINATE.DUE.T,JH.CD4.to.FOXP3.Total,JH.CD8.to.FOXP3.Total,JH.CD4.to.FOXP3.CD3,JH.CD8.to.FOXP3.CD3,Signature.1,Signature.2,Signature.3,Signature.4,Signature.5,Signature.6,Signature.7,Signature.8,Signature.9,Signature.10,Signature.11,Signature.12,Signature.13,Signature.14,Signature.15,Signature.16,Signature.17,Signature.18,Signature.19,Signature.20,Signature.21,Signature.22,Signature.23,Signature.24,Signature.25,Signature.26,Signature.27,Signature.28,Signature.29,Signature.30,Signature.Other,GZMA,PRF1,cytscore,HistPtID,PtSubject,purity_nuclei,purity_areaPt1_on,Pt1,Pt1_on,on,NA,NA,NA,NA,0,0,0,1,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-745.4898597,955.1197257,209.629866,0.804621579,0,0.08771353,0,0.029756737,0.024733661,0.093519698,0.118428119,0.093407402,0,0,0.034956262,0,0,0.105537608,0.074789887,0.296780775,0,0,0,0,0,0.040376321,0.359845617,0.08771353,0.034956262,0.47710827,0,0.040376321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-1-1,CA209038-1-1,1,CA209038,1,1,48,1,2,USA,NIV3-PROG,15-Oct-12,7-Jan-13,21-Jan-13,7-Jan-13,23-Mar-13,22-Mar-13,31-Jan-13,18-Jan-13,7-Dec-12,PD,PD,14.58333333,1,0,0,NA,NA,1,1042,148.8571429,160,22.85714286,PROGRESSION,18-Jan-13,14.58333333,NA,NA,7-Dec-12,54,7.714285714,1,14.58333333,97,NA,17-Apr-13,NA,PD,SDPD,1,1,Pt1,1-Jan,CA209038-1-1,48,MALE,15-Oct-12,7-Jan-13,NIV3-PROG,4-Oct-12,7-Jan-13,NA,18-Jan-13,PROGRESSION,7-Dec-12,PD,NA,12-Oct-12,-3,M1C WITHOUT BRAIN METASTASES,M1C,Pt1,CA209038-1-1,CA209038,United States of America,1,1,CUTANEOUS,CUTANEOUS,2,NIVO 3 mg/kg Q2W,on,36.36,6-Jun-13,0,1,3,EVALUABLE,4,MACROPHAGES ONLY,YES,NA,2310,2064,2419,2288,0.43,0,0.24,0.19,0.45,1.01,1.27,6.99,0,0,69.57,NA,NA,0,0.027181688,0,0.005225523,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,271,256,263.3932421,Pt1_on,1,100,83Pt1_pre,Pt1,Pt1_pre,pre,NA,NA,NA,NA,0,0,0,1,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,185.6829326,2430.79331,2616.476243,0.54947919,0.076763744,0,0,0.080332255,0,0.141421604,0.093808926,0.051001269,0,0,0.029323361,0.004697249,0.049657757,0.106797447,0.086396885,0.186099051,0.022660489,0,0.030260224,0,0,0.04077974,0.366564054,0.076763744,0.03402061,0.379293383,0.030260224,0.113097986,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-1-1,CA209038-1-1,1,CA209038,1,1,48,1,2,USA,NIV3-PROG,15-Oct-12,7-Jan-13,21-Jan-13,7-Jan-13,23-Mar-13,22-Mar-13,31-Jan-13,18-Jan-13,7-Dec-12,PD,PD,14.58333333,1,0,0,NA,NA,1,1042,148.8571429,160,22.85714286,PROGRESSION,18-Jan-13,14.58333333,NA,NA,7-Dec-12,54,7.714285714,1,14.58333333,97,NA,17-Apr-13,NA,PD,SDPD,1,1,Pt1,1-Jan,CA209038-1-1,48,MALE,15-Oct-12,7-Jan-13,NIV3-PROG,4-Oct-12,7-Jan-13,NA,18-Jan-13,PROGRESSION,7-Dec-12,PD,NA,12-Oct-12,-3,M1C WITHOUT BRAIN METASTASES,M1C,Pt1,CA209038-1-1,CA209038,United States of America,1,1,CUTANEOUS,CUTANEOUS,1,PRE-TREATMENT,pre,30.02,7-Jun-13,5,25,15,EVALUABLE,45,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,1701,2090,1766,1612,6.11,0.18,4.5,1.91,24.52,16.13,21.84,7.7,2.88,25.53,98.08,NA,NA,0.023376623,0.248051948,0.005996003,0.06362425,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1036,923,977.8691119,Pt1_pre,1,95,90Pt10_on,Pt10,Pt10_on,on,69,1.838849091,51,1.716003344,1,1,1,1,1,NIV3-NAIVE,4,TripleWt,32,0.463768116,0.5,2.6,0.621422914,3.792898836,-0.638837705,75,300,Pt10_on,26,0.389187517,0.176767677,0.789473684,543.4596364,1464.813547,2008.273184,0.621783531,0.059192992,0,0,0.035403544,0,0.19875831,0.037859142,0,0,0,0,0.015965339,0.05703738,0.204192278,0.09133572,0.208279422,0.017910402,0,0.016898387,0,0,0.057167085,0.272020996,0.059192992,0.015965339,0.50380742,0.016898387,0.132114867,Pt10_on_S0089500,0,0.049099877,0.037593562,0.029659888,17769,5695,null,10.6426334,0.146915898,2352.32007,0,361895,22522,7321,null,10.9770098,0.144947857,0.788961904,"Melanoma, Biopsy, Tissue",0.049099877,Pt10_on,on,0.049,5423,0.149,6,0.8631,0.6725,Pt10_on,0.582784912,21,2,0.636363636,0.636363636,0.666666667,0,0.060606061,0.136363636,66,0.301029996,1.170176693,1.170176693,1.225899394,0,0.1114454,0.250752148,CA209038-8-10,CA209038-8-10,10,CA209038,8,2,81,1,2,SPAIN,NIV3-NAIVE,13-Nov-12,25-Feb-13,11-Mar-13,25-Feb-13,26-Jul-13,10-Jun-13,11-Mar-13,11-Mar-13,11-Mar-13,SD,SD,10.52631579,0,0,0,NA,NA,1,1115,159.2857143,256,36.57142857,STABLE DISEASE,11-Mar-13,10.52631579,NA,NA,11-Mar-13,119,17,1,10.52631579,2,NA,5-Jun-13,NA,PRCRSD,SDPD,1,1,Pt10,10-Aug,CA209038-8-10,81,FEMALE,13-Nov-12,25-Feb-13,NIV3-NAIVE,29-Oct-12,25-Feb-13,NA,11-Mar-13,STABLE DISEASE,11-Mar-13,SD,NA,10-Sep-12,-64,M1A,M1A,Pt10,CA209038-8-10,CA209038,SPAIN,8,10,CUTANEOUS,CUTANEOUS,111,NIVO 3 mg/kg Q2W,on,18.03,7-Jun-13,0,1,2,EVALUABLE,3,MACROPHAGES ONLY,YES,NA,2354,2295,2377,2464,9.26,2.29,6.06,1.09,22.17,9.38,6.37,5.13,24.77,10.07,54.98,NA,NA,0.446393762,0.212475634,0.127010538,0.060454798,0.221102741,0,0.164515999,0.17978847,0,0,0.069239246,0,0,0.076054038,0,0,0,0,0,0,0,0,0,0.158269958,0.071445913,0,0,0,0,0,0,0,0,0,0.709658013,322,149,219.0388093,NA,NA,NA,NAPt10_pre,Pt10,Pt10_pre,pre,75,1.875061263,56,1.755874856,1,1,1,1,1,NIV3-NAIVE,3,NF1,33,0.44,0.8,3.9,0.769044523,3.968017902,-0.812906184,77,300,Pt10_pre,27,0.40849017,0.177304965,0.859375,-492.9648592,-137.8401056,-630.8049649,0.87157412,0.033510875,0.063172895,0.002043333,0,0,0.17442254,0.039387388,0.069634118,0,0,0,0.04940866,0.056348966,0.127015443,0.04258277,0.251127148,0,0.016525937,0.074819928,0,0,0,0.283444046,0.098727103,0.04940866,0.420725361,0.074819928,0.072874903,Pt10_pre_S0089492,0,0.019088826,0.014046737,0.018045988,7831,4592,null,11.4197826,0.061251935,2666.56006,0,410240,10307,5999,null,11.7384195,0.064705499,0.75977491,"Melanoma, Biopsy, Tissue",0.019088826,Pt10_pre,pre,0.019,4441,0.063,5,0.9464,0.8237,Pt10_pre,0.6191047,19,2,0.611111111,0.625,0.625,0.083333333,0.208333333,0.277777778,72,0.301029996,1.145870772,1.17191329,1.17191329,0.156255105,0.390637763,0.520850351,CA209038-8-10,CA209038-8-10,10,CA209038,8,2,81,1,2,SPAIN,NIV3-NAIVE,13-Nov-12,25-Feb-13,11-Mar-13,25-Feb-13,26-Jul-13,10-Jun-13,11-Mar-13,11-Mar-13,11-Mar-13,SD,SD,10.52631579,0,0,0,NA,NA,1,1115,159.2857143,256,36.57142857,STABLE DISEASE,11-Mar-13,10.52631579,NA,NA,11-Mar-13,119,17,1,10.52631579,2,NA,5-Jun-13,NA,PRCRSD,SDPD,1,1,Pt10,10-Aug,CA209038-8-10,81,FEMALE,13-Nov-12,25-Feb-13,NIV3-NAIVE,29-Oct-12,25-Feb-13,NA,11-Mar-13,STABLE DISEASE,11-Mar-13,SD,NA,10-Sep-12,-64,M1A,M1A,Pt10,CA209038-8-10,CA209038,SPAIN,8,10,CUTANEOUS,CUTANEOUS,110,PRE-TREATMENT,pre,34.27,7-Jun-13,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,2139,1954,1998,2576,1.5,0.37,2.46,0.26,7.16,3.45,1.9,13.26,25,0,37.08,NA,NA,0.027903469,0.019607843,0.010796615,0.007586811,0.183305237,0,0.109752847,0.143926469,0,0,0,0,0,0,0,0,0,0,0,0.278653269,0,0,0,0.159124432,0,0,0,0,0,0,0,0,0,0,0.816694763,85,51,65.84071689,NA,NA,NA,NAPt100_on,Pt100,Pt100_on,on,2,0.301029996,3,0.602059991,1,1,0,0,0,NIV3-PROG,4,TripleWt,1,0.5,0.5,2,NA,2,0.006421128,23,300,Pt100_on,0,0,0.11628734,0.171171171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-5-100,CA209038-5-100,100,CA209038,5,1,64,1,2,USA,NIV3-PROG,14-May-13,23-Jul-13,6-Aug-13,23-Jul-13,31-Aug-15,29-Jul-15,29-Aug-13,6-Aug-13,2-Jul-13,PD,PD,20,0,0,0,NA,NA,1,831,118.7142857,840,120,PROGRESSION,2-Jul-13,20,NA,NA,2-Jul-13,50,7.142857143,1,20,2,NA,31-Oct-13,NA,PD,SDPD,1,1,Pt100,5-100,CA209038-5-100,64,MALE,14-May-13,23-Jul-13,NIV3-PROG,30-Apr-13,23-Jul-13,NA,6-Aug-13,PROGRESSION,2-Jul-13,PD,NA,21-Jul-11,-663,M1C WITHOUT BRAIN METASTASES,M1C,Pt100,CA209038-5-100,CA209038,United States of America,5,100,OTHER: SOFT TISSUE,OTHER,74,NIVO 3 mg/kg Q2W,on,NA,28-Feb-14,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO DEFINITIVE TUMOR,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0.109543014,0,0,0.09120448,0,0,0,0,0.762174125,0,0,0,0,0,0,0,0,0,0,0,0.890456986,NA,NA,NA,NA,NA,NA,NAPt100_pre,Pt100,Pt100_pre,pre,6,0.77815125,6,0.84509804,1,1,0,0,0,NIV3-PROG,4,TripleWt,5,0.833333333,0.4,2,NA,2,0.00537093,23,300,Pt100_pre,0,0,0.07226792,0.217391304,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-5-100,CA209038-5-100,100,CA209038,5,1,64,1,2,USA,NIV3-PROG,14-May-13,23-Jul-13,6-Aug-13,23-Jul-13,31-Aug-15,29-Jul-15,29-Aug-13,6-Aug-13,2-Jul-13,PD,PD,20,0,0,0,NA,NA,1,831,118.7142857,840,120,PROGRESSION,2-Jul-13,20,NA,NA,2-Jul-13,50,7.142857143,1,20,2,NA,31-Oct-13,NA,PD,SDPD,1,1,Pt100,5-100,CA209038-5-100,64,MALE,14-May-13,23-Jul-13,NIV3-PROG,30-Apr-13,23-Jul-13,NA,6-Aug-13,PROGRESSION,2-Jul-13,PD,NA,21-Jul-11,-663,M1C WITHOUT BRAIN METASTASES,M1C,Pt100,CA209038-5-100,CA209038,United States of America,5,100,OTHER: SOFT TISSUE,OTHER,73,PRE-TREATMENT,pre,NA,12-Aug-13,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO DEFINITIVE TUMOR,HIGH MELANIN CONTENT,NA,NA,NA,NA,0,0,0.087929152,0,0,0.149848386,0,0.442313146,0,0,0,0,0,0,0,0,0,0,0.075189901,0,0.244719394,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NAPt101_on,Pt101,Pt101_on,on,4,0.602059991,2,0.477121255,1,1,1,1,1,NIV3-PROG,4,TripleWt,2,0.5,0.4,2,NA,2,-0.001361456,25,300,Pt101_on,0,0,0.052255562,0.19047619,519.3077854,3921.990414,4441.298199,0.308749548,0.117420161,0.105648471,0,0.14192166,0,0.057221555,0.117263812,0.13514111,0,0,0.005781985,0,0.056251535,0.060257199,0.066013397,0.113027359,0.001882995,0.019024545,0.003144216,0,0,0,0.451548137,0.223068632,0.005781985,0.239297955,0.003144216,0.077159075,Pt101_on_S0106605,0,0.599729427,0.003979141,0.003222207,246033,163772,null,16.8376141,0.02792597,2666.56006,0,410240,303829,203348,null,17.1470757,0.027590258,0.809774577,"Melanoma, Biopsy, Tissue",0.599729427,Pt101_on,on,0.6,153937,0.031,94,0.9696,0.8403,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-3-101,CA209038-3-101,101,CA209038,3,2,47,1,2,USA,NIV3-PROG,21-May-13,5-May-15,19-May-15,5-May-15,NA,1-Sep-15,28-May-15,22-Jan-15,22-Jan-15,PR,PRCR,-33.33333333,NA,0,1,169,24.14285714,0,444,63.42857143,834,119.1428571,PARTIAL RESPONSE,14-May-15,-40,7-Aug-14,444,22-Jan-15,612,87.42857143,1,-40,1,V600E,13-Aug-15,NA,PRCRSD,PRCR,0,1,Pt101,3-101,CA209038-3-101,47,FEMALE,21-May-13,5-May-15,NIV3-PROG,7-May-13,5-May-15,NA,22-Jan-15,PARTIAL RESPONSE,22-Jan-15,PR,NA,1-Dec-10,-902,M1A,M1A,Pt101,CA209038-3-101,CA209038,United States of America,3,101,CUTANEOUS,CUTANEOUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.183384892,0,0,0,0,0,0,0,0,0,0.062360372,0,0,0,0,0,0,0,0,0.541295409,0,0,0.212959327,0,0,0,0,0,0,0,0.754254736,1663,1848,1753.061322,Pt101_on,101,NA,NAPt101_pre,Pt101,Pt101_pre,pre,10,1,6,0.84509804,1,1,1,1,1,NIV3-PROG,4,TripleWt,5,0.5,0.5,2,0.3,1.966723364,0.007219238,39,300,Pt101_pre,10,0.128686832,0.127062947,0.327272727,174.3902863,3948.979542,4123.369828,0.352785429,0.12957607,0.089481844,0,0.092495567,0,0.158757695,0.122156063,0.0956061,0,0,0.021621977,0,0,0.068849737,0.070464937,0.072153247,0.015779419,0.010454935,0,0,0,0.052602411,0.469015425,0.219057914,0.021621977,0.211467921,0,0.078836765,Pt101_pre_S0101369,0,0.467731084,0.00291846,0.002350009,191882,131135,null,16.4991016,0.029504176,2666.56006,0,410240,238297,163769,null,16.8135624,0.029313039,0.805222055,"Melanoma, Biopsy, Tissue",0.467731084,Pt101_pre,pre,0.468,123404,0.032,80,0.9705,0.8447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-3-101,CA209038-3-101,101,CA209038,3,2,47,1,2,USA,NIV3-PROG,21-May-13,5-May-15,19-May-15,5-May-15,NA,1-Sep-15,28-May-15,22-Jan-15,22-Jan-15,PR,PRCR,-33.33333333,NA,0,1,169,24.14285714,0,444,63.42857143,834,119.1428571,PARTIAL RESPONSE,14-May-15,-40,7-Aug-14,444,22-Jan-15,612,87.42857143,1,-40,1,V600E,13-Aug-15,NA,PRCRSD,PRCR,0,1,Pt101,3-101,CA209038-3-101,47,FEMALE,21-May-13,5-May-15,NIV3-PROG,7-May-13,5-May-15,NA,22-Jan-15,PARTIAL RESPONSE,22-Jan-15,PR,NA,1-Dec-10,-902,M1A,M1A,Pt101,CA209038-3-101,CA209038,United States of America,3,101,CUTANEOUS,CUTANEOUS,47,PRE-TREATMENT,pre,NA,12-Aug-13,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO DEFINITIVE TUMOR,NA,NA,NA,NA,NA,0,0,0.730085847,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.109650639,0.160263515,0,0,0,0,0,0,0,1,1665,1164,1392.142234,NA,NA,NA,NAPt102_on,Pt102,Pt102_on,on,402,2.604226053,781,2.893206753,1,1,0,0,0,NIV3-NAIVE,2,RAS,254,0.631840796,0.8,2,0.781061708,1.929756326,0.040129448,64,300,Pt102_on,18,0.22658873,0.373383591,0.897196262,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt102_on,0.966539391,56,5,0.894736842,0.903047091,0.908587258,0.63434903,0.8033241,0.847645429,361,0.698970004,2.330096995,2.351738762,2.366166609,1.651988271,2.09203755,2.20746031,CA209038-6-102,CA209038-6-102,102,CA209038,6,2,62,1,2,USA,NIV3-NAIVE,16-May-13,17-Oct-13,31-Oct-13,17-Oct-13,NA,10-Feb-15,25-Nov-13,29-Oct-13,4-Sep-13,SD,SD,-2.97029703,NA,0,1,NA,NA,1,931,133,636,90.85714286,STABLE DISEASE,29-Oct-13,-2.97029703,NA,NA,4-Sep-13,112,16,1,-2.97029703,2,NA,25-Jan-14,NA,PRCRSD,SDPD,0,1,Pt102,6-102,CA209038-6-102,62,FEMALE,16-May-13,17-Oct-13,NIV3-NAIVE,7-May-13,17-Oct-13,NA,29-Oct-13,STABLE DISEASE,4-Sep-13,SD,NA,NA,NA,NA,NA,Pt102,CA209038-6-102,CA209038,United States of America,6,102,CUTANEOUS,CUTANEOUS,92,NIVO 3 mg/kg Q2W,on,NA,28-Feb-14,2,2,0,EVALUABLE,4,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0.115109645,0,0,0.624604646,0,0,0,0,0,0,0,0,0,0,0.084847936,0,0.126425433,0,0,0,0,0,0,0,0,0,0,0.375395354,NA,NA,NA,NA,NA,NA,NAPt102_pre,Pt102,Pt102_pre,pre,393,2.59439255,770,2.887054378,1,1,0,0,0,NIV3-NAIVE,2,RAS,248,0.631043257,0.9,2,0.882951382,1.953310863,0.030047751,75,300,Pt102_pre,30,0.250051632,0.424528302,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt102_pre,0.969801766,64,2,0.898351648,0.906593407,0.909340659,0.67032967,0.82967033,0.868131868,364,0.301029996,2.330676823,2.352059181,2.359186631,1.739098302,2.152490523,2.252274851,CA209038-6-102,CA209038-6-102,102,CA209038,6,2,62,1,2,USA,NIV3-NAIVE,16-May-13,17-Oct-13,31-Oct-13,17-Oct-13,NA,10-Feb-15,25-Nov-13,29-Oct-13,4-Sep-13,SD,SD,-2.97029703,NA,0,1,NA,NA,1,931,133,636,90.85714286,STABLE DISEASE,29-Oct-13,-2.97029703,NA,NA,4-Sep-13,112,16,1,-2.97029703,2,NA,25-Jan-14,NA,PRCRSD,SDPD,0,1,Pt102,6-102,CA209038-6-102,62,FEMALE,16-May-13,17-Oct-13,NIV3-NAIVE,7-May-13,17-Oct-13,NA,29-Oct-13,STABLE DISEASE,4-Sep-13,SD,NA,NA,NA,NA,NA,Pt102,CA209038-6-102,CA209038,United States of America,6,102,CUTANEOUS,CUTANEOUS,91,PRE-TREATMENT,pre,NA,13-Mar-14,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0.159247851,0,0,0.61715274,0,0,0,0,0,0,0,0,0,0,0,0,0.116716183,0,0,0,0,0,0,0,0,0,0,0.38284726,NA,NA,NA,NA,NA,NA,NAPt103_on,Pt103,Pt103_on,on,43,1.633468456,20,1.322219295,1,1,1,1,1,NIV3-PROG,4,TripleWt,15,0.348837209,0.8,2.3,0.841378799,2.077180073,-0.04609824,80,300,Pt103_on,15,0.21201441,0.191950464,0.897435897,-51.84891979,284.3449829,232.4960631,0.802624005,0,0.004473396,0,0.029220731,0,0.192074367,0.059990672,0.109302268,0,0,0,0.022723075,0.003785062,0.007003436,0.086130419,0.22374008,0.07901849,0,0.15187614,0,0,0.030661865,0.390588038,0.004473396,0.022723075,0.316873935,0.15187614,0.113465417,Pt103_on_S0101377,0,0.01199298,0.012601626,0.009825674,4920,2966,null,11.0030527,0.04605832,2666.56006,0,410240,6310,3785,null,11.3567677,0.044531923,0.779714739,"Melanoma, Biopsy, Tissue",0.01199298,Pt103_on,on,0.012,2911,0.047,4,0.9208,0.831,Pt103_on,0.44106347,26,2,0.465116279,0.465116279,0.465116279,0.046511628,0.093023256,0.186046512,43,0.301029996,0.75975277,0.75975277,0.75975277,0.075975277,0.151950554,0.303901109,CA209038-7-103,CA209038-7-103,103,CA209038,7,2,52,11,2,USA,NIV3-PROG,28-May-13,9-Jul-13,23-Jul-13,9-Jul-13,NA,23-Sep-14,23-Jul-13,16-Jul-13,16-Jul-13,PD,PD,24.19354839,NA,0,1,NA,NA,1,817,116.7142857,484,69.14285714,PROGRESSION,16-Jul-13,24.19354839,NA,NA,16-Jul-13,50,7.142857143,1,24.19354839,2,NA,17-Oct-13,NA,PD,SDPD,0,1,Pt103,7-103,CA209038-7-103,52,FEMALE,28-May-13,9-Jul-13,NIV3-PROG,7-May-13,9-Jul-13,NA,16-Jul-13,PROGRESSION,16-Jul-13,PD,NA,10-May-13,-18,M1B,M1B,Pt103,CA209038-7-103,CA209038,United States of America,7,103,CUTANEOUS,CUTANEOUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.279775845,0,0.401181553,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.103578077,0,0,0,0,0,0,0,0.720224155,101,81,90.44888059,NA,NA,NA,NAPt103_pre,Pt103,Pt103_pre,pre,21,1.322219295,11,1.079181246,1,1,1,1,1,NIV3-PROG,4,TripleWt,5,0.238095238,0.3,2,0.3,2.108439365,-0.023277931,29,300,Pt103_pre,0,0,0.070063694,0.183673469,1565.815089,3167.902751,4733.717841,0.267651,0,0.049634045,0,0.146167285,0,0.081390106,0.065547595,0.086013423,0,0,0.023164504,0.009335322,0.044555345,0.072473506,0.060273471,0.183579689,0.061852567,0,0.09959409,0,0,0.016419054,0.379118409,0.049634045,0.032499826,0.316326666,0.09959409,0.122826966,Pt103_pre_S0101384,0,0.363418974,0.017224612,0.019087434,149089,28245,null,11.6283512,0.213541105,2666.56006,0,410240,187296,36607,null,11.99821,0.208552569,0.796007389,"Melanoma, Biopsy, Tissue",0.363418974,Pt103_pre,pre,0.363,24513,0.218,21,0.8,0.4101,Pt103_pre,0.456351076,14,1,0.285714286,0.285714286,0.285714286,0,0,0,21,0,0.377776942,0.377776942,0.377776942,0,0,0,CA209038-7-103,CA209038-7-103,103,CA209038,7,2,52,11,2,USA,NIV3-PROG,28-May-13,9-Jul-13,23-Jul-13,9-Jul-13,NA,23-Sep-14,23-Jul-13,16-Jul-13,16-Jul-13,PD,PD,24.19354839,NA,0,1,NA,NA,1,817,116.7142857,484,69.14285714,PROGRESSION,16-Jul-13,24.19354839,NA,NA,16-Jul-13,50,7.142857143,1,24.19354839,2,NA,17-Oct-13,NA,PD,SDPD,0,1,Pt103,7-103,CA209038-7-103,52,FEMALE,28-May-13,9-Jul-13,NIV3-PROG,7-May-13,9-Jul-13,NA,16-Jul-13,PROGRESSION,16-Jul-13,PD,NA,10-May-13,-18,M1B,M1B,Pt103,CA209038-7-103,CA209038,United States of America,7,103,CUTANEOUS,CUTANEOUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0.074996475,0.36086171,0,0.146484434,0,0,0,0,0.238710299,0,0,0,0,0.128584677,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.761289701,1795,685,1108.862029,NA,NA,NA,NAPt104_pre,Pt104,Pt104_pre,pre,5,0.698970004,5,0.77815125,1,0,0,0,0,NIV3-PROG,4,TripleWt,4,0.8,0.4,2,NA,2,-0.001055042,23,300,Pt104_pre,0,0,0.155555556,0.675675676,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-6-104,CA209038-6-104,104,CA209038,6,1,64,1,2,USA,NIV3-PROG,23-May-13,14-May-15,4-Jun-15,14-May-15,NA,18-Aug-15,18-Aug-15,NA,NA,PR,PRCR,-37.07865169,NA,1,1,290,41.42857143,0,453,64.71428571,818,116.8571429,PARTIAL RESPONSE,3-Jun-15,-42.69662921,18-Aug-14,453,3-Jun-15,742,106,1,-42.69662921,2,NA,22-Aug-15,NA,PRCRSD,PRCR,0,0,Pt104,6-104,CA209038-6-104,64,MALE,23-May-13,14-May-15,NIV3-PROG,14-May-13,14-May-15,NA,NA,PARTIAL RESPONSE,NA,PR,NA,NA,NA,NA,NA,Pt104,CA209038-6-104,CA209038,United States of America,6,104,ACRAL,ACRAL,93,PRE-TREATMENT,pre,NA,28-Feb-14,4,0,0,EVALUABLE,4,LYMPHOCYTES ONLY,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.212064067,0,0.2412331,0,0.198886899,0,0,0,0,0,0.111324648,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.199569544,0.477724386,NA,NA,NA,NA,NA,NA,NAPt105_on,Pt105,Pt105_on,on,NA,NA,NA,NA,0,0,0,0,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,228.2529926,2596.228794,2824.481787,0.523716665,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-4-105,CA209038-4-105,105,CA209038,4,1,66,1,2,USA,NIV3-PROG,10-Jun-13,5-Jan-15,22-Jan-15,5-Jan-15,NA,27-Jan-16,9-Feb-15,17-Jan-15,17-Jan-15,PR,PRCR,-79.26829268,NA,0,1,474,67.71428571,0,114,16.28571429,962,137.4285714,PROGRESSION,17-Jan-15,-85.36585366,1-Oct-13,114,17-Jan-15,587,83.85714286,1,-85.36585366,2,NA,15-Apr-15,NA,PRCRSD,PRCR,0,1,Pt105,4-105,CA209038-4-105,66,MALE,10-Jun-13,5-Jan-15,NIV3-PROG,28-May-13,5-Jan-15,NA,17-Jan-15,PROGRESSION,17-Jan-15,PR,NA,1-Mar-13,-101,M1C WITHOUT BRAIN METASTASES,M1C,Pt105,CA209038-4-105,CA209038,United States of America,4,105,CUTANEOUS,CUTANEOUS,62,NIVO 3 mg/kg Q2W,on,NA,28-Feb-14,30,30,20,EVALUABLE,80,LYMPHOCYTES ONLY,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1821,4966,3007.172426,Pt105_on,105,95,75Pt106_on,Pt106,Pt106_on,on,NA,NA,NA,NA,1,0,1,1,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,463.2741706,1249.894498,1713.168669,0.655115767,0.015105605,0,0,0.121271842,0,0.139830401,0.019679121,0.073548199,0.003432477,0,0.017473238,0.028320283,0.048438998,0.149415809,0.092607436,0.174028754,0.018307814,0,0.080044254,0,4.00E-04,0.018048474,0.35776204,0.015105605,0.045793521,0.416051999,0.080444254,0.084795286,Pt106_on_S0101403,0,0.035137968,0.01685744,0.013843788,14415,5698,null,11.0529194,0.114082485,2666.56006,0,410240,17553,7193,null,11.4263744,0.108176909,0.821227141,"Melanoma, Biopsy, Tissue, Tumor",0.035137968,Pt106_on,on,0.035,5162,0.12,6,0.8789,0.7208,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-13-106,CA209038-13-106,106,CA209038,13,1,53,1,2,USA,NIV3-PROG,4-Jun-13,27-Aug-13,2-Sep-13,27-Aug-13,2-Sep-13,2-Sep-13,NA,29-Jul-13,29-Jul-13,PD,PD,27,1,0,0,NA,NA,1,810,115.7142857,91,13,PROGRESSION,26-Aug-13,27,NA,NA,29-Jul-13,56,8,1,27,1,V600E,5-Dec-13,NA,PD,SDPD,1,1,Pt106,13-106,CA209038-13-106,53,MALE,4-Jun-13,27-Aug-13,NIV3-PROG,23-May-13,27-Aug-13,NA,29-Jul-13,PROGRESSION,29-Jul-13,PD,NA,14-Aug-08,-1755,M1C WITHOUT BRAIN METASTASES,M1C,Pt106,CA209038-13-106,CA209038,United States of America,13,106,MUCOSAL,MUCOSAL,42,NIVO 3 mg/kg Q2W,on,NA,28-Feb-14,0,2,0,EVALUABLE,2,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,551,515,532.6959733,NA,NA,NA,NAPt106_pre,Pt106,Pt106_pre,pre,700,2.84509804,273,2.437750563,1,0,1,1,1,NIV3-PROG,1,BRAF,219,0.312857143,0.7,2.1,0.665768119,2.151257662,-0.070871883,50,300,Pt106_pre,9,0.087450186,0.322353715,0.823529412,836.0894254,1372.771253,2208.860679,0.5984572,0.006661756,0,0,0.146474169,0,0.131816584,0.015125614,0.050262536,0.008940279,0,0,0.040344486,0.030573836,0.137540549,0.094637574,0.187472595,0.043297944,0,0.076635855,0,0.017546931,0.012669293,0.352619182,0.006661756,0.040344486,0.419650718,0.094182786,0.086541073,Pt106_pre_S0101363,0,0.035525546,0.046040896,0.037743278,14574,5187,null,10.5825033,0.1424703,2666.56006,0,410240,17778,6591,null,10.9921303,0.133541986,0.819777253,"Melanoma, Biopsy, Tissue, Tumor",0.035525546,Pt106_pre,pre,0.036,4659,0.148,6,0.8667,0.6875,Pt106_pre,0.957890678,49,2,0.989598811,0.989598811,0.991084695,0.812778603,0.968796434,0.982169391,673,0.301029996,2.815505638,2.815505638,2.819733123,2.31243481,2.756320836,2.794368209,CA209038-13-106,CA209038-13-106,106,CA209038,13,1,53,1,2,USA,NIV3-PROG,4-Jun-13,27-Aug-13,2-Sep-13,27-Aug-13,2-Sep-13,2-Sep-13,NA,29-Jul-13,29-Jul-13,PD,PD,27,1,0,0,NA,NA,1,810,115.7142857,91,13,PROGRESSION,26-Aug-13,27,NA,NA,29-Jul-13,56,8,1,27,1,V600E,5-Dec-13,NA,PD,SDPD,1,1,Pt106,13-106,CA209038-13-106,53,MALE,4-Jun-13,27-Aug-13,NIV3-PROG,23-May-13,27-Aug-13,NA,29-Jul-13,PROGRESSION,29-Jul-13,PD,NA,14-Aug-08,-1755,M1C WITHOUT BRAIN METASTASES,M1C,Pt106,CA209038-13-106,CA209038,United States of America,13,106,MUCOSAL,MUCOSAL,41,PRE-TREATMENT,pre,NA,28-Feb-14,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,< 1% + PM TUMOR CELLS,NA,NA,NA,NA,NA,0.12209732,0,0,0,0,0,0.803178204,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.074724476,574,726,645.541633,NA,NA,NA,NAPt108_on,Pt108,Pt108_on,on,NA,NA,NA,NA,1,0,1,0,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt108_on_S0101410,0,0.057765041,0.061979026,0.051905647,14876,6852,null,11.1131516,0.127854168,1673.92004,0,257526,17763,8499,null,11.5368309,0.116160072,0.837471148,"Melanoma, Biopsy, Tissue, Tumor",0.057765041,Pt108_on,on,0.058,6351,0.132,7,0.9183,0.766,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-4-108,CA209038-4-108,108,CA209038,4,2,37,1,2,USA,NIV3-PROG,22-Jul-13,3-Feb-14,2-Apr-14,3-Feb-14,NA,20-Jan-16,NA,NA,21-Jan-15,SD,SD,2.380952381,NA,0,1,NA,NA,1,762,108.8571429,913,130.4285714,STABLE DISEASE,21-Jan-15,2.380952381,NA,NA,21-Jan-15,549,78.42857143,1,2.380952381,2,NA,14-May-14,NA,PRCRSD,SDPD,0,1,Pt108,4-108,CA209038-4-108,37,FEMALE,22-Jul-13,3-Feb-14,NIV3-PROG,28-Jun-13,3-Feb-14,NA,NA,STABLE DISEASE,21-Jan-15,SD,NA,21-Jan-09,-1643,M1B,M1B,Pt108,CA209038-4-108,CA209038,United States of America,4,108,OTHER: ESOPHAGEAL PRIMARY,OTHER,64,NIVO 3 mg/kg Q2W,on,NA,28-Feb-14,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,< 1% + PM TUMOR CELLS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,477,105,223.7967828,NA,NA,NA,NAPt108_pre,Pt108,Pt108_pre,pre,19,1.278753601,26,1.431363764,1,0,1,0,1,NIV3-PROG,4,TripleWt,11,0.578947368,0.5,2.1,0.521786681,2.083765079,-0.031188731,32,300,Pt108_pre,0,0,0.223684211,0.359649123,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt108_pre_S0101409,0,0.093803119,0.059898399,0.050589141,13189,5835,null,10.7518549,0.140574694,913.919983,0,140603,15616,7203,null,11.1545515,0.129528746,0.84458248,"Melanoma, Biopsy, Tissue, Tumor",0.093803119,Pt108_pre,pre,0.094,5466,0.145,6,0.9284,0.7589,Pt108_pre,0.801458411,10,1,0.736842105,0.789473684,0.842105263,0,0.052631579,0.368421053,19,0,0.942239495,1.009542316,1.076845137,0,0.067302821,0.471119748,CA209038-4-108,CA209038-4-108,108,CA209038,4,2,37,1,2,USA,NIV3-PROG,22-Jul-13,3-Feb-14,2-Apr-14,3-Feb-14,NA,20-Jan-16,NA,NA,21-Jan-15,SD,SD,2.380952381,NA,0,1,NA,NA,1,762,108.8571429,913,130.4285714,STABLE DISEASE,21-Jan-15,2.380952381,NA,NA,21-Jan-15,549,78.42857143,1,2.380952381,2,NA,14-May-14,NA,PRCRSD,SDPD,0,1,Pt108,4-108,CA209038-4-108,37,FEMALE,22-Jul-13,3-Feb-14,NIV3-PROG,28-Jun-13,3-Feb-14,NA,NA,STABLE DISEASE,21-Jan-15,SD,NA,21-Jan-09,-1643,M1B,M1B,Pt108,CA209038-4-108,CA209038,United States of America,4,108,OTHER: ESOPHAGEAL PRIMARY,OTHER,63,PRE-TREATMENT,pre,NA,28-Feb-14,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,< 1% + PM TUMOR CELLS,NA,NA,NA,NA,NA,0.349504061,0,0,0,0,0,0,0,0,0,0.185958413,0,0,0.122361848,0,0,0.124248389,0,0,0,0,0.103523607,0,0,0,0,0,0,0,0,0.464537526,NA,NA,NA,NA,NA,NA,NAPt109_on,Pt109,Pt109_on,on,NA,NA,NA,NA,0,0,0,0,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-36.48399564,1439.920906,1403.43691,0.688777092,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-7-109,CA209038-7-109,109,CA209038,7,1,32,1,2,USA,NIV3-PROG,23-Jul-13,3-Sep-13,17-Sep-13,3-Sep-13,28-Dec-13,28-Dec-13,4-Oct-13,10-Sep-13,10-Sep-13,PD,PD,22.76657061,0,0,0,NA,NA,1,761,108.7142857,159,22.71428571,PROGRESSION,10-Sep-13,22.76657061,NA,NA,10-Sep-13,50,7.142857143,1,22.76657061,97,NA,12-Dec-13,NA,PD,SDPD,1,1,Pt109,7-109,CA209038-7-109,32,MALE,23-Jul-13,3-Sep-13,NIV3-PROG,9-Jul-13,3-Sep-13,NA,10-Sep-13,PROGRESSION,10-Sep-13,PD,NA,5-Oct-10,-1022,M1C WITHOUT BRAIN METASTASES,M1C,Pt109,CA209038-7-109,CA209038,United States of America,7,109,OCULAR/UVEAL,OCULAR/UVEAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,400,386,392.9376541,NA,NA,NA,NAPt11_on,Pt11,Pt11_on,on,117,2.068185862,221,2.346352974,1,1,1,1,1,NIV3-NAIVE,1,BRAF,74,0.632478632,0.5,1.8,0.504153486,1.798168386,0.075333117,36,300,Pt11_on,10,0.262294986,0.24822695,0.566371681,497.2758275,2160.438549,2657.714376,0.544411593,0,0,0,0.098125932,0,0.076388208,0.098824973,0.122779551,0,0,0,0.017288776,0.052667645,0,0.084127476,0.203048877,0.059187561,0.032386644,0.101176269,0,0,0.053998088,0.396118664,0,0.017288776,0.287176353,0.101176269,0.198239938,Pt11_on_S0088569,0,0.210676677,0.022215024,0.017639926,86428,21487,null,11.8906336,0.173755303,2666.56006,0,410240,108844,27741,null,12.2837877,0.167749956,0.794053875,"Melanoma, Biopsy, Tissue",0.210676677,Pt11_on,on,0.211,20478,0.176,16,0.8319,0.5794,Pt11_on,0.963344891,19,2,0.924528302,0.924528302,0.933962264,0.603773585,0.764150943,0.820754717,106,0.301029996,1.912096363,1.912096363,1.93160755,1.248715992,1.580406177,1.697473302,CA209038-12-11,CA209038-12-11,11,CA209038,12,2,61,1,2,USA,NIV3-NAIVE,5-Nov-12,17-Dec-12,2-Jan-13,17-Dec-12,19-Feb-15,3-Feb-15,7-Jan-13,2-Jan-13,2-Jan-13,PD,PD,-79.84496124,0,0,0,NA,NA,1,1123,160.4285714,837,119.5714286,PROGRESSION,2-Jan-13,-79.84496124,NA,NA,2-Jan-13,59,8.428571429,1,-79.84496124,1,V600E,27-Mar-13,NA,PD,SDPD,1,1,Pt11,11-Dec,CA209038-12-11,61,FEMALE,5-Nov-12,17-Dec-12,NIV3-NAIVE,29-Oct-12,17-Dec-12,NA,2-Jan-13,PROGRESSION,2-Jan-13,PD,NA,NA,NA,NA,NA,Pt11,CA209038-12-11,CA209038,United States of America,12,11,CUTANEOUS,CUTANEOUS,25,NIVO 3 mg/kg Q2W,on,22.96,7-Jun-13,9,4,3,EVALUABLE,16,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,2236,2257,2213,2373,6.84,1.07,1.82,0.89,12.2,0,1.98,2.8,15.69,12.2,NA,NA,NA,0.382142857,0.317857143,0.046602787,0.038763066,0.075262639,0,0,0,0,0,0.796214824,0,0,0.107702851,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.128522537,932,646,775.9329868,Pt11_on,11,85,85Pt11_pre,Pt11,Pt11_pre,pre,106,2.025305865,187,2.274157849,1,1,1,1,1,NIV3-NAIVE,1,BRAF,67,0.632075472,0.3,2,0.323474036,1.776399777,0.053141056,32,300,Pt11_pre,9,0.262814171,0.153499653,0.397590361,503.629036,2076.679644,2580.30868,0.553907116,0,0,0,0.088609101,0,0.161314871,0.024250213,0.077881232,0,0,0,0.066359096,0.069237223,0.059117938,0.105416139,0.181093537,0.027254086,0,0.093699956,0,0,0.045766609,0.352055417,0,0.066359096,0.345627614,0.093699956,0.142257918,Pt11_pre_S0088541,0,0.219103452,0.029916003,0.024296364,89885,16959,null,10.5750322,0.247316003,2666.56006,0,410240,110675,21730,null,11.0236263,0.234863639,0.812152699,"Melanoma, Biopsy, Tissue",0.219103452,Pt11_pre,pre,0.219,16264,0.25,13,0.7919,0.4481,Pt11_pre,0.910036976,15,1,0.968421053,0.968421053,0.989473684,0,0.642105263,0.873684211,95,0,1.961348839,1.961348839,2.003986856,0,1.300459555,1.769477757,CA209038-12-11,CA209038-12-11,11,CA209038,12,2,61,1,2,USA,NIV3-NAIVE,5-Nov-12,17-Dec-12,2-Jan-13,17-Dec-12,19-Feb-15,3-Feb-15,7-Jan-13,2-Jan-13,2-Jan-13,PD,PD,-79.84496124,0,0,0,NA,NA,1,1123,160.4285714,837,119.5714286,PROGRESSION,2-Jan-13,-79.84496124,NA,NA,2-Jan-13,59,8.428571429,1,-79.84496124,1,V600E,27-Mar-13,NA,PD,SDPD,1,1,Pt11,11-Dec,CA209038-12-11,61,FEMALE,5-Nov-12,17-Dec-12,NIV3-NAIVE,29-Oct-12,17-Dec-12,NA,2-Jan-13,PROGRESSION,2-Jan-13,PD,NA,NA,NA,NA,NA,Pt11,CA209038-12-11,CA209038,United States of America,12,11,CUTANEOUS,CUTANEOUS,24,PRE-TREATMENT,pre,12.73,7-Jun-13,0,1,1,EVALUABLE,2,MACROPHAGES ONLY,YES,MACROPHAGES,1712,1961,1912,1929,1.17,0,0.51,0.05,2.88,0.31,0.62,0.42,0,10,83.33,< 1% + PM TUMOR CELLS,NA,0,0.119047619,0,0.00392773,0.071091697,0,0,0,0,0,0.849197859,0,0,0.079710444,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.079710444,644,564,602.6740413,Pt11_pre,11,65,46Pt13_on,Pt13,Pt13_on,on,174,2.240549248,240,2.382017043,1,1,0,0,1,NIV3-NAIVE,1,BRAF,99,0.568965517,0.4,2.1,0.547115842,1.839735047,0.064678678,46,300,Pt13_on,14,0.337473482,0.269328358,0.59223301,895.6060033,2456.320379,3351.926382,0.45625781,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt13_on,0.945060108,16,4,0.947058824,0.952941176,0.952941176,0.264705882,0.823529412,0.905882353,170,0.602059991,2.121931936,2.135111636,2.135111636,0.593086565,1.845158205,2.029674025,CA209038-12-13,CA209038-12-13,13,CA209038,12,1,67,1,2,USA,NIV3-NAIVE,13-Nov-12,14-Jan-13,29-Jan-13,14-Jan-13,19-Aug-13,25-Jul-13,15-Feb-13,29-Jan-13,13-Jan-13,PD,PD,25,0,0,0,NA,NA,1,1115,159.2857143,280,40,PROGRESSION,13-Jan-13,25,NA,NA,13-Jan-13,62,8.857142857,1,25,1,V600E,24-Apr-13,NA,PD,SDPD,1,1,Pt13,13-Dec,CA209038-12-13,67,MALE,13-Nov-12,14-Jan-13,NIV3-NAIVE,30-Oct-12,14-Jan-13,NA,29-Jan-13,PROGRESSION,13-Jan-13,PD,NA,NA,NA,NA,NA,Pt13,CA209038-12-13,CA209038,United States of America,12,13,CUTANEOUS,CUTANEOUS,28,NIVO 3 mg/kg Q2W,on,29.37,6-Jun-13,10,10,5,EVALUABLE,25,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,1899,2101,1909,2001,31.6,13.06,11.19,14.37,60.29,28.99,32.03,18.39,41,54.47,85.69,NA,NA,0.71016857,0.781402936,0.444671433,0.48927477,0,0,0.164879054,0,0,0,0.830533266,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.169466734,1664,1482,1570.365563,Pt13_on,13,80,75Pt13_pre,Pt13,Pt13_pre,pre,171,2.23299611,235,2.372912003,1,1,0,0,1,NIV3-NAIVE,1,BRAF,102,0.596491228,0.3,2,0.469772529,1.782750723,0.075563899,43,300,Pt13_pre,16,0.388566463,0.235849057,0.692307692,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt13_pre,0.937011042,25,2,0.93373494,0.939759036,0.951807229,0.126506024,0.710843373,0.819277108,166,0.301029996,2.085026489,2.098478272,2.12538184,0.28248746,1.587310487,1.829442595,CA209038-12-13,CA209038-12-13,13,CA209038,12,1,67,1,2,USA,NIV3-NAIVE,13-Nov-12,14-Jan-13,29-Jan-13,14-Jan-13,19-Aug-13,25-Jul-13,15-Feb-13,29-Jan-13,13-Jan-13,PD,PD,25,0,0,0,NA,NA,1,1115,159.2857143,280,40,PROGRESSION,13-Jan-13,25,NA,NA,13-Jan-13,62,8.857142857,1,25,1,V600E,24-Apr-13,NA,PD,SDPD,1,1,Pt13,13-Dec,CA209038-12-13,67,MALE,13-Nov-12,14-Jan-13,NIV3-NAIVE,30-Oct-12,14-Jan-13,NA,29-Jan-13,PROGRESSION,13-Jan-13,PD,NA,NA,NA,NA,NA,Pt13,CA209038-12-13,CA209038,United States of America,12,13,CUTANEOUS,CUTANEOUS,27,PRE-TREATMENT,pre,38.15,7-Jun-13,5,1,1,EVALUABLE,7,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,1595,2184,2102,2020,19.94,6.96,15.98,19.09,53.38,42.77,61.58,21.88,33.96,65.9,99.31,NA,NA,0.31809872,0.872486289,0.182437746,0.500393185,0,0,0,0,0,0,0.817589506,0.146258065,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.182410494,NA,NA,NA,Pt13_pre,13,50,65Pt16_on,Pt16,Pt16_on,on,NA,NA,NA,NA,0,0,0,0,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-673.7754791,-535.6444471,-1209.419926,0.910022337,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-12-16,CA209038-12-16,16,CA209038,12,2,21,1,2,USA,NIV3-PROG,26-Nov-12,26-Nov-12,26-Dec-12,26-Nov-12,9-Jan-13,7-Jan-13,NA,NA,NA,NE,NA,NA,1,0,0,NA,NA,1,1000,142.8571429,45,6.428571429,OTHER: PATIENT CANCELLED APPTS AND WENT TO SEEK TREATMENT SOMEWHERE ELSE.,NA,NA,NA,NA,9-Jan-13,45,6.428571429,1,NA,1,V600E,6-Mar-13,NA,PD,SDPD,1,1,Pt16,16-Dec,CA209038-12-16,21,FEMALE,26-Nov-12,26-Nov-12,NIV3-PROG,16-Nov-12,26-Nov-12,NA,NA,OTHER: PATIENT CANCELLED APPTS AND WENT TO SEEK TREATMENT SOMEWHERE ELSE.,NA,NE,NA,NA,NA,NA,NA,Pt16,CA209038-12-16,CA209038,United States of America,12,16,CUTANEOUS,CUTANEOUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,14,12,12.9614814,Pt16_on,16,95,75Pt17_on,Pt17,Pt17_on,on,24,1.380211242,38,1.591064607,1,1,1,1,1,NIV3-PROG,4,TripleWt,15,0.625,0.9,2.3,0.91110611,2.076931695,-0.04969554,39,300,Pt17_on,9,0.203279349,0.07927203,0.507246377,-1093.521408,-729.5888598,-1823.110267,0.943626568,0,0.057531217,0.034324743,0,0,0.136990993,0.02572878,0,0,0.020542099,0,0.033298358,0.024353279,0.230095636,0.063701891,0.293231441,0,0,0.080201564,0,0,0,0.183261872,0.09185596,0.033298358,0.587028968,0.080201564,0.024353279,Pt17_on_S0089497,0,0.00199883,0.040243901,0.032835823,820,454,null,8.22229385,0.068458818,2666.56006,0,410240,1005,572,null,8.5779295,0.063531667,0.815920398,"Melanoma, Biopsy, Tissue",0.00199883,Pt17_on,on,0.002,438,0.07,1,0,0.8128,Pt17_on,0.144437926,8,2,0.217391304,0.217391304,0.217391304,0.043478261,0.086956522,0.130434783,23,0.301029996,0.300045922,0.300045922,0.300045922,0.060009185,0.120018369,0.180027554,CA209038-8-17,CA209038-8-17,17,CA209038,8,2,48,1,2,SPAIN,NIV3-PROG,26-Nov-12,26-Dec-12,18-Jan-13,26-Dec-12,21-Jan-13,18-Jan-13,NA,18-Jan-13,12-Jan-13,PD,PD,21.68141593,1,0,0,NA,NA,1,1000,142.8571429,57,8.142857143,PROGRESSION,12-Jan-13,21.68141593,NA,NA,12-Jan-13,48,6.857142857,1,21.68141593,2,NA,5-Apr-13,NA,PD,SDPD,1,1,Pt17,17-Aug,CA209038-8-17,48,FEMALE,26-Nov-12,26-Dec-12,NIV3-PROG,20-Nov-12,26-Dec-12,NA,18-Jan-13,PROGRESSION,12-Jan-13,PD,NA,1-Jun-11,-544,M1C WITHOUT BRAIN METASTASES,M1C,Pt17,CA209038-8-17,CA209038,SPAIN,8,17,CUTANEOUS,CUTANEOUS,113,NIVO 3 mg/kg Q2W,on,14.86,7-Jun-13,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,2065,2159,2103,2345,3.39,2.52,1.07,0.42,3.52,4.26,9.3,6.23,71.43,8.7,72,NA,NA,0.404494382,0.06741573,0.169582773,0.028263795,0.173365148,0,0,0,0,0,0,0,0,0,0,0.079414867,0,0,0,0,0.14088302,0,0.405772068,0.104347857,0,0,0,0,0,0,0,0,0,0,0.826634852,21,41,29.3428015,NA,NA,NA,NAPt17_pre,Pt17,Pt17_pre,pre,20,1.301029996,32,1.51851394,1,1,1,1,1,NIV3-PROG,4,TripleWt,13,0.65,0.9,2.2,0.902712432,2.082281626,-0.05260832,40,300,Pt17_pre,10,0.263615815,0.112517136,0.440677966,-704.3102684,-728.4932209,-1432.803489,0.923124166,0,0,0.049901823,0,0,0.147562953,0.026279098,0.028926797,0,0.01232609,0,0.064470585,0.018293573,0.179435109,0.058543565,0.309756842,0,0,0.104503566,0,0,0,0.215094938,0.049901823,0.064470585,0.547735516,0.104503566,0.018293573,Pt17_pre_S0089490,0,0.001757508,0.054091539,0.043673012,721,458,null,8.17346668,0.075316452,2666.56006,0,410240,893,592,null,8.63452053,0.06242853,0.807390817,"Melanoma, Biopsy, Tissue",0.001757508,Pt17_pre,pre,0.002,443,0.077,1,0,0.8375,Pt17_pre,0.313973662,13,2,0.210526316,0.210526316,0.315789474,0,0.052631579,0.105263158,19,0.301029996,0.273901052,0.273901052,0.410851578,0,0.068475263,0.136950526,CA209038-8-17,CA209038-8-17,17,CA209038,8,2,48,1,2,SPAIN,NIV3-PROG,26-Nov-12,26-Dec-12,18-Jan-13,26-Dec-12,21-Jan-13,18-Jan-13,NA,18-Jan-13,12-Jan-13,PD,PD,21.68141593,1,0,0,NA,NA,1,1000,142.8571429,57,8.142857143,PROGRESSION,12-Jan-13,21.68141593,NA,NA,12-Jan-13,48,6.857142857,1,21.68141593,2,NA,5-Apr-13,NA,PD,SDPD,1,1,Pt17,17-Aug,CA209038-8-17,48,FEMALE,26-Nov-12,26-Dec-12,NIV3-PROG,20-Nov-12,26-Dec-12,NA,18-Jan-13,PROGRESSION,12-Jan-13,PD,NA,1-Jun-11,-544,M1C WITHOUT BRAIN METASTASES,M1C,Pt17,CA209038-8-17,CA209038,SPAIN,8,17,CUTANEOUS,CUTANEOUS,112,PRE-TREATMENT,pre,25,7-Jun-13,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,2346,2205,1813,2353,0.77,0.21,0,0.09,0.44,1.53,3.06,9.32,27.78,NA,72.22,NA,NA,0.022532189,0.009656652,0.0084,0.0036,0.348460695,0,0.066638754,0,0,0,0,0,0,0,0,0.080194963,0,0,0,0,0.116580868,0,0.226939591,0,0,0,0,0,0.093682369,0,0.06750274,0,0,0,0.651539305,19,23,20.90454496,NA,NA,NA,NAPt18_on,Pt18,Pt18_on,on,7,0.84509804,15,1.204119983,1,1,1,1,1,NIV3-NAIVE,4,TripleWt,4,0.571428571,0.4,2,NA,2,0.000711234,23,300,Pt18_on,0,0,0.047619048,0.58974359,816.9250734,3841.296664,4658.221737,0.278311984,0.171508374,0.031400548,0,0.146336898,0,0.062359256,0.057800373,0.138446007,0,9.00E-04,0,0.035655924,7.00E-04,0.08497909,0.057412235,0.154513818,0.018266938,0,0.038006302,0,0.00165075,0,0.405842534,0.202908922,0.035655924,0.296905143,0.039657052,0.018966938,Pt18_on_S0089493,0,0.467773693,0.026143147,0.02146937,60819,22892,null,12.3577557,0.146714434,845.119995,0,130018,74059,28222,null,12.6822901,0.142192051,0.821223619,"Melanoma, Biopsy, Tissue",0.467773693,Pt18_on,on,0.468,21994,0.149,18,0.9098,0.724,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-8-18,CA209038-8-18,18,CA209038,8,1,53,1,NA,SPAIN,NIV3-NAIVE,12-Dec-12,24-Aug-15,18-Sep-15,24-Aug-15,NA,19-Nov-15,NA,NA,14-May-14,PR,PRCR,-76.31578947,NA,0,1,463,66.14285714,0,57,8.142857143,1073,153.2857143,NA,19-Nov-15,-76.31578947,6-Feb-13,57,14-May-14,519,74.14285714,1,-76.31578947,1,V600,2-Dec-15,NA,PRCRSD,PRCR,0,1,Pt18,18-Aug,CA209038-8-18,53,MALE,12-Dec-12,24-Aug-15,NIV3-NAIVE,23-Nov-12,24-Aug-15,NA,NA,NA,14-May-14,PR,NA,1-Jun-11,-560,M1A,M1A,Pt18,CA209038-8-18,CA209038,SPAIN,8,18,CUTANEOUS,CUTANEOUS,115,NIVO 3 mg/kg Q2W,on,68.23,7-Jun-13,1,1,1,EVALUABLE,3,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,3017,2716,2527,2701,95.76,92.18,63.84,52.17,87.57,69.49,76.23,60.51,94.91,71.8,96.59,NA,NA,1.523384565,0.862171542,1.351018614,0.764619669,0,0,0.518463873,0,0,0,0,0,0.151411346,0,0,0,0,0.063690129,0.177749433,0,0,0.08868522,0,0,0,0,0,0,0,0,0,0,0,0,1,2710,1647,2112.668928,NA,NA,NA,NAPt18_pre,Pt18,Pt18_pre,pre,217,2.336459734,311,2.494154594,1,1,1,1,1,NIV3-NAIVE,1,BRAF,137,0.631336406,0.3,2.2,0.222829957,2.34759047,-0.054816234,59,300,Pt18_pre,5,0.047692999,0.107526882,0.504950495,190.0161284,2946.209938,3136.226066,0.484199049,0.187772828,0,0,0.11924479,0,0.128942915,0.066142909,0.064309237,0,0,0,0.021801578,0,0.089190597,0.078186512,0.161684749,0.007281279,0,0.021384323,0,0.005820445,0.04823784,0.378639851,0.187772828,0.021801578,0.329061858,0.027204768,0.055519119,Pt18_pre_S0089499,0,0.23712461,0.019099899,0.015544215,97278,43146,null,13.7685089,0.105763234,2666.56006,0,410240,119530,53176,null,14.0537958,0.104767524,0.81383753,"Melanoma, Biopsy, Tissue",0.23712461,Pt18_pre,pre,0.237,41841,0.107,29,0.9147,0.768,Pt18_pre,0.939612218,10,1,1,1,1,0,1,1,212,0,2.336459734,2.336459734,2.336459734,0,2.336459734,2.336459734,CA209038-8-18,CA209038-8-18,18,CA209038,8,1,53,1,NA,SPAIN,NIV3-NAIVE,12-Dec-12,24-Aug-15,18-Sep-15,24-Aug-15,NA,19-Nov-15,NA,NA,14-May-14,PR,PRCR,-76.31578947,NA,0,1,463,66.14285714,0,57,8.142857143,1073,153.2857143,NA,19-Nov-15,-76.31578947,6-Feb-13,57,14-May-14,519,74.14285714,1,-76.31578947,1,V600,2-Dec-15,NA,PRCRSD,PRCR,0,1,Pt18,18-Aug,CA209038-8-18,53,MALE,12-Dec-12,24-Aug-15,NIV3-NAIVE,23-Nov-12,24-Aug-15,NA,NA,NA,14-May-14,PR,NA,1-Jun-11,-560,M1A,M1A,Pt18,CA209038-8-18,CA209038,SPAIN,8,18,CUTANEOUS,CUTANEOUS,114,PRE-TREATMENT,pre,28.24,7-Jun-13,5,8,7,EVALUABLE,20,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,2433,2186,2673,2634,25.2,14.51,6.77,3.16,27.68,21.72,24.91,8.87,53.51,19.59,87.24,NA,NA,1.635851184,0.356257046,0.513810198,0.111898017,0.147442711,0,0,0,0,0,0.702156206,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.093801382,0,0,0,0,0,0,0.150401084,1170,704,907.5681793,NA,NA,NA,NAPt2_on,Pt2,Pt2_on,on,NA,NA,NA,NA,0,0,0,1,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,278.6985527,1971.429141,2250.127693,0.59359324,0.020152984,0,0,0.138490785,0,0.156721051,0.039317747,0.067307472,0.02016198,0,0.005392285,0.007639585,0.072013135,0.178823225,0.108136399,0.155248389,0,0,0,0,0,0.030594963,0.421999035,0.020152984,0.01303187,0.442208013,0,0.102608098,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-1-2,CA209038-1-2,2,CA209038,1,1,75,1,2,USA,NIV3-PROG,23-Oct-12,28-Jan-13,14-Feb-13,28-Jan-13,24-Jul-13,16-Apr-13,26-Feb-13,14-Feb-13,NA,SD,SD,2.068965517,0,1,0,NA,NA,1,1034,147.7142857,275,39.28571429,STABLE DISEASE,14-Feb-13,2.068965517,NA,NA,14-Feb-13,115,16.42857143,1,2.068965517,2,NA,8-May-13,NA,PRCRSD,SDPD,1,0,Pt2,2-Jan,CA209038-1-2,75,MALE,23-Oct-12,28-Jan-13,NIV3-PROG,8-Oct-12,28-Jan-13,NA,14-Feb-13,STABLE DISEASE,NA,SD,NA,15-Oct-12,-8,M1B,M1B,Pt2,CA209038-1-2,CA209038,United States of America,1,2,OTHER: LUNG METASTASIS,OTHER,4,NIVO 3 mg/kg Q2W,on,NA,29-May-13,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,RARE ATYPICAL CELL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,841,835,837.9946301,Pt2_on,2,NA,NAPt2_pre,Pt2,Pt2_pre,pre,NA,NA,NA,NA,0,0,0,1,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,920.2299866,2388.003158,3308.233145,0.461955567,0.009718797,0,0,0.13412184,0,0.12626848,0.051101971,0.040525472,0.031714217,0,0.002074147,0.003656488,0.085062804,0.131390621,0.106448282,0.199200874,0,0,0.047558137,0,0,0.031157871,0.38373198,0.009718797,0.005730635,0.437039777,0.047558137,0.116220675,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-1-2,CA209038-1-2,2,CA209038,1,1,75,1,2,USA,NIV3-PROG,23-Oct-12,28-Jan-13,14-Feb-13,28-Jan-13,24-Jul-13,16-Apr-13,26-Feb-13,14-Feb-13,NA,SD,SD,2.068965517,0,1,0,NA,NA,1,1034,147.7142857,275,39.28571429,STABLE DISEASE,14-Feb-13,2.068965517,NA,NA,14-Feb-13,115,16.42857143,1,2.068965517,2,NA,8-May-13,NA,PRCRSD,SDPD,1,0,Pt2,2-Jan,CA209038-1-2,75,MALE,23-Oct-12,28-Jan-13,NIV3-PROG,8-Oct-12,28-Jan-13,NA,14-Feb-13,STABLE DISEASE,NA,SD,NA,15-Oct-12,-8,M1B,M1B,Pt2,CA209038-1-2,CA209038,United States of America,1,2,OTHER: LUNG METASTASIS,OTHER,3,PRE-TREATMENT,pre,25.46,6-Jun-13,20,15,3,EVALUABLE,38,LYMPHOCYTES AND MACROPHAGES,YES,LYMPHOCYTES,1799,1687,1800,1814,12.62,0.28,8.77,2.96,24,5.73,10.31,6.56,2.2,26.35,94.23,NA,NA,0.042682927,0.451219512,0.010997643,0.116260801,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,785,709,746.0328411,Pt2_pre,2,60,40Pt23_on,Pt23,Pt23_on,on,719,2.85672889,991,2.996511672,1,1,1,1,1,NIV3-NAIVE,1,BRAF,434,0.603616134,0.4,2.3,0.574741982,1.431157232,0.257508935,55,300,Pt23_on,26,0.667456441,0.333333333,0.744186047,-71.33016265,2005.341519,1934.011357,0.630283789,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt23_on_S0088547,0,0.376874512,0.054440558,0.044607323,154609,49475,null,12.9506798,0.169530734,2666.56006,0,410240,188691,62898,null,13.4327917,0.15732874,0.819376653,"Melanoma, Biopsy, Tissue",0.376874512,Pt23_on,on,0.377,43456,0.175,35,0.8558,0.6448,Pt23_on,0.964885443,40,4,0.863965268,0.863965268,0.865412446,0.681620839,0.808972504,0.832127352,691,0.602059991,2.468114541,2.468114541,2.472248737,1.947205943,2.311015124,2.377162247,CA209038-1-23,CA209038-1-23,23,CA209038,1,2,53,1,2,USA,NIV3-NAIVE,3-Jan-13,31-Jan-13,13-Feb-13,31-Jan-13,23-Feb-13,23-Feb-13,NA,13-Feb-13,NA,NE,PD,NA,1,0,0,NA,NA,1,1064,152,52,7.428571429,DEATH PRIOR TO DISEASE ASSESSMENT,NA,NA,NA,NA,23-Feb-13,52,7.428571429,1,NA,1,V600E,11-May-13,NA,PD,SDPD,1,1,Pt23,23-Jan,CA209038-1-23,53,FEMALE,3-Jan-13,31-Jan-13,NIV3-NAIVE,4-Dec-12,31-Jan-13,NA,13-Feb-13,DEATH PRIOR TO DISEASE ASSESSMENT,NA,NE,NA,1-Mar-09,-1404,M1C WITHOUT BRAIN METASTASES,M1C,Pt23,CA209038-1-23,CA209038,United States of America,1,23,CUTANEOUS,CUTANEOUS,6,NIVO 3 mg/kg Q2W,on,15.7,6-Jun-13,1,1,5,EVALUABLE,7,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,1777,2055,2147,2148,19.25,0.79,2.29,2.04,11.27,5.91,6.98,2.28,4.09,61.7,92.13,NA,NA,0.346491228,0.894736842,0.050318471,0.129936306,0,0,0,0,0,0,0.893807983,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.106192017,1479,1821,1641.11517,Pt23_on,23,50,60Pt23_pre,Pt23,Pt23_pre,pre,646,2.810232518,865,2.937517892,1,1,1,1,1,NIV3-NAIVE,1,BRAF,392,0.606811146,0.3,2.1,0.315567413,1.481399155,0.123161715,40,300,Pt23_pre,23,0.681536646,0.176122605,0.595238095,1308.657433,2077.695174,3386.352608,0.451755274,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt23_pre_S0088546,0,0.215303598,0.016125009,0.013312982,68155,19120,null,12.1729784,0.1441219,2057.6001,0,316553,82551,23900,null,12.5498219,0.137156382,0.825610835,"Melanoma, Biopsy, Tissue",0.215303598,Pt23_pre,pre,0.215,18053,0.146,16,0.832,0.623,Pt23_pre,0.967815186,41,2,0.967689822,0.969305331,0.972536349,0.747980614,0.867528271,0.901453958,619,0.301029996,2.719433405,2.723973361,2.733053273,2.101999444,2.437956157,2.533295226,CA209038-1-23,CA209038-1-23,23,CA209038,1,2,53,1,2,USA,NIV3-NAIVE,3-Jan-13,31-Jan-13,13-Feb-13,31-Jan-13,23-Feb-13,23-Feb-13,NA,13-Feb-13,NA,NE,PD,NA,1,0,0,NA,NA,1,1064,152,52,7.428571429,DEATH PRIOR TO DISEASE ASSESSMENT,NA,NA,NA,NA,23-Feb-13,52,7.428571429,1,NA,1,V600E,11-May-13,NA,PD,SDPD,1,1,Pt23,23-Jan,CA209038-1-23,53,FEMALE,3-Jan-13,31-Jan-13,NIV3-NAIVE,4-Dec-12,31-Jan-13,NA,13-Feb-13,DEATH PRIOR TO DISEASE ASSESSMENT,NA,NE,NA,1-Mar-09,-1404,M1C WITHOUT BRAIN METASTASES,M1C,Pt23,CA209038-1-23,CA209038,United States of America,1,23,CUTANEOUS,CUTANEOUS,5,PRE-TREATMENT,pre,20.06,6-Jun-13,23,30,7,EVALUABLE,60,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,1636,1624,1594,1605,12.96,1.1,4.19,3.08,21.27,10.97,11.46,4.77,8.49,41.18,84.66,NA,NA,0.230607966,0.645702306,0.054835494,0.153539382,0,0,0,0,0,0,0.893881277,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.106118723,827,688,754.3049781,Pt23_pre,23,50,10Pt24_pre,Pt24,Pt24_pre,pre,1,0,1,0.301029996,1,0,0,1,0,NIV3-NAIVE,4,TripleWt,1,1,0.5,2,NA,2,-0.003455294,29,300,Pt24_pre,0,0,0.042168675,0.042168675,1891.60665,3141.081601,5032.688252,0.225122604,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-10-24,CA209038-10-24,24,CA209038,10,1,63,1,2,USA,NIV3-NAIVE,28-Dec-12,22-Mar-13,5-Apr-13,22-Mar-13,NA,25-May-13,NA,15-Feb-13,15-Feb-13,PD,PD,3.773584906,NA,0,1,NA,NA,1,1070,152.8571429,149,21.28571429,PROGRESSION,26-Mar-13,3.773584906,NA,NA,15-Feb-13,50,7.142857143,1,3.773584906,1,V600E,30-Jun-13,NA,PD,SDPD,0,1,Pt24,24-Oct,CA209038-10-24,63,MALE,28-Dec-12,22-Mar-13,NIV3-NAIVE,18-Dec-12,22-Mar-13,NA,15-Feb-13,PROGRESSION,15-Feb-13,PD,NA,7-Oct-10,-813,M1C WITH BRAIN METASTASES,M1C,Pt24,CA209038-10-24,CA209038,United States of America,10,24,OTHER: NODULAR,OTHER,17,PRE-TREATMENT,pre,NA,28-Aug-13,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0.099324087,0,0,0,0,0,0.498181771,0,0,0,0,0,0,0,0,0,0,0,0,0.38506199,0,0,0,1,753,238,423.3367454,Pt24_pre,24,NA,NAPt25_pre,Pt25,Pt25_pre,pre,96,1.982271233,156,2.195899652,1,0,0,0,0,NIV3-NAIVE,2,RAS,62,0.645833333,0.7,1.7,0.698365539,1.656355847,0.184415746,46,300,Pt25_pre,19,0.402081965,0.351948052,0.739130435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt25_pre,0.969995395,10,3,0.817204301,0.817204301,0.827956989,0.64516129,0.774193548,0.774193548,93,0.477121255,1.619920577,1.619920577,1.641235321,1.278884666,1.534661599,1.534661599,CA209038-8-25,CA209038-8-25,25,CA209038,8,1,42,1,1,SPAIN,NIV3-NAIVE,8-Jan-13,8-Jan-13,31-Jan-13,8-Jan-13,18-Apr-13,31-Jan-13,NA,31-Jan-13,31-Jan-13,PD,PD,40.20100503,1,0,0,NA,NA,1,1059,151.2857143,101,14.42857143,PROGRESSION,31-Jan-13,40.20100503,NA,NA,31-Jan-13,24,3.428571429,1,40.20100503,2,NA,18-Apr-13,NA,PD,SDPD,1,1,Pt25,25-Aug,CA209038-8-25,42,MALE,8-Jan-13,8-Jan-13,NIV3-NAIVE,26-Dec-12,8-Jan-13,NA,31-Jan-13,PROGRESSION,31-Jan-13,PD,NA,20-Jul-12,-172,M1C WITH BRAIN METASTASES,M1C,Pt25,CA209038-8-25,CA209038,SPAIN,8,25,CUTANEOUS,CUTANEOUS,116,PRE-TREATMENT,pre,19.14,28-Aug-13,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,2101,2077,2247,2173,8.28,1.48,3.71,0.82,7.21,6.81,3.5,6.5,17.82,6.49,38.51,< 1% + PM TUMOR CELLS,NA,0.227692308,0.126153846,0.077324974,0.042842215,0,0,0,0,0.145392137,0,0.598535718,0,0,0,0.117075925,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.13899622,NA,NA,NA,NA,NA,NA,NAPt26_on,Pt26,Pt26_on,on,120,2.079181246,272,2.436162647,1,1,1,1,1,NIV3-PROG,2,RAS,84,0.7,0.9,2,0.892525294,1.915356515,0.055551151,32,300,Pt26_on,8,0.161157918,0.430093769,0.956521739,-909.8725072,-332.1061214,-1241.978629,0.911993215,0.153001175,0,0,0.036215148,0,0.127887703,0.045959092,0.11822,0,0,0,0.044383762,0.01009896,0.111083161,0.074400681,0.213650705,0,0,0.018376059,0,0,0.046723554,0.328281943,0.153001175,0.044383762,0.399134547,0.018376059,0.056822514,Pt26_on_S0088548,0,0.019015698,0.067299061,0.056793597,7801,3074,null,9.7726078,0.156508639,2666.56006,0,410240,9244,3759,null,10.1651735,0.144067034,0.843898745,"Melanoma, Biopsy, Tissue",0.019015698,Pt26_on,on,0.019,2990,0.159,4,0.9183,0.7391,Pt26_on,0.97534986,9,3,0.86440678,0.872881356,0.881355932,0.779661017,0.838983051,0.838983051,118,0.477121255,1.797258366,1.814878545,1.832498725,1.621056565,1.744397825,1.744397825,CA209038-12-26,CA209038-12-26,26,CA209038,12,2,22,1,2,USA,NIV3-PROG,8-Jan-13,25-Mar-14,1-Apr-14,25-Mar-14,NA,17-Aug-15,18-Nov-13,31-Mar-14,28-Oct-13,SD,SD,2.564102564,NA,0,1,NA,NA,1,957,136.7142857,952,136,PROGRESSION,28-Oct-13,2.564102564,NA,NA,28-Oct-13,294,42,1,2.564102564,2,NA,3-Jul-14,NA,PRCRSD,SDPD,0,1,Pt26,26-Dec,CA209038-12-26,22,FEMALE,8-Jan-13,25-Mar-14,NIV3-PROG,27-Dec-12,25-Mar-14,NA,31-Mar-14,PROGRESSION,28-Oct-13,SD,NA,27-Dec-12,-12,M1B,M1B,Pt26,CA209038-12-26,CA209038,United States of America,12,26,MUCOSAL,MUCOSAL,32,NIVO 3 mg/kg Q2W,on,9.09,6-Jun-13,0,1,3,EVALUABLE,4,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,2940,2364,2641,2702,0.78,0.24,0.21,0,1.67,1.04,0.93,0.19,30.43,0,50,NA,NA,1.263157895,0,0.02640264,0,0.086511057,0,0,0,0.072930847,0,0.715009884,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.088328604,0.125548212,48,28,36.66060556,Pt26_on,26,98,65Pt26_pre,Pt26,Pt26_pre,pre,125,2.096910013,271,2.434568904,1,1,1,1,1,NIV3-PROG,2,RAS,86,0.688,0.9,2,0.89879727,1.952688568,0.031004928,32,300,Pt26_pre,8,0.161106931,0.439306358,0.929577465,-812.5515799,-57.41229262,-869.9638726,0.888244649,0.131872792,0,0,0.080962521,0,0.048375441,0.058765433,0.109111648,0,0,0,0.05187425,0.041102076,0.090775013,0.072853682,0.241216296,0,0,0.073090847,0,0,0,0.297215043,0.131872792,0.05187425,0.404844991,0.073090847,0.041102076,Pt26_pre_S0088564,0,0.034596821,0.073346019,0.06298022,14193,5025,null,9.75683975,0.206432432,2666.56006,0,410240,16529,6127,null,10.2227745,0.187441155,0.858672636,"Melanoma, Biopsy, Tissue",0.034596821,Pt26_pre,pre,0.035,4863,0.21,5,0.9252,0.7082,Pt26_pre,0.986872715,15,3,0.821138211,0.837398374,0.837398374,0.756097561,0.780487805,0.804878049,123,0.477121255,1.721852937,1.755949035,1.755949035,1.585468546,1.636612693,1.68775684,CA209038-12-26,CA209038-12-26,26,CA209038,12,2,22,1,2,USA,NIV3-PROG,8-Jan-13,25-Mar-14,1-Apr-14,25-Mar-14,NA,17-Aug-15,18-Nov-13,31-Mar-14,28-Oct-13,SD,SD,2.564102564,NA,0,1,NA,NA,1,957,136.7142857,952,136,PROGRESSION,28-Oct-13,2.564102564,NA,NA,28-Oct-13,294,42,1,2.564102564,2,NA,3-Jul-14,NA,PRCRSD,SDPD,0,1,Pt26,26-Dec,CA209038-12-26,22,FEMALE,8-Jan-13,25-Mar-14,NIV3-PROG,27-Dec-12,25-Mar-14,NA,31-Mar-14,PROGRESSION,28-Oct-13,SD,NA,27-Dec-12,-12,M1B,M1B,Pt26,CA209038-12-26,CA209038,United States of America,12,26,MUCOSAL,MUCOSAL,31,PRE-TREATMENT,pre,6.88,7-Jun-13,0,2,2,EVALUABLE,4,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,3010,2913,3296,3318,1.26,0.03,0.89,1.24,9.71,2.2,3.47,1.03,2.63,30.77,78.08,NA,NA,0.029126214,1.203883495,0.004360465,0.180232558,0.12407432,0,0,0,0,0,0.68345681,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.115146219,0.19246887,99,38,61.3351449,Pt26_pre,26,95,78Pt27_on,Pt27,Pt27_on,on,186,2.269512944,325,2.5132176,1,1,1,1,1,NIV3-NAIVE,1,BRAF,122,0.655913978,0.4,2.1,0.563028375,1.61706292,0.164564538,65,300,Pt27_on,27,0.422658308,0.266727163,0.597826087,348.4473512,1656.008712,2004.456063,0.622222261,0,0,0,0.030969966,0,0.197507864,0.005239958,0.02809466,0,0,0.095020153,0,0.10056751,0.098495678,0.040460165,0.272676657,0,0,0.048796128,0,0.015453019,0.066718242,0.261812448,0,0.095020153,0.4116325,0.064249147,0.167285752,Pt27_on_S0088550,0,0.078736837,0.066592366,0.05479138,32301,13093,null,11.8578491,0.13297683,2666.56006,0,410240,39258,16400,null,12.2921991,0.122074053,0.822787712,"Melanoma, Biopsy, Tissue",0.078736837,Pt27_on,on,0.079,12700,0.135,16,0.9103,0.7458,Pt27_on,0.90521665,58,5,0.766666667,0.805555556,0.827777778,0.338888889,0.527777778,0.622222222,180,0.698970004,1.739959925,1.828218762,1.878652382,0.76911272,1.197798499,1.412141387,CA209038-10-27,CA209038-10-27,27,CA209038,10,1,65,1,2,USA,NIV3-NAIVE,9-Jan-13,20-Feb-13,11-Mar-13,20-Feb-13,28-Apr-14,31-Mar-14,20-Mar-13,27-Feb-13,27-Feb-13,PD,PD,17.91044776,0,0,0,NA,NA,1,1058,151.1428571,475,67.85714286,PROGRESSION,27-Feb-13,17.91044776,NA,NA,27-Feb-13,50,7.142857143,1,17.91044776,1,V600E,31-May-13,NA,PD,SDPD,1,1,Pt27,27-Oct,CA209038-10-27,65,MALE,9-Jan-13,20-Feb-13,NIV3-NAIVE,17-Dec-12,20-Feb-13,NA,27-Feb-13,PROGRESSION,27-Feb-13,PD,NA,14-Nov-12,-56,M1C WITHOUT BRAIN METASTASES,M1C,Pt27,CA209038-10-27,CA209038,United States of America,10,27,CUTANEOUS,CUTANEOUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0.753718345,0,0,0,0,0,0,0,0,0,0,0,0,0.093511339,0,0,0,0,0,0,0,0,0,0,0.246281655,387,284,331.5237548,Pt27_on,27,NA,NAPt27_pre,Pt27,Pt27_pre,pre,183,2.26245109,321,2.507855872,1,1,1,1,1,NIV3-NAIVE,1,BRAF,119,0.650273224,0.5,2.2,0.623580976,1.654227977,0.164574575,67,300,Pt27_pre,27,0.419557974,0.304597701,0.75,-304.4525877,1633.173338,1328.72075,0.696686627,0.062103871,0,0,0.106227261,0,0.130107982,0.02945294,0.017754255,0,0,0.035089109,0,0.106322828,0.148498561,0.025564271,0.185854626,0,0,0.058285905,0,0.029061154,0.065677237,0.283542438,0.062103871,0.035089109,0.359917458,0.087347059,0.172000065,Pt27_pre_S0088551,0,0.046765308,0.058639564,0.048159245,19185,9347,null,11.6695957,0.115288749,2666.56006,0,410240,23360,11726,null,12.1029482,0.104640909,0.821275685,"Melanoma, Biopsy, Tissue",0.046765308,Pt27_pre,pre,0.047,9087,0.117,13,0.9475,0.7889,Pt27_pre,0.940336488,46,4,0.813559322,0.824858757,0.824858757,0.406779661,0.621468927,0.694915254,177,0.602059991,1.840638175,1.866202594,1.866202594,0.920319087,1.406043051,1.572211774,CA209038-10-27,CA209038-10-27,27,CA209038,10,1,65,1,2,USA,NIV3-NAIVE,9-Jan-13,20-Feb-13,11-Mar-13,20-Feb-13,28-Apr-14,31-Mar-14,20-Mar-13,27-Feb-13,27-Feb-13,PD,PD,17.91044776,0,0,0,NA,NA,1,1058,151.1428571,475,67.85714286,PROGRESSION,27-Feb-13,17.91044776,NA,NA,27-Feb-13,50,7.142857143,1,17.91044776,1,V600E,31-May-13,NA,PD,SDPD,1,1,Pt27,27-Oct,CA209038-10-27,65,MALE,9-Jan-13,20-Feb-13,NIV3-NAIVE,17-Dec-12,20-Feb-13,NA,27-Feb-13,PROGRESSION,27-Feb-13,PD,NA,14-Nov-12,-56,M1C WITHOUT BRAIN METASTASES,M1C,Pt27,CA209038-10-27,CA209038,United States of America,10,27,CUTANEOUS,CUTANEOUS,18,PRE-TREATMENT,pre,NA,28-Aug-13,0,0,0,EVALUABLE,0,LYMPHOCYTES AND MACROPHAGES,YES,LYMPHOCYTES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,< 1% + PM TUMOR CELLS,NA,NA,NA,NA,NA,0,0,0,0,0,0,0.770511457,0,0,0,0,0,0,0,0,0,0,0,0,0.116630093,0,0,0,0,0,0,0,0,0,0,0.229488543,350,156,233.6664289,Pt27_pre,27,NA,NAPt28_on,Pt28,Pt28_on,on,53,1.72427587,40,1.612783857,1,1,1,1,1,NIV3-NAIVE,4,TripleWt,26,0.490566038,0.3,2.4,0.375951031,3.095207859,-0.270077091,109,300,Pt28_on,39,0.388565098,0.160305344,0.642857143,1125.875073,2611.042484,3736.917556,0.405268924,0,0.004228485,0.023566193,0.153689207,0,0.162220358,0.108875567,0.106972936,0,0,0.023882926,0,0.059711316,0.10058585,0.08270509,0.172915484,0,0,6.00E-04,0,0,0,0.531758068,0.027794678,0.023882926,0.356206424,6.00E-04,0.059711316,Pt28_on_S0088561,0,0.338314158,0.208790258,0.192960262,138790,9520,null,6.52201891,0.506533682,2666.56006,0,410240,150176,11708,null,6.97202778,0.484134614,0.924182293,"Melanoma, Biopsy, Tissue",0.338314158,Pt28_on,on,0.338,8254,0.513,9,0.799,0.0801,Pt28_on,0.675602725,23,2,0.826923077,0.846153846,0.865384615,0,0.019230769,0.076923077,52,0.301029996,1.425843508,1.459002659,1.49216181,0,0.033159151,0.132636605,CA209038-12-28,CA209038-12-28,28,CA209038,12,2,79,1,2,USA,NIV3-NAIVE,28-Jan-13,22-Apr-13,6-May-13,22-Apr-13,6-Feb-15,5-Feb-15,17-Jun-13,6-May-13,29-Mar-13,PD,PD,3.225806452,0,0,0,NA,NA,1,1039,148.4285714,740,105.7142857,PROGRESSION,29-Mar-13,3.225806452,NA,NA,29-Mar-13,61,8.714285714,1,3.225806452,2,NA,31-Jul-13,NA,PD,SDPD,1,1,Pt28,28-Dec,CA209038-12-28,79,FEMALE,28-Jan-13,22-Apr-13,NIV3-NAIVE,7-Jan-13,22-Apr-13,NA,6-May-13,PROGRESSION,29-Mar-13,PD,NA,NA,NA,NA,NA,Pt28,CA209038-12-28,CA209038,United States of America,12,28,CUTANEOUS,CUTANEOUS,34,NIVO 3 mg/kg Q2W,on,26.03,6-Jun-13,5,5,15,EVALUABLE,25,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,1774,1719,2042,1711,13.53,7.27,2.21,5.29,36.88,17.48,28.4,9.89,51.67,28.95,99,NA,NA,0.735085945,0.534883721,0.279293123,0.203227046,0.584028142,0,0,0,0,0,0,0,0,0,0,0,0.236802659,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.067135423,0,0,0.415971858,3265,1924,2506.3639,Pt28_on,28,90,85Pt28_pre,Pt28,Pt28_pre,pre,42,1.62324929,26,1.431363764,1,1,1,1,1,NIV3-NAIVE,4,TripleWt,16,0.380952381,0.7,2.1,0.727925538,2.010713423,-0.005614543,143,300,Pt28_pre,40,0.298367394,0.282020263,0.555555556,333.5481659,845.6796343,1179.2278,0.712259601,0.044760807,0,0.053629644,0.129079034,0,0.116114077,0.046056401,0.10637391,0,0,0,0.01246693,0.040910953,0.097914554,0.090708411,0.204520783,0,0,0.024854897,0,0.032426916,2.00E-04,0.397623422,0.098390451,0.01246693,0.393143748,0.057281813,0.041110953,Pt28_pre_S0088571,0,0.076908639,0.105036288,0.094456323,31551,7197,null,9.4408741,0.263190389,2666.56006,0,410240,35085,8629,null,9.89005947,0.24358882,0.899273194,"Melanoma, Biopsy, Tissue",0.076908639,Pt28_pre,pre,0.077,6884,0.267,8,0.8568,0.5424,Pt28_pre,0.80054217,14,3,0.619047619,0.619047619,0.619047619,0,0.166666667,0.333333333,42,0.477121255,1.004868608,1.004868608,1.004868608,0,0.270541549,0.541083096,CA209038-12-28,CA209038-12-28,28,CA209038,12,2,79,1,2,USA,NIV3-NAIVE,28-Jan-13,22-Apr-13,6-May-13,22-Apr-13,6-Feb-15,5-Feb-15,17-Jun-13,6-May-13,29-Mar-13,PD,PD,3.225806452,0,0,0,NA,NA,1,1039,148.4285714,740,105.7142857,PROGRESSION,29-Mar-13,3.225806452,NA,NA,29-Mar-13,61,8.714285714,1,3.225806452,2,NA,31-Jul-13,NA,PD,SDPD,1,1,Pt28,28-Dec,CA209038-12-28,79,FEMALE,28-Jan-13,22-Apr-13,NIV3-NAIVE,7-Jan-13,22-Apr-13,NA,6-May-13,PROGRESSION,29-Mar-13,PD,NA,NA,NA,NA,NA,Pt28,CA209038-12-28,CA209038,United States of America,12,28,CUTANEOUS,CUTANEOUS,33,PRE-TREATMENT,pre,20.37,6-Jun-13,0,1,3,EVALUABLE,4,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,2263,2318,2345,2366,9.59,4.46,3.58,2.24,16.12,10.99,12.81,3.41,42.86,33.73,82.69,NA,NA,1.307917889,0.656891496,0.218949435,0.109965636,0.415978607,0.090293375,0.261983061,0,0,0,0,0,0,0.120609114,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.075619465,0,0,0,0,0.584021393,531,145,277.479729,Pt28_pre,28,90,75Pt29_pre,Pt29,Pt29_pre,pre,412,2.614897216,581,2.764922985,1,0,0,1,0,NIV3-NAIVE,2,RAS,238,0.577669903,0.6,2.1,0.585445098,1.97546553,0.010398522,38,300,Pt29_pre,14,0.164284763,0.278544061,0.592274678,-135.7097707,1262.760474,1127.050703,0.717614628,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt29_pre,0.964623614,29,2,0.965346535,0.967821782,0.97029703,0.821782178,0.935643564,0.948019802,404,0.301029996,2.524281967,2.530754483,2.537227002,2.148875929,2.446611751,2.478974341,CA209038-10-29,CA209038-10-29,29,CA209038,10,2,57,1,2,USA,NIV3-NAIVE,15-Jan-13,26-Feb-13,8-Mar-13,26-Feb-13,14-Oct-13,20-Aug-13,9-Mar-13,5-Mar-13,5-Mar-13,PD,PD,25.92592593,0,0,0,NA,NA,1,1052,150.2857143,273,39,PROGRESSION,5-Mar-13,25.92592593,NA,NA,5-Mar-13,50,7.142857143,1,25.92592593,2,NA,6-Jun-13,NA,PD,SDPD,1,1,Pt29,29-Oct,CA209038-10-29,57,FEMALE,15-Jan-13,26-Feb-13,NIV3-NAIVE,8-Jan-13,26-Feb-13,NA,5-Mar-13,PROGRESSION,5-Mar-13,PD,NA,21-Nov-12,-55,M1C WITH BRAIN METASTASES,M1C,Pt29,CA209038-10-29,CA209038,United States of America,10,29,OTHER: NODULAR,OTHER,19,PRE-TREATMENT,pre,0,28-Aug-13,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,604,722,1000,719,1.16,0.33,0.14,0.42,0.1,1.25,1.67,11.9,0,0,55.56,< 100 VIABLE TUMOR CELLS,NA,0.027731092,0.035294118,NA,NA,0.102168794,0,0,0,0,0,0.773836651,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.08573364,0,0,0,0,0,0,0,0.123994554,294,147,207.8893937,Pt29_pre,29,30,30Pt3_on,Pt3,Pt3_on,on,180,2.255272505,348,2.542825427,1,1,1,1,1,NIV3-NAIVE,2,RAS,118,0.655555556,0.3,1.8,0.356122516,3.601474593,-0.361948635,68,300,Pt3_on,21,0.432475625,0.238470095,0.666666667,198.2443029,1716.011709,1914.256012,0.632532481,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt3_on_S0089498,0,0.064669462,0.014134942,0.011571931,26530,8247,null,11.3286514,0.129211918,2666.56006,0,410240,32406,10306,null,11.6821117,0.123701192,0.818675554,"Melanoma, Biopsy, Tissue",0.064669462,Pt3_on,on,0.065,7936,0.13,9,0.8576,0.6672,Pt3_on,0.985145441,4,1,1,1,1,0.982857143,0.994285714,1,175,0,2.255272505,2.255272505,2.255272505,2.216610691,2.242385233,2.255272505,CA209038-8-3,CA209038-8-3,3,CA209038,8,1,52,1,NA,SPAIN,NIV3-NAIVE,30-Oct-12,5-Jun-14,30-Jun-14,5-Jun-14,NA,17-Dec-15,14-Aug-14,4-Jun-14,4-Jun-14,PR,PRCR,-76.98412698,NA,0,1,408,58.28571429,0,176,25.14285714,1144,163.4285714,PARTIAL RESPONSE,4-Jun-14,-76.98412698,23-Apr-13,176,4-Jun-14,583,83.28571429,1,-76.98412698,2,NA,13-Sep-14,NA,PRCRSD,PRCR,0,1,Pt3,3-Aug,CA209038-8-3,52,MALE,30-Oct-12,5-Jun-14,NIV3-NAIVE,10-Oct-12,5-Jun-14,NA,4-Jun-14,PARTIAL RESPONSE,4-Jun-14,PR,NA,11-Jul-12,-111,UNKNOWN,UNKNOWN,Pt3,CA209038-8-3,CA209038,SPAIN,8,3,CUTANEOUS,CUTANEOUS,118,NIVO 3 mg/kg Q2W,on,28.39,7-Jun-13,0,2,2,EVALUABLE,4,MACROPHAGES ONLY,YES,NA,2551,2643,2676,3188,7.13,3.61,5.15,0.26,5.79,10.54,8.06,3.62,48.35,5.15,71.13,NA,NA,0.997237569,0.071823204,0.12715745,0.009158154,0.083506501,0,0,0,0.158272722,0,0.712304923,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.045915854,453,406,428.8566194,NA,NA,NA,NAPt3_pre,Pt3,Pt3_pre,pre,182,2.260071388,346,2.540329475,1,1,1,1,1,NIV3-NAIVE,2,RAS,119,0.653846154,0.4,1.9,0.515968492,3.618587416,-0.503420033,83,300,Pt3_pre,24,0.435872562,0.313253012,0.904761905,-239.636156,228.2451872,-11.3909688,0.823459214,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt3_pre_S0089487,0,0.01874025,0.101456814,0.083502837,7688,2613,null,9.2270298,0.187152654,2666.56006,0,410240,9341,3321,null,9.68311787,0.172199249,0.823038219,"Melanoma, Biopsy, Tissue",0.01874025,Pt3_pre,pre,0.019,2525,0.191,3,0.8983,0.6958,Pt3_pre,0.965730218,8,2,0.977272727,0.977272727,0.977272727,0.795454545,0.926136364,0.943181818,176,0.301029996,2.208706129,2.208706129,2.208706129,1.797784058,2.093134298,2.131658241,CA209038-8-3,CA209038-8-3,3,CA209038,8,1,52,1,NA,SPAIN,NIV3-NAIVE,30-Oct-12,5-Jun-14,30-Jun-14,5-Jun-14,NA,17-Dec-15,14-Aug-14,4-Jun-14,4-Jun-14,PR,PRCR,-76.98412698,NA,0,1,408,58.28571429,0,176,25.14285714,1144,163.4285714,PARTIAL RESPONSE,4-Jun-14,-76.98412698,23-Apr-13,176,4-Jun-14,583,83.28571429,1,-76.98412698,2,NA,13-Sep-14,NA,PRCRSD,PRCR,0,1,Pt3,3-Aug,CA209038-8-3,52,MALE,30-Oct-12,5-Jun-14,NIV3-NAIVE,10-Oct-12,5-Jun-14,NA,4-Jun-14,PARTIAL RESPONSE,4-Jun-14,PR,NA,11-Jul-12,-111,UNKNOWN,UNKNOWN,Pt3,CA209038-8-3,CA209038,SPAIN,8,3,CUTANEOUS,CUTANEOUS,117,PRE-TREATMENT,pre,12.24,7-Jun-13,0,0,0,EVALUABLE,0,MACROPHAGES ONLY,YES,MACROPHAGES,2014,1960,2100,2051,6.06,0.74,0.77,0.36,4.67,0.88,0.49,0.86,12.3,6.67,27.78,NA,NA,0.860465116,0.418604651,0.060457516,0.029411765,0,0,0,0,0,0,0.695437246,0,0,0.107920013,0,0,0,0,0,0,0,0,0,0,0,0,0.060504867,0,0,0,0,0,0,0,0.304562754,24,55,36.33180425,NA,NA,NA,NAPt30_on,Pt30,Pt30_on,on,10,1,7,0.903089987,1,1,1,1,1,NIV3-NAIVE,4,TripleWt,5,0.5,0.4,2,NA,2,0.008483637,23,300,Pt30_on,0,0,0.069604125,0.094736842,1954.925873,3897.835764,5852.761637,0.10648931,0,0.005570056,0.002118076,0.170717942,0,0.072272781,0.037235676,0.082809637,0.019576299,0.002532697,0,0.050653534,0.014171663,0.147113838,0.061761603,0.232244393,0,0,0.066105211,0,0,0.035116596,0.385145032,0.007688132,0.050653534,0.441119834,0.066105211,0.049288259,Pt30_on_S0088570,0,0.686797972,0.044975724,0.036086321,281752,16356,null,9.12753677,0.347918153,2666.56006,0,410240,351158,20361,null,9.44612122,0.340056032,0.802351078,"Melanoma, Biopsy, Tissue",0.686797972,Pt30_on,on,0.687,13776,0.349,15,0.6486,0.1053,Pt30_on,0.265822254,3,2,0,0,0,0,0,0,10,0.301029996,0,0,0,0,0,0,CA209038-10-30,CA209038-10-30,30,CA209038,10,2,89,1,2,USA,NIV3-NAIVE,14-Jan-13,24-Feb-14,7-Apr-14,24-Feb-14,NA,2-Dec-15,NA,16-Sep-14,8-Sep-14,CR,PRCR,-78.125,NA,0,1,554,79.14285714,0,50,7.142857143,1053,150.4285714,PARTIAL RESPONSE,8-Sep-14,-78.125,4-Mar-13,50,8-Sep-14,603,86.14285714,1,-78.125,2,NA,4-Jun-14,NA,PRCRSD,PRCR,0,1,Pt30,30-Oct,CA209038-10-30,89,FEMALE,14-Jan-13,24-Feb-14,NIV3-NAIVE,24-Dec-12,24-Feb-14,NA,16-Sep-14,PARTIAL RESPONSE,8-Sep-14,CR,NA,25-Sep-12,-111,M1A,M1A,Pt30,CA209038-10-30,CA209038,United States of America,10,30,MUCOSAL,MUCOSAL,21,NIVO 3 mg/kg Q2W,on,NA,8-Aug-13,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO DEFINITIVE TUMOR,NA,NA,NA,NA,NA,0.231347008,0,0,0,0.314785573,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.244345339,0,0,0,0,0.122089449,0.087432631,0,0,0,0,0.453867419,6756,4008,5203.657175,Pt30_on,30,NA,NAPt30_pre,Pt30,Pt30_pre,pre,66,1.819543936,86,1.939519253,1,1,1,1,1,NIV3-NAIVE,4,TripleWt,35,0.53030303,0.9,2.5,0.857613695,2.4844518,-0.272305427,116,300,Pt30_pre,23,0.210977452,0.351505044,0.9375,-1280.244349,-335.9268031,-1616.171152,0.933137892,0.070952759,0,0,0.034988202,0,0.081376073,0.067165234,0.143504336,0.004103157,0,0,0,0.0464063,0.147677341,0.127614191,0.275993197,2.00E-04,0,0,0,0,0,0.331137002,0.070952759,0,0.551284729,0,0.0466063,Pt30_pre_S0088549,0,0.0375,0.045436818,0.037246231,15384,3776,null,9.82463455,0.173194543,2666.56006,0,410240,18767,4701,null,10.1925993,0.164455578,0.819736772,"Melanoma, Biopsy, Tissue",0.0375,Pt30_pre,pre,0.038,3600,0.175,4,0.7897,0.5728,Pt30_pre,0.868274206,19,3,0.830769231,0.846153846,0.846153846,0.153846154,0.353846154,0.538461538,65,0.477121255,1.511621116,1.539614099,1.539614099,0.279929837,0.643838624,0.979754426,CA209038-10-30,CA209038-10-30,30,CA209038,10,2,89,1,2,USA,NIV3-NAIVE,14-Jan-13,24-Feb-14,7-Apr-14,24-Feb-14,NA,2-Dec-15,NA,16-Sep-14,8-Sep-14,CR,PRCR,-78.125,NA,0,1,554,79.14285714,0,50,7.142857143,1053,150.4285714,PARTIAL RESPONSE,8-Sep-14,-78.125,4-Mar-13,50,8-Sep-14,603,86.14285714,1,-78.125,2,NA,4-Jun-14,NA,PRCRSD,PRCR,0,1,Pt30,30-Oct,CA209038-10-30,89,FEMALE,14-Jan-13,24-Feb-14,NIV3-NAIVE,24-Dec-12,24-Feb-14,NA,16-Sep-14,PARTIAL RESPONSE,8-Sep-14,CR,NA,25-Sep-12,-111,M1A,M1A,Pt30,CA209038-10-30,CA209038,United States of America,10,30,MUCOSAL,MUCOSAL,20,PRE-TREATMENT,pre,NA,21-Jun-13,0,1,0,EVALUABLE,1,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.465825115,0,0.313855926,0.065767269,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.075667993,0,0,0,0,0,0,0,0,0,0,0,0.534174885,67,63,64.96922348,NA,NA,NA,NAPt31_on,Pt31,Pt31_on,on,461,2.663700925,860,2.935003151,1,1,1,1,1,NIV3-NAIVE,4,TripleWt,299,0.648590022,0.5,2.1,0.509283031,2.15165761,-0.054665583,32,300,Pt31_on,1,0.004646056,0.240740741,0.515923567,-24.79367959,2488.597054,2463.803374,0.568063871,0.052282834,0,0.014535721,0.11224552,0,0.127314425,0.052067525,0.079943864,0,0,0,0.041263638,0.062319796,0.131487415,0.084206257,0.201768238,0,0,0.018145977,0,0,0.022418792,0.371571334,0.066818555,0.041263638,0.41746191,0.018145977,0.084738588,Pt31_on_S0087103,0,0.300292512,0.013296318,0.010753606,123192,45658,null,13.7350416,0.112642042,2666.56006,0,410240,152321,57090,null,14.0529041,0.110629171,0.808765699,"Melanoma, Biopsy, Tissue",0.300292512,Pt31_on,on,0.3,41280,0.118,31,0.8812,0.702,Pt31_on,0.946290856,10,2,0.946635731,0.946635731,0.948955916,0.361948956,0.909512761,0.928074246,431,0.301029996,2.521554473,2.521554473,2.527734752,0.964123769,2.422669983,2.472112228,CA209038-10-31,CA209038-10-31,31,CA209038,10,2,56,1,2,USA,NIV3-NAIVE,10-Jan-13,21-Mar-13,4-Apr-13,21-Mar-13,NA,28-Aug-15,22-Apr-13,28-Feb-13,28-Feb-13,PD,PD,27.45098039,NA,0,1,NA,NA,1,1057,151,961,137.2857143,PROGRESSION,4-Apr-13,27.45098039,NA,NA,28-Feb-13,50,7.142857143,1,27.45098039,2,NA,29-Jun-13,NA,PD,SDPD,0,1,Pt31,31-Oct,CA209038-10-31,56,FEMALE,10-Jan-13,21-Mar-13,NIV3-NAIVE,17-Dec-12,21-Mar-13,NA,28-Feb-13,PROGRESSION,28-Feb-13,PD,NA,21-May-12,-234,M1A,M1A,Pt31,CA209038-10-31,CA209038,United States of America,10,31,OTHER: NODULAR,OTHER,23,NIVO 3 mg/kg Q2W,on,41.3,18-Jun-13,1,2,2,EVALUABLE,5,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,2871,2980,2841,2964,64.4,53.36,24.16,11.88,55.05,25.13,22.23,24.71,80.31,38.47,77.85,NA,NA,2.159449616,0.480777013,1.292009685,0.287651332,0,0,0,0,0,0.087262362,0.798539369,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.201460631,1121,961,1037.921481,Pt31_on,31,70,97Pt31_pre,Pt31,Pt31_pre,pre,450,2.653212514,870,2.940018155,1,1,1,1,1,NIV3-NAIVE,4,TripleWt,294,0.653333333,0.6,2.1,0.631617674,2.060427165,-0.02727217,28,300,Pt31_pre,1,0.004923163,0.283783784,0.529636711,157.3973147,1463.875341,1621.272655,0.665247384,0.0078455,0.039005484,0.019092591,0.084998554,0,0.202491784,0.103116699,0.071885712,0,0,0,0.011189739,0.075502179,0.038637034,0.071663127,0.209226632,0,0.029683777,0.012792681,0,0,0.022868506,0.462492749,0.065943575,0.011189739,0.319526793,0.012792681,0.128054462,Pt31_pre_S0087101,0,0.139505897,0.020395588,0.016627317,32458,13931,null,12.3923922,0.099783361,1512.31995,0,232664,39814,17432,null,12.7754898,0.093258478,0.81524087,"Melanoma, Biopsy, Tissue",0.139505897,Pt31_pre,pre,0.14,13437,0.102,13,0.913,0.7587,Pt31_pre,0.900689639,47,7,0.956937799,0.956937799,0.956937799,0.004784689,0.504784689,0.83492823,418,0.84509804,2.538959343,2.538959343,2.538959343,0.012694797,1.339301054,2.215242028,CA209038-10-31,CA209038-10-31,31,CA209038,10,2,56,1,2,USA,NIV3-NAIVE,10-Jan-13,21-Mar-13,4-Apr-13,21-Mar-13,NA,28-Aug-15,22-Apr-13,28-Feb-13,28-Feb-13,PD,PD,27.45098039,NA,0,1,NA,NA,1,1057,151,961,137.2857143,PROGRESSION,4-Apr-13,27.45098039,NA,NA,28-Feb-13,50,7.142857143,1,27.45098039,2,NA,29-Jun-13,NA,PD,SDPD,0,1,Pt31,31-Oct,CA209038-10-31,56,FEMALE,10-Jan-13,21-Mar-13,NIV3-NAIVE,17-Dec-12,21-Mar-13,NA,28-Feb-13,PROGRESSION,28-Feb-13,PD,NA,21-May-12,-234,M1A,M1A,Pt31,CA209038-10-31,CA209038,United States of America,10,31,OTHER: NODULAR,OTHER,22,PRE-TREATMENT,pre,NA,18-Jun-13,0,2,2,EVALUABLE,4,MACROPHAGES ONLY,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0.103167239,0.834350289,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.165649711,439,310,368.9037815,Pt31_pre,31,NA,NAPt32_on,Pt32,Pt32_on,on,NA,NA,NA,NA,1,0,0,0,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-8-32,CA209038-8-32,32,CA209038,8,1,34,1,NA,SPAIN,NIV3-PROG,15-Jan-13,24-Apr-13,8-May-13,24-Apr-13,NA,8-May-13,NA,8-May-13,12-Mar-13,PD,PD,14.73214286,NA,0,1,NA,NA,1,950,135.7142857,114,16.28571429,PROGRESSION,8-May-13,14.73214286,NA,NA,12-Mar-13,57,8.142857143,1,14.73214286,1,V600E,2-Aug-13,NA,PD,SDPD,0,1,Pt32,Aug-32,CA209038-8-32,34,MALE,15-Jan-13,24-Apr-13,NIV3-PROG,10-Jan-13,24-Apr-13,NA,8-May-13,PROGRESSION,12-Mar-13,PD,NA,1-Dec-12,-45,M1C WITHOUT BRAIN METASTASES,M1C,Pt32,CA209038-8-32,CA209038,SPAIN,8,32,CUTANEOUS,CUTANEOUS,120,NIVO 3 mg/kg Q2W,on,NA,7-Jun-13,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,< 100 VIABLE TUMOR CELLS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,85,60,71.41428429,NA,NA,NA,NAPt32_pre,Pt32,Pt32_pre,pre,112,2.049218023,185,2.269512944,1,0,0,0,1,NIV3-PROG,1,BRAF,67,0.598214286,0.7,2.3,0.687609088,2.491338133,-0.225181482,98,300,Pt32_pre,9,0.109183645,0.318009937,0.804210526,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt32_pre,0.906508816,14,1,0.981651376,0.981651376,0.990825688,0,0.568807339,0.844036697,109,0,2.011617692,2.011617692,2.030417857,0,1.165610251,1.729615211,CA209038-8-32,CA209038-8-32,32,CA209038,8,1,34,1,NA,SPAIN,NIV3-PROG,15-Jan-13,24-Apr-13,8-May-13,24-Apr-13,NA,8-May-13,NA,8-May-13,12-Mar-13,PD,PD,14.73214286,NA,0,1,NA,NA,1,950,135.7142857,114,16.28571429,PROGRESSION,8-May-13,14.73214286,NA,NA,12-Mar-13,57,8.142857143,1,14.73214286,1,V600E,2-Aug-13,NA,PD,SDPD,0,1,Pt32,Aug-32,CA209038-8-32,34,MALE,15-Jan-13,24-Apr-13,NIV3-PROG,10-Jan-13,24-Apr-13,NA,8-May-13,PROGRESSION,12-Mar-13,PD,NA,1-Dec-12,-45,M1C WITHOUT BRAIN METASTASES,M1C,Pt32,CA209038-8-32,CA209038,SPAIN,8,32,CUTANEOUS,CUTANEOUS,119,PRE-TREATMENT,pre,25.71,7-Jun-13,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,1434,1318,1434,1507,2.3,0.14,0.91,0.46,2.44,1.19,1.39,0.84,6.06,16.67,66.67,< 100 VIABLE TUMOR CELLS,NA,0.166666667,0.547619048,0.005445352,0.017891871,0.065493826,0,0,0,0,0,0.404062429,0.095142054,0,0,0.187823528,0,0,0,0,0,0,0,0,0,0,0,0.103223186,0,0,0,0,0,0,0,0.342620217,NA,NA,NA,NA,NA,NA,NAPt34_on,Pt34,Pt34_on,on,7,0.84509804,12,1.113943352,1,1,1,1,1,NIV3-PROG,4,TripleWt,3,0.428571429,0.5,2,NA,2,-0.005445513,23,300,Pt34_on,0,0,0.069230769,0.173076923,2066.761522,3563.989149,5630.750671,0.138830364,0,0,0.007170983,0.181039653,0,0.15689472,0.009218234,0.015223528,0.009311091,0,0.018090731,0.001127642,0.040415501,0.164250998,0.044854274,0.275811375,0,0,0.033634515,0,0,0.042956757,0.371687226,0.007170983,0.019218373,0.484916647,0.033634515,0.083372258,Pt34_on_S0088552,0,0.470602574,0.049197141,0.040298868,193060,19094,null,10.2600613,0.278518885,2666.56006,0,410240,235689,24103,null,10.5957575,0.272115648,0.819130295,"Melanoma, Biopsy, Tissue",0.470602574,Pt34_on,on,0.471,15563,0.282,14,0.7158,0.2209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-14-34,CA209038-14-34,34,CA209038,14,1,71,1,2,USA,NIV3-PROG,15-Jan-13,2-Dec-14,13-Jan-15,2-Dec-14,NA,28-Apr-15,NA,NA,NA,PR,PRCR,-56.46258503,NA,1,1,779,111.2857143,0,56,8,834,119.1428571,NA,28-Apr-15,-61.9047619,11-Mar-13,56,28-Apr-15,834,119.1428571,1,-61.9047619,2,NA,12-Mar-15,NA,PRCRSD,PRCR,0,0,Pt34,14-34,CA209038-14-34,71,MALE,15-Jan-13,2-Dec-14,NIV3-PROG,19-Dec-12,2-Dec-14,NA,NA,NA,NA,PR,NA,26-Nov-12,-50,M1B,M1B,Pt34,CA209038-14-34,CA209038,United States of America,14,34,CUTANEOUS,CUTANEOUS,44,NIVO 3 mg/kg Q2W,on,12.25,28-Aug-13,NA,NA,NA,INDETERMINATE,NA,NA,NA,NA,532,2317,2225,1471,41.92,0.38,15.15,20.5,65.3,46.7,3.06,12.63,0.9,50.14,6.26,NA,HIGH MELANIN CONTENT,0.030087094,1.623119557,0.031020408,1.673469388,0.143014147,0,0.138614459,0,0,0.258014165,0,0,0,0,0,0,0,0,0,0,0.174766438,0,0,0,0.127049151,0,0,0.158541623,0,0,0,0,0,0,0.856985853,2761,1262,1866.64994,Pt34_on,34,NA,NAPt34_pre,Pt34,Pt34_pre,pre,212,2.326335861,368,2.567026366,1,1,1,1,1,NIV3-PROG,1,BRAF,144,0.679245283,0.3,1.9,0.20831139,1.693166105,0.046859194,30,300,Pt34_pre,9,0.264849383,0.099723757,0.274193548,1612.196078,3392.841088,5005.037167,0.229075409,0.019059233,0,0,0.168888019,0,0.109220926,0.045070052,0.029533843,0.03952438,0,0,0.003600883,0.04754124,0.14633039,0.068255307,0.239045722,0.005004093,0,0.048458072,0,0.001030036,0.029437807,0.39223722,0.019059233,0.003600883,0.453631419,0.049488108,0.08198314,Pt34_pre_S0088543,0,0.335237301,0.025088543,0.020049723,104470,16748,null,11.066515,0.211320519,2025.59998,0,311630,130725,21340,null,11.3387375,0.211562306,0.799158539,"Melanoma, Biopsy, Tissue",0.335237301,Pt34_pre,pre,0.335,13944,0.214,14,0.7776,0.3798,Pt34_pre,0.894487231,16,1,1,1,1,0,0.219512195,0.931707317,205,0,2.326335861,2.326335861,2.326335861,0,0.510659091,2.167464143,CA209038-14-34,CA209038-14-34,34,CA209038,14,1,71,1,2,USA,NIV3-PROG,15-Jan-13,2-Dec-14,13-Jan-15,2-Dec-14,NA,28-Apr-15,NA,NA,NA,PR,PRCR,-56.46258503,NA,1,1,779,111.2857143,0,56,8,834,119.1428571,NA,28-Apr-15,-61.9047619,11-Mar-13,56,28-Apr-15,834,119.1428571,1,-61.9047619,2,NA,12-Mar-15,NA,PRCRSD,PRCR,0,0,Pt34,14-34,CA209038-14-34,71,MALE,15-Jan-13,2-Dec-14,NIV3-PROG,19-Dec-12,2-Dec-14,NA,NA,NA,NA,PR,NA,26-Nov-12,-50,M1B,M1B,Pt34,CA209038-14-34,CA209038,United States of America,14,34,CUTANEOUS,CUTANEOUS,43,PRE-TREATMENT,pre,31.52,6-Jun-13,1,2,5,EVALUABLE,8,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,1569,1463,1276,1154,4.14,0.45,1.16,2.94,14.42,11.35,11.44,9.01,10.77,17.65,84.73,NO TUMOR,NA,0.049944506,0.326304107,0.01427665,0.093274112,0.106626215,0,0,0,0.060243052,0,0.70325412,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.129876612,1854,1475,1653.67772,Pt34_pre,34,20,15Pt35_on,Pt35,Pt35_on,on,NA,NA,NA,NA,0,0,0,0,1,NIV3-NAIVE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-7.404713711,2690.352086,2682.947372,0.541300958,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-14-35,CA209038-14-35,35,CA209038,14,1,80,1,2,USA,NIV3-NAIVE,29-Jan-13,30-Dec-14,13-Jan-15,30-Dec-14,4-Jul-15,4-Jul-15,NA,NA,NA,PR,PRCR,-89.36170213,0,1,0,653,93.28571429,0,161,23,887,126.7142857,NA,21-Apr-15,-89.36170213,8-Jul-13,161,21-Apr-15,813,116.1428571,1,-89.36170213,2,NA,9-Apr-15,NA,PRCRSD,PRCR,1,0,Pt35,14-35,CA209038-14-35,80,MALE,29-Jan-13,30-Dec-14,NIV3-NAIVE,21-Dec-12,30-Dec-14,NA,NA,NA,NA,PR,NA,4-Dec-12,-56,M1C WITHOUT BRAIN METASTASES,M1C,Pt35,CA209038-14-35,CA209038,United States of America,14,35,CUTANEOUS,CUTANEOUS,46,NIVO 3 mg/kg Q2W,on,10.06,18-Jun-13,0,0,0,EVALUABLE,0,MACROPHAGES ONLY,YES,NA,1515,2481,2579,2555,19.8,0.2,12.7,9.63,38.54,25.44,22.07,8.84,1,47.94,64.92,NA,NA,0.022624434,1.089366516,0.019880716,0.957256461,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1906,1802,1853.270622,Pt35_on,35,95,100Pt36_on,Pt36,Pt36_on,on,NA,NA,NA,NA,1,0,0,1,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,605.0468727,2545.562339,3150.609212,0.482350691,0.029231458,0,0,0.127816833,0,0.058870001,0.024940795,0.086974545,0.011106118,0,0.063241235,0,0.083303036,0.227041073,0.06185725,0.162138391,0,0,0.033276266,0,0,0.030203,0.309708292,0.029231458,0.063241235,0.451036714,0.033276266,0.113506036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-9-36,CA209038-9-36,36,CA209038,9,1,58,1,2,USA,NIV3-PROG,29-Jan-13,22-Jan-15,5-Feb-15,22-Jan-15,NA,14-Jan-16,NA,NA,NA,SD,SD,-15.54621849,NA,1,1,NA,NA,1,936,133.7142857,1081,154.4285714,NA,4-Feb-15,-15.54621849,NA,NA,4-Feb-15,737,105.2857143,1,-15.54621849,2,NA,2-May-15,NA,PRCRSD,SDPD,0,0,Pt36,Sep-36,CA209038-9-36,58,MALE,29-Jan-13,22-Jan-15,NIV3-PROG,10-Jan-13,22-Jan-15,NA,NA,NA,NA,SD,NA,27-Nov-12,-63,M1C WITHOUT BRAIN METASTASES,M1C,Pt36,CA209038-9-36,CA209038,United States of America,9,36,CUTANEOUS,CUTANEOUS,132,NIVO 3 mg/kg Q2W,on,1.61,4-Dec-13,0,0,1,EVALUABLE,1,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,1643,1761,1665,1647,0.79,0,0.45,0.51,3.72,1.21,0.12,2.04,0,62.5,10,NA,NA,0,0.25,0,0.316770186,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1072,1429,1237.694631,Pt36_on,36,65,15Pt36_pre,Pt36,Pt36_pre,pre,2,0.301029996,1,0.301029996,1,0,0,1,1,NIV3-PROG,4,TripleWt,1,0.5,0.4,2,NA,2,-0.005614985,23,300,Pt36_pre,0,0,0.064295486,0.069767442,2493.356101,2113.77272,4607.128821,0.285507624,0,0,0,0,0,0.2205565,0,0,0,0,0.011436663,0.009354113,0.043065582,0.088769639,0.027939556,0.392799972,0,0,0.138101032,0,0,0.067976944,0.2205565,0,0.020790776,0.509509167,0.138101032,0.111042526,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-9-36,CA209038-9-36,36,CA209038,9,1,58,1,2,USA,NIV3-PROG,29-Jan-13,22-Jan-15,5-Feb-15,22-Jan-15,NA,14-Jan-16,NA,NA,NA,SD,SD,-15.54621849,NA,1,1,NA,NA,1,936,133.7142857,1081,154.4285714,NA,4-Feb-15,-15.54621849,NA,NA,4-Feb-15,737,105.2857143,1,-15.54621849,2,NA,2-May-15,NA,PRCRSD,SDPD,0,0,Pt36,Sep-36,CA209038-9-36,58,MALE,29-Jan-13,22-Jan-15,NIV3-PROG,10-Jan-13,22-Jan-15,NA,NA,NA,NA,SD,NA,27-Nov-12,-63,M1C WITHOUT BRAIN METASTASES,M1C,Pt36,CA209038-9-36,CA209038,United States of America,9,36,CUTANEOUS,CUTANEOUS,131,PRE-TREATMENT,pre,0,4-Dec-13,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,739,806,774,792,0.95,0.14,0.87,0.12,0.52,1.77,1.01,0.9,14.29,14.29,21.43,< 100 VIABLE TUMOR CELLS,NA,0.155555556,0.133333333,NA,NA,0,0,0,0,0,0.136458557,0.338789371,0,0,0,0,0,0,0,0.325685865,0,0,0,0,0,0,0,0.199066189,0,0,0,0,0,0,0,0.661210629,119,107,112.8405955,Pt36_pre,36,10,1Pt37_on,Pt37,Pt37_on,on,28,1.447158031,56,1.755874856,1,1,1,1,1,NIV3-PROG,2,RAS,19,0.678571429,0.5,2.1,0.453965751,2.073439711,-0.023850843,39,300,Pt37_on,6,0.091473762,0.203531766,0.547169811,409.204651,2102.622574,2511.827225,0.562248304,0,0,0,0,0,0.156033957,0.078180137,0.065852712,0,0,0.077743322,0,0.035537771,0.083754104,0.048512266,0.196534583,0,0.05601774,0,0.024161275,0.028298166,0.149373969,0.300066806,0,0.077743322,0.328800953,0.052459441,0.24092948,Pt37_on_S0101350,0,0.084531006,0.009804487,0.0084173,34678,11332,null,12.0134401,0.10800878,2666.56006,0,410240,40393,13426,null,12.2946672,0.103412926,0.858515089,"Melanoma, Biopsy, Tissue",0.084531006,Pt37_on,on,0.085,10926,0.109,12,0.873,0.6848,Pt37_on,0.884699605,9,2,0.785714286,0.785714286,0.857142857,0,0.428571429,0.571428571,28,0.301029996,1.137052739,1.137052739,1.24042117,0,0.620210585,0.826947446,CA209038-9-37,CA209038-9-37,37,CA209038,9,1,63,1,2,USA,NIV3-PROG,28-Jan-13,8-Jul-13,22-Jul-13,8-Jul-13,4-Nov-14,4-Nov-14,27-Aug-13,22-Jul-13,22-Jul-13,SD,SD,0,0,0,0,NA,NA,1,937,133.8571429,646,92.28571429,STABLE DISEASE,22-Jul-13,0,NA,NA,22-Jul-13,176,25.14285714,1,0,2,NA,16-Oct-13,NA,PRCRSD,SDPD,1,1,Pt37,Sep-37,CA209038-9-37,63,MALE,28-Jan-13,8-Jul-13,NIV3-PROG,14-Jan-13,8-Jul-13,NA,22-Jul-13,STABLE DISEASE,22-Jul-13,SD,NA,14-Jan-13,-14,M1A,M1A,Pt37,CA209038-9-37,CA209038,United States of America,9,37,CUTANEOUS,CUTANEOUS,134,NIVO 3 mg/kg Q2W,on,20.19,4-Dec-13,1,1,1,EVALUABLE,3,MACROPHAGES ONLY,YES,NA,1758,2183,2442,2248,2.62,0,4.44,0,17.24,7.83,0,4.3,0,0,0,NA,NA,0,0,0,0,0,0,0.196744687,0,0,0.284935235,0.32206197,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.191057911,0,0,0,0,0,0.67793803,1099,145,399.1929358,NA,NA,NA,NAPt37_pre,Pt37,Pt37_pre,pre,29,1.462397998,46,1.672097858,1,1,1,1,1,NIV3-PROG,2,RAS,19,0.655172414,0.7,2.1,0.715464226,1.985846829,0.007322982,64,300,Pt37_pre,11,0.130060329,0.286103542,0.703125,87.9774374,740.3521633,828.3296007,0.74745314,0,0,0,0.061149223,0,0.154511058,0,0.088807939,0,0,0.03338548,0,0.045463903,0.135311643,0.086499435,0.22416982,0.052129854,0,0.115422669,0,0,0.003148975,0.30446822,0,0.03338548,0.445980898,0.115422669,0.100742732,Pt37_pre_S0101353,0,0.05475819,0.065438032,0.056188364,22464,7659,null,10.5088558,0.185545653,2666.56006,0,410240,26162,9029,null,10.7956285,0.178436816,0.85864995,"Melanoma, Biopsy, Tissue",0.05475819,Pt37_pre,pre,0.055,7441,0.186,9,0.9154,0.7014,Pt37_pre,0.885221102,8,2,0.7,0.7,0.7,0.05,0.45,0.6,20,0.301029996,1.023678599,1.023678599,1.023678599,0.0731199,0.658079099,0.877438799,CA209038-9-37,CA209038-9-37,37,CA209038,9,1,63,1,2,USA,NIV3-PROG,28-Jan-13,8-Jul-13,22-Jul-13,8-Jul-13,4-Nov-14,4-Nov-14,27-Aug-13,22-Jul-13,22-Jul-13,SD,SD,0,0,0,0,NA,NA,1,937,133.8571429,646,92.28571429,STABLE DISEASE,22-Jul-13,0,NA,NA,22-Jul-13,176,25.14285714,1,0,2,NA,16-Oct-13,NA,PRCRSD,SDPD,1,1,Pt37,Sep-37,CA209038-9-37,63,MALE,28-Jan-13,8-Jul-13,NIV3-PROG,14-Jan-13,8-Jul-13,NA,22-Jul-13,STABLE DISEASE,22-Jul-13,SD,NA,14-Jan-13,-14,M1A,M1A,Pt37,CA209038-9-37,CA209038,United States of America,9,37,CUTANEOUS,CUTANEOUS,133,PRE-TREATMENT,pre,NA,13-Mar-14,1,0,0,EVALUABLE,1,MACROPHAGES ONLY,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0.066082997,0,0,0.375155521,0.270978085,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.197125214,0,0,0,0,0,0.729021915,179,76,116.6361865,NA,NA,NA,NAPt38_on,Pt38,Pt38_on,on,NA,NA,NA,NA,1,0,0,1,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-988.1071415,-22.47853262,-1010.585674,0.897536921,0,0.086093396,0,0.002465718,0,0.053091316,0.044741312,0.112539409,0,0,0.003112691,0.021330006,0.038801585,0.127834785,0.093349811,0.288586687,0,0,0.09427337,0,0.015870682,0.017909231,0.212837755,0.086093396,0.024442697,0.509771283,0.110144052,0.056710816,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-8-38,CA209038-8-38,38,CA209038,8,2,54,1,NA,SPAIN,NIV3-PROG,21-Jan-13,16-Apr-13,31-May-13,16-Apr-13,6-Jul-13,6-Jul-13,NA,30-Apr-13,NA,SD,SD,5.150214592,1,0,0,NA,NA,1,944,134.8571429,167,23.85714286,PROGRESSION,30-Apr-13,5.150214592,NA,NA,6-Jul-13,167,23.85714286,1,5.150214592,2,NA,25-Jul-13,NA,PRCRSD,SDPD,1,1,Pt38,Aug-38,CA209038-8-38,54,FEMALE,21-Jan-13,16-Apr-13,NIV3-PROG,15-Jan-13,16-Apr-13,NA,30-Apr-13,PROGRESSION,NA,SD,NA,12-Dec-12,-40,M1C WITHOUT BRAIN METASTASES,M1C,Pt38,CA209038-8-38,CA209038,SPAIN,8,38,CUTANEOUS,CUTANEOUS,122,NIVO 3 mg/kg Q2W,on,16.36,7-Jun-13,0,0,0,EVALUABLE,0,MACROPHAGES ONLY,YES,NA,2610,2578,2007,2647,2.45,0.5,0.47,0.19,2.74,1.55,5.06,0.7,20.31,33.33,85.37,< 1% + PM TUMOR CELLS,NA,0.714285714,0.271428571,0.030562347,0.011613692,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,58,49,53.31041174,NA,NA,NA,NAPt38_pre,Pt38,Pt38_pre,pre,449,2.652246341,893,2.951337519,1,0,0,1,1,NIV3-PROG,4,TripleWt,290,0.645879733,0.9,2,0.912759936,1.879728164,0.081445318,51,300,Pt38_pre,13,0.228940134,0.408450704,0.898305085,-1079.34807,-213.3924066,-1292.740476,0.915024411,0,0,0.018991355,0,0,0.133487774,0.054735673,0.128200669,0,0,0,0.077048711,0.010213751,0.118841347,0.050464209,0.272972551,0,0,0.107267401,0,0,0.02777656,0.316424116,0.018991355,0.077048711,0.442278107,0.107267401,0.037990311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt38_pre,0.953790159,39,4,0.651270208,0.653579677,0.653579677,0.515011547,0.602771363,0.630484988,433,0.602059991,1.727329026,1.733454307,1.733454307,1.365937491,1.598698142,1.672201502,CA209038-8-38,CA209038-8-38,38,CA209038,8,2,54,1,NA,SPAIN,NIV3-PROG,21-Jan-13,16-Apr-13,31-May-13,16-Apr-13,6-Jul-13,6-Jul-13,NA,30-Apr-13,NA,SD,SD,5.150214592,1,0,0,NA,NA,1,944,134.8571429,167,23.85714286,PROGRESSION,30-Apr-13,5.150214592,NA,NA,6-Jul-13,167,23.85714286,1,5.150214592,2,NA,25-Jul-13,NA,PRCRSD,SDPD,1,1,Pt38,Aug-38,CA209038-8-38,54,FEMALE,21-Jan-13,16-Apr-13,NIV3-PROG,15-Jan-13,16-Apr-13,NA,30-Apr-13,PROGRESSION,NA,SD,NA,12-Dec-12,-40,M1C WITHOUT BRAIN METASTASES,M1C,Pt38,CA209038-8-38,CA209038,SPAIN,8,38,CUTANEOUS,CUTANEOUS,121,PRE-TREATMENT,pre,10.81,7-Jun-13,0,0,0,EVALUABLE,0,MACROPHAGES ONLY,YES,NA,2586,2477,2706,2915,0.85,0.27,0.08,0.2,1.37,0.14,0.75,0.18,31.82,50,100,NA,NA,1.5,1.111111111,0.024976873,0.018501388,0.156630957,0,0,0,0.176563744,0,0.51939918,0,0,0,0.119304281,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.028101838,25,26,25.49509757,Pt38_pre,38,98,99Pt39_pre,Pt39,Pt39_pre,pre,NA,NA,NA,NA,0,0,0,1,0,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-751.5948004,-986.3327267,-1737.927527,0.939413991,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-1-39,CA209038-1-39,39,CA209038,1,1,40,1,2,USA,NIV3-PROG,7-Feb-13,20-May-13,7-Jun-13,20-May-13,22-Jul-13,22-Jul-13,NA,23-May-13,4-Apr-13,PD,PD,72.88135593,1,0,0,NA,NA,1,927,132.4285714,166,23.71428571,PROGRESSION,23-May-13,72.88135593,NA,NA,4-Apr-13,57,8.142857143,1,72.88135593,2,NA,28-Aug-13,NA,PD,SDPD,1,1,Pt39,Jan-39,CA209038-1-39,40,MALE,7-Feb-13,20-May-13,NIV3-PROG,7-Jan-13,20-May-13,NA,23-May-13,PROGRESSION,4-Apr-13,PD,NA,3-Oct-12,-127,M1C WITHOUT BRAIN METASTASES,M1C,Pt39,CA209038-1-39,CA209038,United States of America,1,39,MUCOSAL,MUCOSAL,7,PRE-TREATMENT,pre,2.5,28-Aug-13,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,1696,1569,1611,1768,0.24,0.12,0.57,0.06,2.48,2.21,0.9,0.56,50,0,33.33,< 1% + PM TUMOR CELLS,NA,0.214285714,0.107142857,0.048,0.024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,12,6.92820323,Pt39_pre,39,85,85Pt4_on,Pt4,Pt4_on,on,NA,NA,NA,NA,1,0,0,1,1,NIV3-NAIVE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1377.293914,3324.418521,4701.712435,0.272174649,0.052544929,0,0.010419104,0.216757137,0,0.011594242,0.059915846,0.082534888,0.055452813,0,0,0.059824336,0.050448326,0.054583892,0.093024404,0.156743409,0.011351617,0,0.072064497,0,0,0.012740559,0.426254926,0.062964033,0.059824336,0.304351705,0.072064497,0.074540502,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-8-4,CA209038-8-4,4,CA209038,8,2,62,1,NA,SPAIN,NIV3-NAIVE,23-Oct-12,18-Sep-13,2-Oct-13,18-Sep-13,17-Jul-14,14-Jul-14,1-Dec-13,7-Aug-13,15-Apr-13,SD,SD,-29.50819672,0,0,0,NA,NA,1,1136,162.2857143,633,90.42857143,STABLE DISEASE,2-Oct-13,-29.50819672,NA,NA,15-Apr-13,175,25,1,-29.50819672,2,NA,27-Dec-13,NA,PRCRSD,SDPD,1,1,Pt4,4-Aug,CA209038-8-4,62,FEMALE,23-Oct-12,18-Sep-13,NIV3-NAIVE,10-Oct-12,18-Sep-13,NA,7-Aug-13,STABLE DISEASE,15-Apr-13,SD,NA,13-Mar-06,-2416,M1B,M1B,Pt4,CA209038-8-4,CA209038,SPAIN,8,4,CUTANEOUS,CUTANEOUS,124,NIVO 3 mg/kg Q2W,on,22.21,7-Jun-13,5,10,5,EVALUABLE,20,MACROPHAGES ONLY,YES,NA,2565,3271,2997,2856,82.69,63,69.43,54.97,86.39,68.66,55.01,20.05,75.15,71.91,76.39,NA,NA,3.142144638,2.741645885,2.836560108,2.475011256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3534,4608,4035.427115,NA,NA,NA,NAPt4_pre,Pt4,Pt4_pre,pre,285,2.45484486,315,2.499687083,1,0,0,1,1,NIV3-NAIVE,2,RAS,151,0.529824561,0.7,2.8,0.674996961,3.607229359,-0.625212001,48,300,Pt4_pre,14,0.354264443,0.28125,0.810176125,-995.5017937,1273.726759,278.2249655,0.798602062,0.045185666,0,0,0.175149601,0,0.100142584,0,0.053963629,0.019685245,0,0.09093567,0,0.080863531,0.141302202,0.059396273,0.132522927,0,0,0,0,0,0.100852672,0.348941059,0.045185666,0.09093567,0.333221402,0,0.181716203,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt4_pre,0.90826576,8,2,0.980916031,0.980916031,0.980916031,0,0.683206107,0.935114504,262,0.301029996,2.407996677,2.407996677,2.407996677,0,1.677165,2.295561034,CA209038-8-4,CA209038-8-4,4,CA209038,8,2,62,1,NA,SPAIN,NIV3-NAIVE,23-Oct-12,18-Sep-13,2-Oct-13,18-Sep-13,17-Jul-14,14-Jul-14,1-Dec-13,7-Aug-13,15-Apr-13,SD,SD,-29.50819672,0,0,0,NA,NA,1,1136,162.2857143,633,90.42857143,STABLE DISEASE,2-Oct-13,-29.50819672,NA,NA,15-Apr-13,175,25,1,-29.50819672,2,NA,27-Dec-13,NA,PRCRSD,SDPD,1,1,Pt4,4-Aug,CA209038-8-4,62,FEMALE,23-Oct-12,18-Sep-13,NIV3-NAIVE,10-Oct-12,18-Sep-13,NA,7-Aug-13,STABLE DISEASE,15-Apr-13,SD,NA,13-Mar-06,-2416,M1B,M1B,Pt4,CA209038-8-4,CA209038,SPAIN,8,4,CUTANEOUS,CUTANEOUS,123,PRE-TREATMENT,pre,19.85,8-Jun-13,0,0,0,EVALUABLE,0,MACROPHAGES ONLY,YES,NA,2396,2229,2524,1921,8.26,1.84,4.93,1.21,20.76,5.67,15.51,5.07,22.22,14.55,98.17,< 1% + PM TUMOR CELLS,NA,0.362919132,0.238658777,0.092695214,0.060957179,0,0,0,0,0.205571561,0,0.608821749,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.18560669,332,690,478.6230249,NA,NA,NA,NAPt44_on,Pt44,Pt44_on,on,10,1,13,1.146128036,1,1,1,1,1,NIV3-NAIVE,4,TripleWt,4,0.4,0.5,2,NA,2,-0.001127089,23,300,Pt44_on,0,0,0.056132892,0.191489362,2551.63993,2322.672179,4874.31211,0.247710752,0,0.036836892,0,0.160578428,0,0.04641231,0.045684233,0.062375533,0,0,0,0.077236566,0.054468255,0.035852325,0.042791637,0.209957467,0,0.029206933,0.180035805,0,0,0.018563616,0.315050504,0.036836892,0.077236566,0.288601429,0.180035805,0.102238804,Pt44_on_S0087102,0,0.320695203,0.045879509,0.038627435,131562,15022,null,10.4443989,0.247239128,2666.56006,0,410240,156262,18696,null,10.7823029,0.240171447,0.84193214,"Melanoma, Biopsy, Tissue",0.320695203,Pt44_on,on,0.321,12747,0.249,12,0.7235,0.2716,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-12-44,CA209038-12-44,44,CA209038,12,1,61,1,2,USA,NIV3-NAIVE,4-Feb-13,24-Nov-14,8-Dec-14,24-Nov-14,NA,1-Feb-16,NA,7-Dec-14,17-Aug-14,PR,PRCR,-94.89795918,NA,0,1,505,72.14285714,0,56,8,1093,156.1428571,PARTIAL RESPONSE,7-Dec-14,-100,31-Mar-13,56,17-Aug-14,560,80,1,-100,1,V600E,4-Mar-15,NA,PRCRSD,PRCR,0,1,Pt44,Dec-44,CA209038-12-44,61,MALE,4-Feb-13,24-Nov-14,NIV3-NAIVE,28-Jan-13,24-Nov-14,NA,7-Dec-14,PARTIAL RESPONSE,17-Aug-14,PR,NA,NA,NA,NA,NA,Pt44,CA209038-12-44,CA209038,United States of America,12,44,MUCOSAL,MUCOSAL,36,NIVO 3 mg/kg Q2W,on,NA,8-Aug-13,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO DEFINITIVE TUMOR,NA,NA,NA,NA,NA,0.387367435,0,0.134938322,0,0,0,0,0,0.171760544,0,0,0,0,0,0,0,0,0,0,0.107186057,0,0,0,0,0,0,0.172512997,0,0,0,0.612632565,1700,906,1241.047944,Pt44_on,44,NA,NAPt44_pre,Pt44,Pt44_pre,pre,365,2.562292864,510,2.7084209,1,1,1,1,1,NIV3-NAIVE,1,BRAF,232,0.635616438,0.8,2.7,0.782974823,2.707673544,-0.352809684,74,300,Pt44_pre,10,0.093341308,0.410628019,0.961538462,1190.32661,1953.554912,3143.881522,0.483215525,0.108892586,0,0,0.128680611,0,0.138954682,0.077488647,0.077033315,0,0,0,0.016812062,0.030939032,0.080230765,0.089580502,0.188720504,0,0,0.028816368,0,5.00E-04,0.033393167,0.422157255,0.108892586,0.016812062,0.358531771,0.029316368,0.064332199,Pt44_pre_S0087105,0,0.073449688,0.036871102,0.031632595,30132,6105,null,10.3702831,0.175376251,2666.56006,0,410240,35122,7524,null,10.7356625,0.166310042,0.857923808,"Melanoma, Biopsy, Tissue",0.073449688,Pt44_pre,pre,0.073,5787,0.177,7,0.7855,0.48,Pt44_pre,0.979080962,3,2,0.980446927,0.980446927,0.980446927,0.955307263,0.966480447,0.977653631,358,0.301029996,2.512192165,2.512192165,2.512192165,2.447776983,2.476405953,2.505034923,CA209038-12-44,CA209038-12-44,44,CA209038,12,1,61,1,2,USA,NIV3-NAIVE,4-Feb-13,24-Nov-14,8-Dec-14,24-Nov-14,NA,1-Feb-16,NA,7-Dec-14,17-Aug-14,PR,PRCR,-94.89795918,NA,0,1,505,72.14285714,0,56,8,1093,156.1428571,PARTIAL RESPONSE,7-Dec-14,-100,31-Mar-13,56,17-Aug-14,560,80,1,-100,1,V600E,4-Mar-15,NA,PRCRSD,PRCR,0,1,Pt44,Dec-44,CA209038-12-44,61,MALE,4-Feb-13,24-Nov-14,NIV3-NAIVE,28-Jan-13,24-Nov-14,NA,7-Dec-14,PARTIAL RESPONSE,17-Aug-14,PR,NA,NA,NA,NA,NA,Pt44,CA209038-12-44,CA209038,United States of America,12,44,MUCOSAL,MUCOSAL,35,PRE-TREATMENT,pre,16.82,28-Aug-13,0,0,0,EVALUABLE,0,LYMPHOCYTES ONLY,YES,MACROPHAGES,3210,3004,3147,2899,7.35,4.92,7.69,6.42,30.79,9.49,19.56,5.53,61.86,45.02,93.09,< 1% + PM TUMOR CELLS,NA,0.889692586,1.160940325,0.292508918,0.381688466,0,0,0,0,0.074442307,0,0.626911382,0,0,0,0.065692807,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.232953503,1206,976,1084.922117,Pt44_pre,44,96,65Pt46_on,Pt46,Pt46_on,on,NA,NA,NA,NA,1,0,0,1,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2132.643814,3204.748296,5337.39211,0.181333121,0,0,0,0.051057818,0,0.13960623,0.016116985,0.043340271,0,0.001419636,0,0.027921109,0.058123266,0.204049561,0.062151031,0.2525246,0,0,0.115625495,0,0,0.028063999,0.25154094,0,0.027921109,0.518725192,0.115625495,0.086187265,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-9-46,CA209038-9-46,46,CA209038,9,1,79,1,2,USA,NIV3-PROG,4-Mar-13,29-May-13,12-Jun-13,29-May-13,16-Oct-13,16-Oct-13,6-Jun-13,23-Apr-13,23-Apr-13,PD,PD,55.14018692,0,0,0,NA,NA,1,902,128.8571429,227,32.42857143,PROGRESSION,23-Apr-13,55.14018692,NA,NA,23-Apr-13,51,7.285714286,1,55.14018692,1,V600E,6-Sep-13,NA,PD,SDPD,1,1,Pt46,Sep-46,CA209038-9-46,79,MALE,4-Mar-13,29-May-13,NIV3-PROG,24-Jan-13,29-May-13,NA,23-Apr-13,PROGRESSION,23-Apr-13,PD,NA,5-Mar-12,-364,M1A,M1A,Pt46,CA209038-9-46,CA209038,United States of America,9,46,OTHER: IN SITU,OTHER,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1523,476,851.4387823,Pt46_on,46,NA,NAPt46_pre,Pt46,Pt46_pre,pre,180,2.255272505,163,2.214843848,1,0,0,1,1,NIV3-PROG,1,BRAF,105,0.583333333,0.4,2.1,0.3,2.052749482,-0.011370288,34,300,Pt46_pre,1,0.01327538,0.065615168,0.252525253,2084.174679,3249.229254,5333.403933,0.181908803,0.037338435,0,0,0.071154123,0,0.124799261,0.028867029,0.038155109,0,0,9.00E-04,0.014922525,0.033980517,0.210189787,0.048873557,0.232517821,0,0,0.118808935,0,0,0.039489432,0.262975522,0.037338435,0.015822525,0.491581165,0.118808935,0.073469949,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt46_pre,0.417856673,20,2,0,0,0,0,0,0,166,0.301029996,0,0,0,0,0,0,CA209038-9-46,CA209038-9-46,46,CA209038,9,1,79,1,2,USA,NIV3-PROG,4-Mar-13,29-May-13,12-Jun-13,29-May-13,16-Oct-13,16-Oct-13,6-Jun-13,23-Apr-13,23-Apr-13,PD,PD,55.14018692,0,0,0,NA,NA,1,902,128.8571429,227,32.42857143,PROGRESSION,23-Apr-13,55.14018692,NA,NA,23-Apr-13,51,7.285714286,1,55.14018692,1,V600E,6-Sep-13,NA,PD,SDPD,1,1,Pt46,Sep-46,CA209038-9-46,79,MALE,4-Mar-13,29-May-13,NIV3-PROG,24-Jan-13,29-May-13,NA,23-Apr-13,PROGRESSION,23-Apr-13,PD,NA,5-Mar-12,-364,M1A,M1A,Pt46,CA209038-9-46,CA209038,United States of America,9,46,OTHER: IN SITU,OTHER,135,PRE-TREATMENT,pre,47.4,4-Dec-13,NA,NA,NA,INDETERMINATE,NA,NA,NA,NA,1071,1650,1081,1472,23.25,11.67,6.12,10.79,17.76,27.24,20.04,43.85,47.39,18.81,60.1,NA,HIGH MELANIN CONTENT,0.26613455,0.246066135,0.246202532,0.227637131,0.243041385,0,0,0,0,0,0.648044334,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.108914281,0,0,0,0,0,0,0,0.108914281,1319,620,904.3118931,Pt46_pre,46,60,60Pt47_on,Pt47,Pt47_on,on,1007,3.003029471,853,2.931457871,1,1,1,1,1,NIV3-PROG,1,BRAF,481,0.477656405,0.6,2.1,0.596434813,2.070083193,-0.029841597,44,300,Pt47_on,7,0.072154834,0.285714286,0.717948718,613.6910558,1449.834712,2063.525768,0.615411143,0,0,0,0.066723683,0,0.226934458,0.03141437,0.046268397,0,0,0,0.044756466,0.125564011,0.12298347,0.079233594,0.187333926,0.01511803,0.005492308,0.048177287,0,0,0,0.371340908,0,0.044756466,0.38955099,0.048177287,0.146174349,Pt47_on_S0088565,0,0.110142843,0.05701007,0.044209514,45185,10970,null,10.7877407,0.19622089,2666.56006,0,410240,58268,13759,null,10.979146,0.201405585,0.775468525,"Melanoma, Biopsy, Tissue",0.110142843,Pt47_on,on,0.11,10559,0.198,11,0.8158,0.5733,Pt47_on,0.948122491,10,3,0.969604863,0.969604863,0.969604863,0,0.946301925,0.95845998,987,0.477121255,2.911751978,2.911751978,2.911751978,0,2.841772569,2.878283566,CA209038-4-47,CA209038-4-47,47,CA209038,4,1,52,1,2,USA,NIV3-PROG,18-Feb-13,8-Apr-13,6-May-13,8-Apr-13,5-Feb-15,26-Nov-14,NA,15-Apr-13,15-Apr-13,PD,PD,58.06451613,0,0,0,NA,NA,1,916,130.8571429,718,102.5714286,PROGRESSION,15-Apr-13,58.06451613,NA,NA,15-Apr-13,57,8.142857143,1,58.06451613,1,V600E,17-Jul-13,NA,PD,SDPD,1,1,Pt47,Apr-47,CA209038-4-47,52,MALE,18-Feb-13,8-Apr-13,NIV3-PROG,28-Jan-13,8-Apr-13,NA,15-Apr-13,PROGRESSION,15-Apr-13,PD,NA,29-Mar-12,-326,M1B,M1B,Pt47,CA209038-4-47,CA209038,United States of America,4,47,CUTANEOUS,CUTANEOUS,66,NIVO 3 mg/kg Q2W,on,35.65,15-Jun-13,1,2,0,EVALUABLE,3,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,1794,1763,2083,1972,8.81,8.75,5.96,2.61,15.22,4.46,6.69,5.71,79.75,33.33,95.45,NA,NA,1.532399299,0.45709282,0.245441795,0.073211781,0,0,0,0,0,0.067760593,0.928359531,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.071640469,181,237,207.1159096,Pt47_on,47,85,45Pt47_pre,Pt47,Pt47_pre,pre,1005,3.002166062,871,2.940516485,1,1,1,1,1,NIV3-PROG,1,BRAF,491,0.488557214,0.5,2.1,0.511723297,2.069000617,-0.025247999,45,300,Pt47_pre,7,0.072239285,0.246153846,0.670886076,1340.569873,1737.101547,3077.67142,0.491701459,0,0.022050594,0,0.013792921,0,0.219708965,0.060564762,0.043199078,0,0,0.006499146,0.012060398,0.116969809,0.075955727,0.053575271,0.186886432,0.055031521,0.024964222,0.081361474,0,0,0.027379682,0.337265726,0.022050594,0.018559544,0.31641743,0.081361474,0.224345234,Pt47_pre_S0088566,0,0.125202321,0.030741975,0.024750767,51363,12159,null,11.2660961,0.169763118,2666.56006,0,410240,63796,15188,null,11.5992308,0.164960921,0.805113173,"Melanoma, Biopsy, Tissue",0.125202321,Pt47_pre,pre,0.125,11715,0.17,12,0.8127,0.5638,Pt47_pre,0.953196418,35,2,0.973577236,0.973577236,0.973577236,0.707317073,0.941056911,0.955284553,984,0.301029996,2.922840536,2.922840536,2.922840536,2.123483311,2.82520912,2.867922864,CA209038-4-47,CA209038-4-47,47,CA209038,4,1,52,1,2,USA,NIV3-PROG,18-Feb-13,8-Apr-13,6-May-13,8-Apr-13,5-Feb-15,26-Nov-14,NA,15-Apr-13,15-Apr-13,PD,PD,58.06451613,0,0,0,NA,NA,1,916,130.8571429,718,102.5714286,PROGRESSION,15-Apr-13,58.06451613,NA,NA,15-Apr-13,57,8.142857143,1,58.06451613,1,V600E,17-Jul-13,NA,PD,SDPD,1,1,Pt47,Apr-47,CA209038-4-47,52,MALE,18-Feb-13,8-Apr-13,NIV3-PROG,28-Jan-13,8-Apr-13,NA,15-Apr-13,PROGRESSION,15-Apr-13,PD,NA,29-Mar-12,-326,M1B,M1B,Pt47,CA209038-4-47,CA209038,United States of America,4,47,CUTANEOUS,CUTANEOUS,65,PRE-TREATMENT,pre,31.91,18-Jun-13,1,2,2,EVALUABLE,5,MACROPHAGES ONLY,YES,MACROPHAGES,2134,2124,2199,2135,16.78,9.37,4.76,1.18,19.24,9.7,13.72,6.5,51.68,12.87,92.27,< 1% + PM TUMOR CELLS,NA,1.441538462,0.181538462,0.293638358,0.036979003,0,0,0,0,0,0.070708224,0.924570402,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.075429598,220,215,217.4856317,Pt47_pre,47,50,35Pt48_on,Pt48,Pt48_on,on,7,0.84509804,9,1,1,1,1,1,1,NIV3-PROG,4,TripleWt,4,0.571428571,0.4,2,NA,2,0.007218876,23,300,NA,NA,NA,0.091743119,0.193548387,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt48_on_S0089503,0,0.077036372,0.029495962,0.023449564,19562,8802,null,11.7938871,0.099951662,1650.56006,0,253932,24606,11260,null,12.1944895,0.093947358,0.795009347,"Melanoma, Biopsy, Tissue",0.077036372,Pt48_on,on,0.077,8510,0.105,8,0.9183,0.7703,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-8-48,CA209038-8-48,48,CA209038,8,1,44,1,NA,SPAIN,NIV3-PROG,18-Feb-13,18-Feb-15,18-Feb-15,18-Feb-15,NA,30-Dec-15,NA,NA,NA,CR,PRCR,-100,NA,1,1,986,140.8571429,0,61,8.714285714,1046,149.4285714,NA,30-Dec-15,-100,19-Apr-13,61,30-Dec-15,1046,149.4285714,1,-100,2,NA,29-May-15,NA,PRCRSD,PRCR,0,0,Pt48,Aug-48,CA209038-8-48,44,MALE,18-Feb-13,18-Feb-15,NIV3-PROG,5-Feb-13,18-Feb-15,NA,NA,NA,NA,CR,NA,1-Apr-12,-323,M1C WITHOUT BRAIN METASTASES,M1C,Pt48,CA209038-8-48,CA209038,SPAIN,8,48,CUTANEOUS,CUTANEOUS,126,NIVO 3 mg/kg Q2W,on,NA,17-Jun-13,0,0,0,UNEVALUABLE,0,LYMPHOCYTES ONLY,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO DEFINITIVE TUMOR,NA,NA,NA,NA,NA,0.209435098,0,0,0,0,0,0.135115857,0,0,0,0,0,0,0,0,0.323097913,0,0,0,0,0,0,0,0,0,0,0.332351108,0,0,0,0.655449045,184,177,180.4660633,NA,NA,NA,NAPt48_pre,Pt48,Pt48_pre,pre,99,1.995635195,167,2.225309282,1,1,1,1,1,NIV3-PROG,4,TripleWt,63,0.636363636,0.6,2,NA,2,0.00644154,25,300,Pt48_pre,0,0,0.054945055,0.166666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt48_pre_S0089502,0,0.104692742,0.024501056,0.019336043,24652,8855,null,11.5600252,0.118381552,1530.56006,0,235470,31237,11411,null,11.9406986,0.114069112,0.789192304,"Melanoma, Biopsy, Tissue",0.104692742,Pt48_pre,pre,0.105,8505,0.122,8,0.8867,0.7102,Pt48_pre,0.202260923,2,1,0,0,0,0,0,0,93,0,0,0,0,0,0,0,CA209038-8-48,CA209038-8-48,48,CA209038,8,1,44,1,NA,SPAIN,NIV3-PROG,18-Feb-13,18-Feb-15,18-Feb-15,18-Feb-15,NA,30-Dec-15,NA,NA,NA,CR,PRCR,-100,NA,1,1,986,140.8571429,0,61,8.714285714,1046,149.4285714,NA,30-Dec-15,-100,19-Apr-13,61,30-Dec-15,1046,149.4285714,1,-100,2,NA,29-May-15,NA,PRCRSD,PRCR,0,0,Pt48,Aug-48,CA209038-8-48,44,MALE,18-Feb-13,18-Feb-15,NIV3-PROG,5-Feb-13,18-Feb-15,NA,NA,NA,NA,CR,NA,1-Apr-12,-323,M1C WITHOUT BRAIN METASTASES,M1C,Pt48,CA209038-8-48,CA209038,SPAIN,8,48,CUTANEOUS,CUTANEOUS,125,PRE-TREATMENT,pre,NA,17-Jun-13,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO DEFINITIVE TUMOR,NA,NA,NA,NA,NA,0,0,0,0,0,0,0.93816962,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.06183038,291,188,233.8974134,NA,NA,NA,NAPt49_on,Pt49,Pt49_on,on,NA,NA,NA,NA,1,0,0,1,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1361.160753,3632.327989,4993.488741,0.230725177,0,0.045729301,0,0.204966648,0,0.034409279,0.066926859,0.053340179,0.061260252,0,0,0.059044787,0.026349127,0.087267604,0.093184603,0.149219531,7.00E-04,0,0.074806262,0,0.018141154,0.024667122,0.420903217,0.045729301,0.059044787,0.329671738,0.092947416,0.051716249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-3-49,CA209038-3-49,49,CA209038,3,2,52,1,2,USA,NIV3-PROG,19-Feb-13,31-Mar-15,31-Mar-15,31-Mar-15,NA,26-May-15,NA,NA,NA,PR,PRCR,-88.88888889,NA,1,1,720,102.8571429,0,108,15.42857143,827,118.1428571,PARTIAL RESPONSE,26-May-15,-88.88888889,6-Jun-13,108,26-May-15,827,118.1428571,1,-88.88888889,2,NA,9-Jul-15,NA,PRCRSD,PRCR,0,0,Pt49,Mar-49,CA209038-3-49,52,FEMALE,19-Feb-13,31-Mar-15,NIV3-PROG,5-Feb-13,31-Mar-15,NA,NA,PARTIAL RESPONSE,NA,PR,NA,5-Feb-13,-14,UNKNOWN,UNKNOWN,Pt49,CA209038-3-49,CA209038,United States of America,3,49,CUTANEOUS,CUTANEOUS,49,NIVO 3 mg/kg Q2W,on,70.4,6-Jun-13,0,10,70,EVALUABLE,80,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,2732,3206,2951,2240,90.01,65.12,68.03,63.91,93.87,79.91,91.07,69.74,72.1,76.66,99.94,NA,NA,0.933753943,0.916403785,0.925,0.9078125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5143,7921,6382.609419,Pt49_on,49,35,11Pt49_pre,Pt49,Pt49_pre,pre,852,2.930439595,1766,3.24723655,1,0,0,1,1,NIV3-PROG,2,RAS,529,0.620892019,0.3,2,0.265309658,2.083657955,-0.015922311,46,300,Pt49_pre,5,0.081039234,0.094271261,0.380566802,1683.199178,2829.266384,4512.465562,0.298796721,0,0.053623695,0,0.151771116,0,0.156921436,0.036381237,0.064050599,0.004393279,0,0,0.039259273,0.032056364,0.067023196,0.099103515,0.19815827,0,0,0.082291813,0,0,0.014966206,0.413517667,0.053623695,0.039259273,0.364284981,0.082291813,0.04702257,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt49_pre,0.67330634,55,2,0.577553594,0.633039092,0.677175284,0.151324086,0.194199243,0.234552333,793,0.301029996,1.69248592,1.85508282,1.984421265,0.443446093,0.569089151,0.687341444,CA209038-3-49,CA209038-3-49,49,CA209038,3,2,52,1,2,USA,NIV3-PROG,19-Feb-13,31-Mar-15,31-Mar-15,31-Mar-15,NA,26-May-15,NA,NA,NA,PR,PRCR,-88.88888889,NA,1,1,720,102.8571429,0,108,15.42857143,827,118.1428571,PARTIAL RESPONSE,26-May-15,-88.88888889,6-Jun-13,108,26-May-15,827,118.1428571,1,-88.88888889,2,NA,9-Jul-15,NA,PRCRSD,PRCR,0,0,Pt49,Mar-49,CA209038-3-49,52,FEMALE,19-Feb-13,31-Mar-15,NIV3-PROG,5-Feb-13,31-Mar-15,NA,NA,PARTIAL RESPONSE,NA,PR,NA,5-Feb-13,-14,UNKNOWN,UNKNOWN,Pt49,CA209038-3-49,CA209038,United States of America,3,49,CUTANEOUS,CUTANEOUS,48,PRE-TREATMENT,pre,23.48,8-Aug-13,2,1,0,UNEVALUABLE,3,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,639,1320,1843,1717,19.25,1.88,6.06,0.38,7.16,6.41,3.96,2.44,9.76,5,52.73,CONSISTENT WITH ATYPICAL CELLS,NA,0.770491803,0.155737705,0.080068143,0.016183986,0,0,0,0,0,0,0.913058986,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.086941014,1942,981,1380.254324,Pt49_pre,49,NA,NAPt5_on,Pt5,Pt5_on,on,64,1.806179974,32,1.51851394,1,1,1,1,1,NIV3-NAIVE,4,TripleWt,19,0.296875,0.8,2.4,0.79937291,3.717723609,-0.754075825,155,300,Pt5_on,37,0.4502776,0.291849817,0.845070423,-443.2870191,1941.237138,1497.950119,0.678653257,0,0,0,0.134786872,0,0.080765369,0.042171709,0.056585699,0.009116064,0,0.031921424,0,0.059635468,0.173620849,0.091013445,0.180203517,0,0,0,0.002534033,0,0.137645552,0.323425713,0,0.031921424,0.444837811,0.002534033,0.19728102,Pt5_on_S0089494,0,0.048981084,0.087140441,0.068717867,20094,1847,null,7.50680017,0.308190763,2666.56006,0,410240,25481,2386,null,7.84064579,0.301213801,0.788587575,"Melanoma, Biopsy, Tissue",0.048981084,Pt5_on,on,0.049,1689,0.324,3,0.6452,0.2084,Pt5_on,0.860358671,13,1,0.983606557,0.983606557,1,0,0.163934426,0.557377049,61,0,1.776570466,1.776570466,1.806179974,0,0.296095077,1.006723264,CA209038-8-5,CA209038-8-5,5,CA209038,8,2,58,1,NA,SPAIN,NIV3-NAIVE,23-Oct-12,18-Dec-12,2-Jan-13,18-Dec-12,1-Jun-13,15-Apr-13,3-Jan-13,2-Jan-13,17-Dec-12,PD,PD,61.53846154,0,0,0,NA,NA,1,1136,162.2857143,222,31.71428571,PROGRESSION,17-Dec-12,61.53846154,NA,NA,17-Dec-12,56,8,1,61.53846154,2,NA,28-Mar-13,NA,PD,SDPD,1,1,Pt5,5-Aug,CA209038-8-5,58,FEMALE,23-Oct-12,18-Dec-12,NIV3-NAIVE,10-Oct-12,18-Dec-12,NA,2-Jan-13,PROGRESSION,17-Dec-12,PD,NA,28-Aug-12,-56,M1C WITHOUT BRAIN METASTASES,M1C,Pt5,CA209038-8-5,CA209038,SPAIN,8,5,CUTANEOUS,CUTANEOUS,128,NIVO 3 mg/kg Q2W,on,10.67,6-Jul-13,0,2,1,EVALUABLE,3,MACROPHAGES ONLY,YES,NA,2118,2044,2067,2149,7.03,1.61,0.78,1.37,7.26,4.28,1.44,1.06,22.82,50,27.17,NA,NA,1.518867925,1.29245283,0.150890347,0.128397376,0.408400528,0,0.171744147,0.07961305,0,0,0.098233011,0,0,0,0.089055482,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.404310979,435,694,549.4451747,NA,NA,NA,NAPt5_pre,Pt5,Pt5_pre,pre,52,1.716003344,26,1.431363764,1,1,1,1,1,NIV3-NAIVE,4,TripleWt,13,0.25,0.3,2,0.399644802,1.867330905,0.038762317,85,300,Pt5_pre,28,0.449883692,0.164277281,0.421052632,-425.9993857,2652.229902,2226.230516,0.59641256,0,0.026238041,0.018088539,0.163396563,0,0.112999143,0,0.0919423,0.002516297,0,0,0.050964902,0.051602012,0.080459877,0.077100383,0.212190069,0,0,0,0,0,0.112501876,0.370854303,0.04432658,0.050964902,0.369750329,0,0.164103888,Pt5_pre_S0089505,0,0.08298223,0.065484092,0.052636072,18829,5805,null,9.63715553,0.229217499,1474.88,0,226904,23425,7306,null,9.95570755,0.224323213,0.80379936,"Melanoma, Biopsy, Tissue",0.08298223,Pt5_pre,pre,0.083,5548,0.243,6,0.9366,0.6611,Pt5_pre,0.786372552,11,2,0.734693878,0.775510204,0.857142857,0,0.346938776,0.448979592,49,0.301029996,1.260737151,1.330778103,1.470860009,0,0.5953481,0.770450481,CA209038-8-5,CA209038-8-5,5,CA209038,8,2,58,1,NA,SPAIN,NIV3-NAIVE,23-Oct-12,18-Dec-12,2-Jan-13,18-Dec-12,1-Jun-13,15-Apr-13,3-Jan-13,2-Jan-13,17-Dec-12,PD,PD,61.53846154,0,0,0,NA,NA,1,1136,162.2857143,222,31.71428571,PROGRESSION,17-Dec-12,61.53846154,NA,NA,17-Dec-12,56,8,1,61.53846154,2,NA,28-Mar-13,NA,PD,SDPD,1,1,Pt5,5-Aug,CA209038-8-5,58,FEMALE,23-Oct-12,18-Dec-12,NIV3-NAIVE,10-Oct-12,18-Dec-12,NA,2-Jan-13,PROGRESSION,17-Dec-12,PD,NA,28-Aug-12,-56,M1C WITHOUT BRAIN METASTASES,M1C,Pt5,CA209038-8-5,CA209038,SPAIN,8,5,CUTANEOUS,CUTANEOUS,127,PRE-TREATMENT,pre,7.69,21-Jun-13,0,1,1,EVALUABLE,2,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,2225,2275,2048,2268,31.46,4.58,10.2,10.81,12.7,7.72,7.14,1.66,14,56.9,62.86,< 100 VIABLE TUMOR CELLS,NA,2.759036145,6.512048193,0.595578674,1.405721717,0.352833408,0,0.068987337,0.120024502,0,0,0.165664626,0,0,0,0,0,0,0,0.149360561,0,0.120092334,0,0,0,0,0,0,0,0,0,0,0,0,0,0.481501965,740,1357,1002.087821,NA,NA,NA,NAPt51_on,Pt51,Pt51_on,on,214,2.330413773,182,2.26245109,1,1,0,0,0,NIV3-PROG,1,BRAF,107,0.5,0.6,2,0.573290954,1.998120073,0.000777638,34,300,Pt51_on,6,0.092435454,0.276459173,0.708860759,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt51_on,0.961584216,3,2,0.980676329,0.980676329,0.980676329,0.93236715,0.975845411,0.975845411,207,0.301029996,2.285381624,2.285381624,2.285381624,2.172801248,2.274123586,2.274123586,CA209038-1-51,CA209038-1-51,51,CA209038,1,1,43,1,2,USA,NIV3-PROG,18-Feb-13,1-Apr-13,9-Apr-13,1-Apr-13,NA,15-Apr-13,NA,5-Apr-13,5-Apr-13,PD,PD,38.49206349,NA,0,1,NA,NA,1,916,130.8571429,57,8.142857143,PROGRESSION,5-Apr-13,38.49206349,NA,NA,5-Apr-13,47,6.714285714,1,38.49206349,1,V600E,10-Jul-13,NA,PD,SDPD,0,1,Pt51,Jan-51,CA209038-1-51,43,MALE,18-Feb-13,1-Apr-13,NIV3-PROG,5-Feb-13,1-Apr-13,NA,5-Apr-13,PROGRESSION,5-Apr-13,PD,NA,22-Jan-13,-27,M1A,M1A,Pt51,CA209038-1-51,CA209038,United States of America,1,51,CUTANEOUS,CUTANEOUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0.105421214,0.72051815,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.27948185,NA,NA,NA,NA,NA,NA,NAPt51_pre,Pt51,Pt51_pre,pre,204,2.309630167,168,2.227886705,1,1,0,0,0,NIV3-PROG,1,BRAF,98,0.480392157,0.6,2,0.629578495,2.003069447,-0.001393301,52,300,Pt51_pre,16,0.164683656,0.304245048,0.660714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt51_pre,0.971478585,2,2,0.97382199,0.97382199,0.97382199,0.958115183,0.97382199,0.97382199,191,0.301029996,2.249168646,2.249168646,2.249168646,2.212891731,2.249168646,2.249168646,CA209038-1-51,CA209038-1-51,51,CA209038,1,1,43,1,2,USA,NIV3-PROG,18-Feb-13,1-Apr-13,9-Apr-13,1-Apr-13,NA,15-Apr-13,NA,5-Apr-13,5-Apr-13,PD,PD,38.49206349,NA,0,1,NA,NA,1,916,130.8571429,57,8.142857143,PROGRESSION,5-Apr-13,38.49206349,NA,NA,5-Apr-13,47,6.714285714,1,38.49206349,1,V600E,10-Jul-13,NA,PD,SDPD,0,1,Pt51,Jan-51,CA209038-1-51,43,MALE,18-Feb-13,1-Apr-13,NIV3-PROG,5-Feb-13,1-Apr-13,NA,5-Apr-13,PROGRESSION,5-Apr-13,PD,NA,22-Jan-13,-27,M1A,M1A,Pt51,CA209038-1-51,CA209038,United States of America,1,51,CUTANEOUS,CUTANEOUS,8,PRE-TREATMENT,pre,25.68,18-Jun-13,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,918,874,881,836,7.63,2.07,3.89,0.46,16.8,5.86,7.78,4.88,27.14,5.88,87.76,NA,NA,0.424180328,0.094262295,0.080607477,0.017912773,0,0,0,0,0,0.073302317,0.775428353,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.224571647,NA,NA,NA,NA,NA,NA,NAPt52_on,Pt52,Pt52_on,on,356,2.551449998,633,2.802089258,1,1,1,1,1,NIV3-PROG,4,TripleWt,241,0.676966292,0.3,2.2,0.32743112,4.551247233,-0.503530773,31,300,Pt52_on,18,0.532233548,0.169122427,0.627659574,301.2518433,632.1040839,933.3559272,0.73712322,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt52_on_S0088563,0,0.137207488,0.020821489,0.016922478,56288,17628,null,12.1862478,0.136069044,2666.56006,0,410240,69257,22065,null,12.5523748,0.130087733,0.81274095,"Melanoma, Biopsy, Tissue",0.137207488,Pt52_on,on,0.137,16755,0.139,14,0.862,0.6646,Pt52_on,0.938555842,15,1,1,1,1,0,0.959302326,0.973837209,344,0,2.551449998,2.551449998,2.551449998,0,2.447611918,2.484696945,CA209038-4-52,CA209038-4-52,52,CA209038,4,2,45,1,2,USA,NIV3-PROG,25-Feb-13,15-Apr-13,29-Apr-13,15-Apr-13,15-Jun-14,28-Apr-14,NA,22-Apr-13,22-Apr-13,PD,PD,26.66666667,0,0,0,NA,NA,1,909,129.8571429,476,68,PROGRESSION,22-Apr-13,26.66666667,NA,NA,22-Apr-13,57,8.142857143,1,26.66666667,97,NA,24-Jul-13,NA,PD,SDPD,1,1,Pt52,Apr-52,CA209038-4-52,45,FEMALE,25-Feb-13,15-Apr-13,NIV3-PROG,8-Feb-13,15-Apr-13,NA,22-Apr-13,PROGRESSION,22-Apr-13,PD,NA,26-Mar-12,-336,M1C WITHOUT BRAIN METASTASES,M1C,Pt52,CA209038-4-52,CA209038,United States of America,4,52,CUTANEOUS,CUTANEOUS,68,NIVO 3 mg/kg Q2W,on,29.11,15-Jun-13,0,0,0,EVALUABLE,0,MACROPHAGES ONLY,YES,NA,1256,1375,1318,1509,10.11,6.69,6.84,4.73,16.16,5.1,7.29,5.31,63.78,36.17,83.12,< 1% + PM TUMOR CELLS,NA,1.259887006,0.890772128,0.229817932,0.162487118,0,0,0,0,0,0,0.674658506,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.162873875,0.325341494,275,197,232.7552362,Pt52_on,52,15,15Pt52_pre,Pt52,Pt52_pre,pre,353,2.547774705,631,2.800717078,1,1,1,1,1,NIV3-PROG,4,TripleWt,236,0.668555241,0.3,2.1,0.365319504,2.35377206,-0.090338461,29,300,Pt52_pre,8,0.203309165,0.126984127,0.52,327.033243,741.3538642,1068.387107,0.723585091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt52_pre_S0088568,0,0.115919949,0.009147303,0.008196581,47555,18444,null,12.8089838,0.096104279,2666.56006,0,410240,58561,22947,null,13.119381,0.094341777,0.81205922,"Melanoma, Biopsy, Tissue",0.115919949,Pt52_pre,pre,0.116,17840,0.098,15,0.8849,0.7337,Pt52_pre,0.658395871,6,3,0.340175953,0.53372434,0.765395894,0,0,0,341,0.477121255,0.866691688,1.359809373,1.950056298,0,0,0,CA209038-4-52,CA209038-4-52,52,CA209038,4,2,45,1,2,USA,NIV3-PROG,25-Feb-13,15-Apr-13,29-Apr-13,15-Apr-13,15-Jun-14,28-Apr-14,NA,22-Apr-13,22-Apr-13,PD,PD,26.66666667,0,0,0,NA,NA,1,909,129.8571429,476,68,PROGRESSION,22-Apr-13,26.66666667,NA,NA,22-Apr-13,57,8.142857143,1,26.66666667,97,NA,24-Jul-13,NA,PD,SDPD,1,1,Pt52,Apr-52,CA209038-4-52,45,FEMALE,25-Feb-13,15-Apr-13,NIV3-PROG,8-Feb-13,15-Apr-13,NA,22-Apr-13,PROGRESSION,22-Apr-13,PD,NA,26-Mar-12,-336,M1C WITHOUT BRAIN METASTASES,M1C,Pt52,CA209038-4-52,CA209038,United States of America,4,52,CUTANEOUS,CUTANEOUS,67,PRE-TREATMENT,pre,30.43,18-Jun-13,3,1,1,EVALUABLE,5,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,MACROPHAGES,1118,1281,1288,1307,7.6,2.5,0.86,0.47,5.36,2.14,3.21,1.94,32.94,18.18,100,NA,NA,1.288659794,0.242268041,0.082155767,0.015445284,0.067667758,0,0,0,0.066692402,0,0.670073113,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11386449,0.195566726,226,158,188.9656053,Pt52_pre,52,85,100Pt53_on,Pt53,Pt53_on,on,7,0.84509804,7,0.903089987,1,1,0,0,0,NIV3-PROG,4,TripleWt,4,0.571428571,0.3,2,0.3,1.974920872,0.005437464,25,300,Pt53_on,0,0,0.073033708,0.68,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-9-53,CA209038-9-53,53,CA209038,9,1,82,1,2,USA,NIV3-PROG,5-Mar-13,5-Nov-13,17-Dec-13,5-Nov-13,11-May-14,14-Feb-14,NA,NA,NA,PR,PRCR,-52.77777778,0,1,0,156,22.28571429,0,108,15.42857143,433,61.85714286,PARTIAL RESPONSE,22-Nov-13,-64.81481481,20-Jun-13,108,22-Nov-13,263,37.57142857,1,-64.81481481,2,NA,13-Feb-14,NA,PRCRSD,PRCR,1,0,Pt53,Sep-53,CA209038-9-53,82,MALE,5-Mar-13,5-Nov-13,NIV3-PROG,7-Feb-13,5-Nov-13,NA,NA,PARTIAL RESPONSE,NA,PR,NA,6-Jan-13,-58,M1C WITHOUT BRAIN METASTASES,M1C,Pt53,CA209038-9-53,CA209038,United States of America,9,53,OTHER: DERMAL,OTHER,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0.15762219,0,0,0.460828175,0,0,0,0,0.134777998,0,0,0,0,0,0,0,0,0.117562555,0.129209082,0,0,0,0,0,0,0,0,0,0.865222002,NA,NA,NA,NA,NA,NA,NAPt53_pre,Pt53,Pt53_pre,pre,81,1.908485019,88,1.949390007,1,1,0,0,0,NIV3-PROG,4,TripleWt,47,0.580246914,0.8,2.7,0.739031748,2.762516124,-0.358128193,203,300,Pt53_pre,52,0.253948645,0.225274725,0.848739496,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt53_pre,0.80531298,24,2,0.807692308,0.820512821,0.846153846,0.051282051,0.256410256,0.384615385,78,0.301029996,1.54146867,1.565936427,1.614871939,0.097871026,0.489355132,0.7340327,CA209038-9-53,CA209038-9-53,53,CA209038,9,1,82,1,2,USA,NIV3-PROG,5-Mar-13,5-Nov-13,17-Dec-13,5-Nov-13,11-May-14,14-Feb-14,NA,NA,NA,PR,PRCR,-52.77777778,0,1,0,156,22.28571429,0,108,15.42857143,433,61.85714286,PARTIAL RESPONSE,22-Nov-13,-64.81481481,20-Jun-13,108,22-Nov-13,263,37.57142857,1,-64.81481481,2,NA,13-Feb-14,NA,PRCRSD,PRCR,1,0,Pt53,Sep-53,CA209038-9-53,82,MALE,5-Mar-13,5-Nov-13,NIV3-PROG,7-Feb-13,5-Nov-13,NA,NA,PARTIAL RESPONSE,NA,PR,NA,6-Jan-13,-58,M1C WITHOUT BRAIN METASTASES,M1C,Pt53,CA209038-9-53,CA209038,United States of America,9,53,OTHER: DERMAL,OTHER,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.214634313,0,0.076143025,0,0,0.368470107,0.119967216,0,0,0,0,0,0.108725721,0,0,0,0,0,0,0,0,0.062013378,0,0,0,0,0,0,0,0,0.665398471,NA,NA,NA,NA,NA,NA,NAPt54_pre,Pt54,Pt54_pre,pre,7360,3.866877814,10697,4.029302594,1,0,0,0,0,NIV3-PROG,4,TripleWt,3277,0.445244565,0.7,2,0.744259805,1.954093098,0.024858984,70,300,Pt54_pre,19,0.188960302,0.353651475,0.966501241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-9-54,CA209038-9-54,54,CA209038,9,1,59,1,2,USA,NIV3-PROG,15-Apr-13,14-May-15,21-May-15,14-May-15,NA,27-Aug-15,NA,NA,NA,PR,PRCR,-85.71428571,NA,1,1,809,115.5714286,0,57,8.142857143,865,123.5714286,NA,27-Aug-15,-85.71428571,10-Jun-13,57,27-Aug-15,865,123.5714286,1,-85.71428571,2,NA,22-Aug-15,NA,PRCRSD,PRCR,0,0,Pt54,Sep-54,CA209038-9-54,59,MALE,15-Apr-13,14-May-15,NIV3-PROG,14-Feb-13,14-May-15,NA,NA,NA,NA,PR,NA,NA,NA,NA,NA,Pt54,CA209038-9-54,CA209038,United States of America,9,54,CUTANEOUS,CUTANEOUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.080287666,0,0,0,0,0,0.787404357,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11285883,0,0,0,0,0,0,0,0.132307977,NA,NA,NA,NA,NA,NA,NAPt58_on,Pt58,Pt58_on,on,1204,3.080626487,1865,3.270911639,1,1,0,0,1,NIV3-PROG,3,NF1,681,0.565614618,0.6,2.7,0.489363937,3.221569399,-0.377285927,38,300,Pt58_on,17,0.346129263,0.185639799,0.725490196,229.9661164,2208.356632,2438.322748,0.571138067,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt58_on,0.858042105,21,2,0.672217353,0.673970202,0.677475898,0.435582822,0.477651183,0.50219106,1141,0.301029996,2.070850583,2.076250456,2.087050196,1.341867979,1.471464886,1.547063081,CA209038-1-58,CA209038-1-58,58,CA209038,1,2,53,1,2,USA,NIV3-PROG,11-Mar-13,12-Aug-13,9-Sep-13,12-Aug-13,22-Jul-14,15-May-14,20-Sep-13,1-Jul-13,1-Jul-13,SD,SD,-3.105590062,0,0,0,NA,NA,1,895,127.8571429,499,71.28571429,STABLE DISEASE,9-Sep-13,-3.105590062,NA,NA,1-Jul-13,113,16.14285714,1,-3.105590062,2,NA,20-Nov-13,NA,PRCRSD,SDPD,1,1,Pt58,Jan-58,CA209038-1-58,53,FEMALE,11-Mar-13,12-Aug-13,NIV3-PROG,19-Feb-13,12-Aug-13,NA,1-Jul-13,STABLE DISEASE,1-Jul-13,SD,NA,27-Dec-12,-74,M1C WITHOUT BRAIN METASTASES,M1C,Pt58,CA209038-1-58,CA209038,United States of America,1,58,CUTANEOUS,CUTANEOUS,10,NIVO 3 mg/kg Q2W,on,17.24,21-Jun-13,3,3,2,EVALUABLE,8,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,2168,1794,2332,1856,31.83,18.36,6.47,7.8,44.51,15.14,21.82,7.8,53.33,44.83,91.1,NA,NA,2.353846154,1,1.064965197,0.452436195,0,0,0,0,0,0,0.483255938,0,0,0,0.368296127,0,0,0,0,0,0,0,0,0,0,0,0.071387871,0,0,0,0,0,0,0,0.148447935,1185,1107,1145.336195,Pt58_on,58,85,8Pt58_pre,Pt58,Pt58_pre,pre,862,2.935507266,1375,3.138618434,1,1,0,0,1,NIV3-PROG,3,NF1,493,0.571925754,0.7,2.9,0.64176755,3.301528389,-0.503490547,43,300,Pt58_pre,20,0.349578451,0.318992313,0.92,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt58_pre,0.98624227,20,2,0.948148148,0.951851852,0.951851852,0.825925926,0.887654321,0.902469136,810,0.301029996,2.783295778,2.794168028,2.794168028,2.424511557,2.605715709,2.649204706,CA209038-1-58,CA209038-1-58,58,CA209038,1,2,53,1,2,USA,NIV3-PROG,11-Mar-13,12-Aug-13,9-Sep-13,12-Aug-13,22-Jul-14,15-May-14,20-Sep-13,1-Jul-13,1-Jul-13,SD,SD,-3.105590062,0,0,0,NA,NA,1,895,127.8571429,499,71.28571429,STABLE DISEASE,9-Sep-13,-3.105590062,NA,NA,1-Jul-13,113,16.14285714,1,-3.105590062,2,NA,20-Nov-13,NA,PRCRSD,SDPD,1,1,Pt58,Jan-58,CA209038-1-58,53,FEMALE,11-Mar-13,12-Aug-13,NIV3-PROG,19-Feb-13,12-Aug-13,NA,1-Jul-13,STABLE DISEASE,1-Jul-13,SD,NA,27-Dec-12,-74,M1C WITHOUT BRAIN METASTASES,M1C,Pt58,CA209038-1-58,CA209038,United States of America,1,58,CUTANEOUS,CUTANEOUS,9,PRE-TREATMENT,pre,27.32,18-Jun-13,0,1,1,EVALUABLE,2,MACROPHAGES ONLY,YES,NA,1897,2065,2060,2056,7.12,3.95,1.84,1.5,8.88,8.9,12.4,2.67,52.59,18.42,91.26,NA,NA,1.479400749,0.561797753,0.144582723,0.054904832,0.073129582,0,0,0,0,0,0.71083646,0,0,0,0.08013974,0,0,0,0,0,0,0,0,0,0,0,0.07005796,0,0,0,0,0,0,0,0.135894219,NA,NA,NA,Pt58_pre,58,98,75Pt59_on,Pt59,Pt59_on,on,8,0.903089987,4,0.698970004,1,1,1,1,0,NIV3-NAIVE,4,TripleWt,4,0.5,0.3,2,NA,2,-0.001236904,23,300,Pt59_on,0,0,0.063860252,0.173076923,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt59_on_S0101359,0,0.596514236,0.036765367,0.035912052,244714,26132,null,9.83515453,0.329734951,2666.56006,0,410240,301041,33113,null,10.1356602,0.324969292,0.812892596,"Melanoma, Biopsy, Tissue",0.596514236,Pt59_on,on,0.597,22319,0.333,20,0.7634,0.1834,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-1-59,CA209038-1-59,59,CA209038,1,2,49,1,2,USA,NIV3-NAIVE,22-Mar-13,16-Jul-13,16-Aug-13,16-Jul-13,27-Feb-15,2-Jan-15,1-Aug-13,10-Jul-13,10-Jul-13,SD,SD,-12.32876712,0,0,0,NA,NA,1,986,140.8571429,708,101.1428571,STABLE DISEASE,10-Jul-13,-12.32876712,NA,NA,10-Jul-13,111,15.85714286,1,-12.32876712,2,NA,24-Oct-13,NA,PRCRSD,SDPD,1,1,Pt59,Jan-59,CA209038-1-59,49,FEMALE,22-Mar-13,16-Jul-13,NIV3-NAIVE,25-Feb-13,16-Jul-13,NA,10-Jul-13,STABLE DISEASE,10-Jul-13,SD,NA,14-Jan-13,-67,M1A,M1A,Pt59,CA209038-1-59,CA209038,United States of America,1,59,CUTANEOUS,CUTANEOUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0.119908743,0,0,0,0,0,0,0,0,0,0.505476831,0,0,0.227058481,0.079929237,0,0,0,0.067626708,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NAPt59_pre,Pt59,Pt59_pre,pre,432,2.635483747,478,2.680335513,1,1,1,1,0,NIV3-NAIVE,2,RAS,220,0.509259259,0.4,2.5,0.335196367,2.909282256,-0.204634122,46,300,Pt59_pre,15,0.315857216,0.222222222,0.623809524,800.7541462,2508.715419,3309.469565,0.461794594,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt59_pre_S0101354,0,0.185161715,0.036126748,0.029405437,75678,14660,null,10.4132786,0.247573569,2656.63989,0,408713,92976,18475,null,10.7733278,0.239885032,0.813951988,"Melanoma, Biopsy, Tissue",0.185161715,Pt59_pre,pre,0.185,13873,0.251,14,0.8341,0.4547,Pt59_pre,0.993679183,3,1,1,1,1,1,1,1,413,0,2.635483747,2.635483747,2.635483747,2.635483747,2.635483747,2.635483747,CA209038-1-59,CA209038-1-59,59,CA209038,1,2,49,1,2,USA,NIV3-NAIVE,22-Mar-13,16-Jul-13,16-Aug-13,16-Jul-13,27-Feb-15,2-Jan-15,1-Aug-13,10-Jul-13,10-Jul-13,SD,SD,-12.32876712,0,0,0,NA,NA,1,986,140.8571429,708,101.1428571,STABLE DISEASE,10-Jul-13,-12.32876712,NA,NA,10-Jul-13,111,15.85714286,1,-12.32876712,2,NA,24-Oct-13,NA,PRCRSD,SDPD,1,1,Pt59,Jan-59,CA209038-1-59,49,FEMALE,22-Mar-13,16-Jul-13,NIV3-NAIVE,25-Feb-13,16-Jul-13,NA,10-Jul-13,STABLE DISEASE,10-Jul-13,SD,NA,14-Jan-13,-67,M1A,M1A,Pt59,CA209038-1-59,CA209038,United States of America,1,59,CUTANEOUS,CUTANEOUS,11,PRE-TREATMENT,pre,43.47,18-Jun-13,0,1,1,EVALUABLE,2,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,1329,1605,1403,1452,25.21,11.06,38.88,25.67,64.43,54.82,63.98,28.94,42.69,49.36,97.36,NA,NA,0.382170007,0.887007602,0.254428341,0.590522199,0,0,0,0,0,0,0.792214084,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.207785916,1176,1562,1355.327267,NA,NA,NA,NAPt60_on,Pt60,Pt60_on,on,854,2.931457871,1461,3.164947373,1,1,0,0,0,NIV3-NAIVE,2,RAS,529,0.619437939,0.5,2,0.517754412,1.992458715,0.002819278,46,300,Pt60_on,6,0.054334374,0.254975248,0.700564972,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt60_on,0.978102199,36,3,0.97705314,0.97705314,0.97826087,0.890096618,0.949275362,0.963768116,828,0.477121255,2.864190117,2.864190117,2.867730527,2.609280737,2.782760731,2.825245629,CA209038-5-60,CA209038-5-60,60,CA209038,5,1,50,1,2,USA,NIV3-NAIVE,5-Mar-13,11-Jun-13,19-Jun-13,11-Jun-13,NA,12-Mar-15,2-Jul-13,19-Jun-13,24-Apr-13,PD,PD,8.333333333,NA,0,1,NA,NA,1,1003,143.2857143,738,105.4285714,PROGRESSION,19-Jun-13,8.333333333,NA,NA,24-Apr-13,51,7.285714286,1,8.333333333,97,NA,19-Sep-13,NA,PD,SDPD,0,1,Pt60,May-60,CA209038-5-60,50,MALE,5-Mar-13,11-Jun-13,NIV3-NAIVE,26-Feb-13,11-Jun-13,NA,19-Jun-13,PROGRESSION,24-Apr-13,PD,NA,11-Nov-12,-114,M1A,M1A,Pt60,CA209038-5-60,CA209038,United States of America,5,60,CUTANEOUS,CUTANEOUS,76,NIVO 3 mg/kg Q2W,on,61.54,15-Jun-13,NA,NA,NA,INDETERMINATE,NA,NA,NA,NA,1106,1970,1527,1944,81.37,46.29,0.1,61.57,0.85,72.94,88.48,91.81,56.89,50,99.37,NA,HIGH MELANIN CONTENT,0.504193443,0.670624115,0.752193695,1.000487488,0,0,0,0,0,0,0.906957728,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.093042272,NA,NA,NA,NA,NA,NA,NAPt60_pre,Pt60,Pt60_pre,pre,829,2.918554531,1410,3.149527014,1,1,0,0,0,NIV3-NAIVE,2,RAS,510,0.615199035,0.3,2.1,0.299521237,1.957959845,0.009111864,36,300,Pt60_pre,4,0.054218676,0.138211382,0.46,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt60_pre,0.902179501,42,2,0.987531172,0.99127182,0.99127182,0,0.60723192,0.947630923,802,0.301029996,2.882163576,2.893080861,2.893080861,0,1.772239471,2.765712524,CA209038-5-60,CA209038-5-60,60,CA209038,5,1,50,1,2,USA,NIV3-NAIVE,5-Mar-13,11-Jun-13,19-Jun-13,11-Jun-13,NA,12-Mar-15,2-Jul-13,19-Jun-13,24-Apr-13,PD,PD,8.333333333,NA,0,1,NA,NA,1,1003,143.2857143,738,105.4285714,PROGRESSION,19-Jun-13,8.333333333,NA,NA,24-Apr-13,51,7.285714286,1,8.333333333,97,NA,19-Sep-13,NA,PD,SDPD,0,1,Pt60,May-60,CA209038-5-60,50,MALE,5-Mar-13,11-Jun-13,NIV3-NAIVE,26-Feb-13,11-Jun-13,NA,19-Jun-13,PROGRESSION,24-Apr-13,PD,NA,11-Nov-12,-114,M1A,M1A,Pt60,CA209038-5-60,CA209038,United States of America,5,60,CUTANEOUS,CUTANEOUS,75,PRE-TREATMENT,pre,52.27,15-Jun-13,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,1045,1734,832,1565,81.15,48.04,2.48,43.94,10.58,65.24,83.64,68.39,59.2,27.91,96.57,NA,NA,0.702441877,0.642491592,0.919074039,0.840635164,0,0,0,0,0,0,0.906495665,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.093504335,NA,NA,NA,NA,NA,NA,NAPt62_on,Pt62,Pt62_on,on,NA,NA,NA,NA,0,0,0,1,1,NIV3-NAIVE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-828.8795272,-56.84174581,-885.721273,0.889304798,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-6-62,CA209038-6-62,62,CA209038,6,1,51,1,2,USA,NIV3-NAIVE,12-Mar-13,18-Jun-13,3-Jul-13,18-Jun-13,26-Jun-14,9-Oct-13,3-Jul-13,2-Jul-13,6-May-13,PD,PD,21.66666667,0,0,0,NA,NA,1,996,142.2857143,472,67.42857143,PROGRESSION,2-Jul-13,21.66666667,NA,NA,6-May-13,56,8,1,21.66666667,2,NA,26-Sep-13,NA,PD,SDPD,1,1,Pt62,Jun-62,CA209038-6-62,51,MALE,12-Mar-13,18-Jun-13,NIV3-NAIVE,26-Feb-13,18-Jun-13,NA,2-Jul-13,PROGRESSION,6-May-13,PD,NA,22-Jan-13,-49,M1C WITHOUT BRAIN METASTASES,M1C,Pt62,CA209038-6-62,CA209038,United States of America,6,62,OCULAR/UVEAL,OCULAR/UVEAL,96,NIVO 3 mg/kg Q2W,on,0,4-Dec-13,0,0,1,EVALUABLE,1,MACROPHAGES ONLY,YES,NA,2388,2366,2272,2438,3.1,1.05,1.01,0.38,0.22,2.87,10.3,6.51,32.43,4.17,77.14,NA,NA,0.161290323,0.058371736,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,141,79,105.541461,Pt62_on,62,80,70Pt62_pre,Pt62,Pt62_pre,pre,NA,NA,NA,NA,0,0,0,1,1,NIV3-NAIVE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1359.849126,208.0540002,-1151.795126,0.906483212,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-6-62,CA209038-6-62,62,CA209038,6,1,51,1,2,USA,NIV3-NAIVE,12-Mar-13,18-Jun-13,3-Jul-13,18-Jun-13,26-Jun-14,9-Oct-13,3-Jul-13,2-Jul-13,6-May-13,PD,PD,21.66666667,0,0,0,NA,NA,1,996,142.2857143,472,67.42857143,PROGRESSION,2-Jul-13,21.66666667,NA,NA,6-May-13,56,8,1,21.66666667,2,NA,26-Sep-13,NA,PD,SDPD,1,1,Pt62,Jun-62,CA209038-6-62,51,MALE,12-Mar-13,18-Jun-13,NIV3-NAIVE,26-Feb-13,18-Jun-13,NA,2-Jul-13,PROGRESSION,6-May-13,PD,NA,22-Jan-13,-49,M1C WITHOUT BRAIN METASTASES,M1C,Pt62,CA209038-6-62,CA209038,United States of America,6,62,OCULAR/UVEAL,OCULAR/UVEAL,95,PRE-TREATMENT,pre,36.84,18-Jun-13,0,0,0,EVALUABLE,0,MACROPHAGES ONLY,YES,NA,2350,2259,2222,2342,5.91,2.85,0.58,0.71,5.99,1.28,7.86,15.12,44.6,38.46,96.67,< 1% + PM TUMOR CELLS,NA,0.188492063,0.046957672,0.077361564,0.01927253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,136,10,36.87817783,Pt62_pre,62,97,92Pt65_on,Pt65,Pt65_on,on,NA,NA,NA,NA,1,0,0,1,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,547.1965781,1803.434216,2350.630794,0.581656625,0.013363131,0,0,0.123289039,0,0.104283524,0.126590947,0.104054375,0,0,0,0.022726473,0.043315914,0.079176849,0.115552827,0.183483013,0,0.026195577,0.057968332,0,0,0,0.458217885,0.013363131,0.022726473,0.378212689,0.057968332,0.069511491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-6-65,CA209038-6-65,65,CA209038,6,2,63,1,2,USA,NIV3-PROG,15-Mar-13,6-Dec-13,20-Dec-13,6-Dec-13,NA,4-Feb-15,22-Jan-14,19-Dec-13,NA,SD,SD,6.25,NA,1,1,NA,NA,1,891,127.2857143,692,98.85714286,STABLE DISEASE,19-Dec-13,6.25,NA,NA,19-Dec-13,280,40,1,6.25,2,NA,16-Mar-14,NA,PRCRSD,SDPD,0,0,Pt65,Jun-65,CA209038-6-65,63,FEMALE,15-Mar-13,6-Dec-13,NIV3-PROG,1-Mar-13,6-Dec-13,NA,19-Dec-13,STABLE DISEASE,NA,SD,1,20-Jan-11,-785,M1B,M1B,Pt65,CA209038-6-65,CA209038,United States of America,6,65,ACRAL,ACRAL,101,NIVO 3 mg/kg Q2W,on,11.54,4-Dec-13,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,1598,1664,1533,1676,3.57,0.69,2.1,0.24,3.39,3.4,1.67,0.59,17.54,2.86,38.6,NA,NA,1.169491525,0.406779661,0.059792028,0.020797227,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,978,484,688.0058139,Pt65_on,65,99,98Pt65_pre,Pt65,Pt65_pre,pre,2619,3.418135498,3880,3.588943643,1,0,0,1,1,NIV3-PROG,4,TripleWt,1570,0.599465445,0.5,2.4,0.443231294,3.181314622,-0.335480745,149,300,Pt65_pre,43,0.303008275,0.082872928,0.579710145,463.5691537,1535.807671,1999.376825,0.622805753,0.032023581,0,0.008731087,0.081279726,0,0.150595548,0.103725798,0.1358761,0,0,0,0.003916336,0.034408367,0.084508431,0.092885547,0.180374799,0,0.029507638,0.062167043,0,0,0,0.471477172,0.040754668,0.003916336,0.357768777,0.062167043,0.063916005,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt65_pre,0.359805634,710,3,0.005919495,0.005919495,0.006314128,0.002762431,0.003157064,0.003157064,2534,0.477121255,0.020233636,0.020233636,0.021582545,0.009442363,0.010791273,0.010791273,CA209038-6-65,CA209038-6-65,65,CA209038,6,2,63,1,2,USA,NIV3-PROG,15-Mar-13,6-Dec-13,20-Dec-13,6-Dec-13,NA,4-Feb-15,22-Jan-14,19-Dec-13,NA,SD,SD,6.25,NA,1,1,NA,NA,1,891,127.2857143,692,98.85714286,STABLE DISEASE,19-Dec-13,6.25,NA,NA,19-Dec-13,280,40,1,6.25,2,NA,16-Mar-14,NA,PRCRSD,SDPD,0,0,Pt65,Jun-65,CA209038-6-65,63,FEMALE,15-Mar-13,6-Dec-13,NIV3-PROG,1-Mar-13,6-Dec-13,NA,19-Dec-13,STABLE DISEASE,NA,SD,1,20-Jan-11,-785,M1B,M1B,Pt65,CA209038-6-65,CA209038,United States of America,6,65,ACRAL,ACRAL,100,PRE-TREATMENT,pre,23.53,18-Jun-13,0,0,0,EVALUABLE,0,MACROPHAGES ONLY,YES,NA,1297,1500,1669,1588,7.25,2.85,1.73,0.53,4.07,1.76,5.29,1.14,37.23,7.69,92.86,NA,NA,2.5,0.464912281,0.121121972,0.022524437,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,544,266,380.3997897,Pt65_pre,65,90,100Pt66_on,Pt66,Pt66_on,on,151,2.178976947,212,2.328379603,1,1,0,1,0,NIV3-NAIVE,1,BRAF,84,0.556291391,0.8,2.5,0.878624446,1.761725003,0.159520038,63,300,Pt66_on,28,0.53057101,0.415307403,0.883333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt66_on,0.771658241,40,5,0.496503497,0.524475524,0.657342657,0.286713287,0.384615385,0.426573427,143,0.698970004,1.081869674,1.142820076,1.432334496,0.624741643,0.838068057,0.929493664,CA209038-3-66,CA209038-3-66,66,CA209038,3,2,49,1,2,USA,NIV3-NAIVE,11-Mar-13,29-Apr-13,13-May-13,29-Apr-13,3-Sep-14,30-Aug-14,15-May-13,8-May-13,8-May-13,PD,PD,21.81818182,0,0,0,NA,NA,1,997,142.4285714,542,77.42857143,PROGRESSION,8-May-13,21.81818182,NA,NA,8-May-13,59,8.428571429,1,21.81818182,2,NA,7-Aug-13,NA,PD,SDPD,1,1,Pt66,Mar-66,CA209038-3-66,49,FEMALE,11-Mar-13,29-Apr-13,NIV3-NAIVE,4-Mar-13,29-Apr-13,NA,8-May-13,PROGRESSION,8-May-13,PD,NA,12-Oct-12,-150,UNKNOWN,UNKNOWN,Pt66,CA209038-3-66,CA209038,United States of America,3,66,CUTANEOUS,CUTANEOUS,51,NIVO 3 mg/kg Q2W,on,NA,13-Mar-14,6,2,0,EVALUABLE,8,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0.077337643,0.067206816,0.755383693,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.167278665,NA,NA,NA,Pt66_on,66,100,98Pt66_pre,Pt66,Pt66_pre,pre,153,2.184691431,236,2.374748346,1,1,0,1,0,NIV3-NAIVE,1,BRAF,92,0.60130719,0.9,2.4,0.915798437,1.830066799,0.11686764,57,300,Pt66_pre,27,0.527699641,0.423913043,0.957627119,-754.8631205,98.51985161,-656.3432689,0.873405857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt66_pre,0.777857714,51,7,0.517241379,0.606896552,0.703448276,0.082758621,0.220689655,0.379310345,145,0.84509804,1.130012808,1.325881697,1.536817421,0.18080205,0.482138798,0.82867606,CA209038-3-66,CA209038-3-66,66,CA209038,3,2,49,1,2,USA,NIV3-NAIVE,11-Mar-13,29-Apr-13,13-May-13,29-Apr-13,3-Sep-14,30-Aug-14,15-May-13,8-May-13,8-May-13,PD,PD,21.81818182,0,0,0,NA,NA,1,997,142.4285714,542,77.42857143,PROGRESSION,8-May-13,21.81818182,NA,NA,8-May-13,59,8.428571429,1,21.81818182,2,NA,7-Aug-13,NA,PD,SDPD,1,1,Pt66,Mar-66,CA209038-3-66,49,FEMALE,11-Mar-13,29-Apr-13,NIV3-NAIVE,4-Mar-13,29-Apr-13,NA,8-May-13,PROGRESSION,8-May-13,PD,NA,12-Oct-12,-150,UNKNOWN,UNKNOWN,Pt66,CA209038-3-66,CA209038,United States of America,3,66,CUTANEOUS,CUTANEOUS,50,PRE-TREATMENT,pre,16.15,28-Aug-13,2,1,0,EVALUABLE,3,MACROPHAGES ONLY,YES,MACROPHAGES,2231,2236,2297,2131,6.86,1.88,0.85,0.63,15.37,6.52,13.7,2.61,26.8,15.79,91.37,NA,NA,0.720306513,0.24137931,0.116408669,0.039009288,0,0,0,0,0.121562926,0,0.745177415,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.133259659,104,67,83.47454702,NA,NA,NA,NAPt67_on,Pt67,Pt67_on,on,10,1,12,1.113943352,1,1,1,1,1,NIV3-PROG,4,TripleWt,7,0.7,0.4,2,NA,2,-0.00166617,23,300,Pt67_on,0,0,0.060241875,0.078571429,NA,NA,NA,NA,0.059695496,0,0,0.131246743,0,0.29372848,0.026590965,0,0.056630141,0.012180367,0,0.024376911,0,0,0.069366863,0.170326892,0,0,0.15300103,0,0.002856112,0,0.520376696,0.059695496,0.024376911,0.239693755,0.155857142,0,Pt67_on_S0088562,0,0.112105109,0.097434223,0.117093481,45990,11883,null,10.0371799,0.258516103,2666.56006,0,410240,68219,14556,null,9.3446188,0.32428968,0.674152362,"Melanoma, Biopsy, Tissue",0.112105109,Pt67_on,on,0.112,11409,0.262,11,0.8915,0.598,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-4-67,CA209038-4-67,67,CA209038,4,2,33,1,2,USA,NIV3-PROG,18-Mar-13,27-Jan-14,17-Feb-14,27-Jan-14,NA,13-Jan-16,14-Mar-14,26-Feb-14,23-Dec-13,SD,SD,0,NA,0,1,NA,NA,1,888,126.8571429,1032,147.4285714,STABLE DISEASE,26-Feb-14,0,NA,NA,23-Dec-13,281,40.14285714,1,0,2,NA,7-May-14,NA,PRCRSD,SDPD,0,1,Pt67,Apr-67,CA209038-4-67,33,FEMALE,18-Mar-13,27-Jan-14,NIV3-PROG,4-Mar-13,27-Jan-14,NA,26-Feb-14,STABLE DISEASE,23-Dec-13,SD,1,8-Mar-10,-1106,M1C WITHOUT BRAIN METASTASES,M1C,Pt67,CA209038-4-67,CA209038,United States of America,4,67,OCULAR/UVEAL,OCULAR/UVEAL,70,NIVO 3 mg/kg Q2W,on,NA,8-Aug-13,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO DEFINITIVE TUMOR,NA,NA,NA,NA,NA,0,0,0.635033203,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.311863856,0,0,0,0,0,0,0,0,0,0,1,346,132,213.710084,Pt67_on,67,NA,NAPt67_pre,Pt67,Pt67_pre,pre,16,1.204119983,21,1.342422681,1,1,1,1,1,NIV3-PROG,4,TripleWt,9,0.5625,0.5,2.1,0.221113385,2.080482082,-0.012780086,32,300,Pt67_pre,2,0.028951463,0.085884522,0.148148148,NA,NA,NA,NA,0.122684983,0,0.036416303,0.184496803,0,0.15397167,0,0.01798201,0.011118121,0,0,0.030726851,0,0.053204463,0.041047225,0.195644191,0,0,0.152707379,0,0,0,0.367568604,0.159101286,0.030726851,0.289895879,0.152707379,0,Pt67_pre_S0088560,0,0.111844286,0.08107578,0.085318074,45883,11838,null,10.1417255,0.250489801,2666.56006,0,410240,64828,14377,null,9.69243622,0.298233062,0.707765163,"Melanoma, Biopsy, Tissue",0.111844286,Pt67_pre,pre,0.112,11445,0.253,11,0.8847,0.6,Pt67_pre,0.71756184,9,1,0.923076923,0.923076923,0.923076923,0,0,0.153846154,13,0,1.111495369,1.111495369,1.111495369,0,0,0.185249228,CA209038-4-67,CA209038-4-67,67,CA209038,4,2,33,1,2,USA,NIV3-PROG,18-Mar-13,27-Jan-14,17-Feb-14,27-Jan-14,NA,13-Jan-16,14-Mar-14,26-Feb-14,23-Dec-13,SD,SD,0,NA,0,1,NA,NA,1,888,126.8571429,1032,147.4285714,STABLE DISEASE,26-Feb-14,0,NA,NA,23-Dec-13,281,40.14285714,1,0,2,NA,7-May-14,NA,PRCRSD,SDPD,0,1,Pt67,Apr-67,CA209038-4-67,33,FEMALE,18-Mar-13,27-Jan-14,NIV3-PROG,4-Mar-13,27-Jan-14,NA,26-Feb-14,STABLE DISEASE,23-Dec-13,SD,1,8-Mar-10,-1106,M1C WITHOUT BRAIN METASTASES,M1C,Pt67,CA209038-4-67,CA209038,United States of America,4,67,OCULAR/UVEAL,OCULAR/UVEAL,69,PRE-TREATMENT,pre,NA,8-Aug-13,0,0,0,UNEVALUABLE,0,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO DEFINITIVE TUMOR,NA,NA,NA,NA,NA,0.317227338,0,0.361604697,0,0,0.167641261,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.153526704,0,0.682772662,274,169,215.1882896,Pt67_pre,67,NA,NAPt68_on,Pt68,Pt68_on,on,NA,NA,NA,NA,1,0,0,0,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1074.232175,-317.2363535,-1391.468528,0.920774225,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-6-68,CA209038-6-68,68,CA209038,6,1,69,1,2,USA,NIV3-PROG,18-Mar-13,31-Mar-15,16-Apr-15,31-Mar-15,NA,7-Jul-15,12-May-15,NA,NA,PR,PRCR,-73.68421053,NA,1,1,704,100.5714286,0,56,8,842,120.2857143,COMPLETE RESPONSE,15-Apr-15,-73.68421053,12-May-13,56,15-Apr-15,759,108.4285714,1,-73.68421053,2,NA,9-Jul-15,NA,PRCRSD,PRCR,0,0,Pt68,Jun-68,CA209038-6-68,69,MALE,18-Mar-13,31-Mar-15,NIV3-PROG,4-Mar-13,31-Mar-15,NA,NA,COMPLETE RESPONSE,NA,PR,NA,15-Aug-12,-215,M1B,M1B,Pt68,CA209038-6-68,CA209038,United States of America,6,68,CUTANEOUS,CUTANEOUS,103,NIVO 3 mg/kg Q2W,on,NA,22-Nov-13,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,RARE POSSIBLE ATYPICAL CELLS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,50,70,59.16079783,Pt68_on,68,NA,NAPt68_pre,Pt68,Pt68_pre,pre,1012,3.005180513,1814,3.258876629,1,0,0,0,1,NIV3-PROG,4,TripleWt,608,0.600790514,0.3,2.1,0.219679583,1.89554623,0.016647987,39,300,Pt68_pre,6,0.142175275,0.108420407,0.366666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt68_pre,0.934710673,126,1,1,1,1,0,0.981762918,1,987,0,3.005180513,3.005180513,3.005180513,0,2.950374789,3.005180513,CA209038-6-68,CA209038-6-68,68,CA209038,6,1,69,1,2,USA,NIV3-PROG,18-Mar-13,31-Mar-15,16-Apr-15,31-Mar-15,NA,7-Jul-15,12-May-15,NA,NA,PR,PRCR,-73.68421053,NA,1,1,704,100.5714286,0,56,8,842,120.2857143,COMPLETE RESPONSE,15-Apr-15,-73.68421053,12-May-13,56,15-Apr-15,759,108.4285714,1,-73.68421053,2,NA,9-Jul-15,NA,PRCRSD,PRCR,0,0,Pt68,Jun-68,CA209038-6-68,69,MALE,18-Mar-13,31-Mar-15,NIV3-PROG,4-Mar-13,31-Mar-15,NA,NA,COMPLETE RESPONSE,NA,PR,NA,15-Aug-12,-215,M1B,M1B,Pt68,CA209038-6-68,CA209038,United States of America,6,68,CUTANEOUS,CUTANEOUS,102,PRE-TREATMENT,pre,24.81,15-Jun-13,1,3,1,EVALUABLE,5,MACROPHAGES ONLY,YES,NA,1948,1829,2303,1964,53.08,27.93,14.71,6.45,45.68,38.29,52.49,13.63,50,19.33,92.29,NA,NA,2.049156273,0.473220836,1.125755744,0.259975816,0.07914025,0,0,0,0,0,0.864205258,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.056654492,NA,NA,NA,Pt68_pre,68,55,40Pt69_on,Pt69,Pt69_on,on,NA,NA,NA,NA,0,0,0,0,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1909.016469,3776.958241,5685.974711,0.130798141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-6-69,CA209038-6-69,69,CA209038,6,2,75,1,2,USA,NIV3-PROG,18-Mar-13,31-Mar-14,15-Apr-14,31-Mar-14,NA,14-Apr-15,NA,NA,NA,CR,PRCR,-100,NA,1,1,337,48.14285714,0,56,8,758,108.2857143,COMPLETE RESPONSE,13-Apr-14,-100,12-May-13,56,13-Apr-14,392,56,1,-100,2,NA,9-Jul-14,NA,PRCRSD,PRCR,0,0,Pt69,Jun-69,CA209038-6-69,75,FEMALE,18-Mar-13,31-Mar-14,NIV3-PROG,4-Mar-13,31-Mar-14,NA,NA,COMPLETE RESPONSE,NA,CR,NA,2-Feb-12,-410,M1A,M1A,Pt69,CA209038-6-69,CA209038,United States of America,6,69,ACRAL,ACRAL,105,NIVO 3 mg/kg Q2W,on,48.27,4-Dec-13,0,0,0,EVALUABLE,0,MACROPHAGES ONLY,YES,NA,2279,2541,2288,2418,84.47,26.2,34.99,63.91,90.91,85.53,75.81,47.07,31.01,82.45,86.85,NA,NA,0.556617803,1.357765031,0.542780195,1.324010773,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4734,2012,3086.228767,Pt69_on,69,75,25Pt7_on,Pt7,Pt7_on,on,5,0.698970004,4,0.698970004,1,1,0,0,0,NIV3-NAIVE,4,TripleWt,2,0.4,0.5,2,NA,2,0.008942657,23,300,Pt7_on,0,0,0.071428571,0.086956522,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-12-7,CA209038-12-7,7,CA209038,12,1,55,1,2,USA,NIV3-NAIVE,29-Oct-12,17-Mar-14,31-Mar-14,17-Mar-14,NA,21-Dec-15,NA,NA,NA,PR,PRCR,-100,NA,1,1,393,56.14285714,0,54,7.714285714,1149,164.1428571,COMPLETE RESPONSE,17-Jan-14,-100,21-Dec-12,54,17-Jan-14,446,63.71428571,1,-100,2,NA,25-Jun-14,NA,PRCRSD,PRCR,0,0,Pt7,7-Dec,CA209038-12-7,55,MALE,29-Oct-12,17-Mar-14,NIV3-NAIVE,22-Oct-12,17-Mar-14,NA,NA,COMPLETE RESPONSE,NA,PR,NA,22-Oct-12,-7,M1C WITHOUT BRAIN METASTASES,M1C,Pt7,CA209038-12-7,CA209038,United States of America,12,7,CUTANEOUS,CUTANEOUS,38,NIVO 3 mg/kg Q2W,on,NA,13-May-13,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO TISSUE ON SLIDE,NA,NA,NA,NA,NA,0.34993637,0,0,0.112324204,0,0,0,0,0,0,0.275050298,0.26268911,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.375013332,NA,NA,NA,Pt7_on,7,9,1Pt7_pre,Pt7,Pt7_pre,pre,1517,3.180985581,1239,3.093421685,1,1,0,0,0,NIV3-NAIVE,3,NF1,757,0.499011206,0.9,3.6,0.805425689,3.620493251,-0.724731852,64,300,Pt7_pre,23,0.459645641,0.440816327,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt7_pre,0.986749134,41,3,0.991891892,0.991891892,0.992567568,0.966891892,0.981756757,0.988513514,1480,0.477121255,3.155193806,3.155193806,3.157343122,3.075669167,3.122954088,3.144447234,CA209038-12-7,CA209038-12-7,7,CA209038,12,1,55,1,2,USA,NIV3-NAIVE,29-Oct-12,17-Mar-14,31-Mar-14,17-Mar-14,NA,21-Dec-15,NA,NA,NA,PR,PRCR,-100,NA,1,1,393,56.14285714,0,54,7.714285714,1149,164.1428571,COMPLETE RESPONSE,17-Jan-14,-100,21-Dec-12,54,17-Jan-14,446,63.71428571,1,-100,2,NA,25-Jun-14,NA,PRCRSD,PRCR,0,0,Pt7,7-Dec,CA209038-12-7,55,MALE,29-Oct-12,17-Mar-14,NIV3-NAIVE,22-Oct-12,17-Mar-14,NA,NA,COMPLETE RESPONSE,NA,PR,NA,22-Oct-12,-7,M1C WITHOUT BRAIN METASTASES,M1C,Pt7,CA209038-12-7,CA209038,United States of America,12,7,CUTANEOUS,CUTANEOUS,37,PRE-TREATMENT,pre,NA,8-Jun-13,0,0,0,EVALUABLE,0,MACROPHAGES ONLY,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0.071654317,0.883935715,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.116064285,NA,NA,NA,Pt7_pre,7,NA,NAPt70_on,Pt70,Pt70_on,on,409,2.611723308,578,2.762678564,1,1,1,0,0,NIV3-PROG,1,BRAF,259,0.633251834,0.3,2,0.208755393,2.418549859,-0.061689488,38,300,Pt70_on,2,0.047838237,0.126436782,0.461538462,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt70_on_S0101380,0,0.502042707,0.094281361,0.077287421,205958,22157,null,9.30115795,0.355673581,2666.56006,0,410240,251244,27401,null,9.61244011,0.347952873,0.81975291,"Melanoma, Biopsy, Tissue",0.502042707,Pt70_on,on,0.502,18742,0.357,17,0.7613,0.2133,Pt70_on,0.995464406,4,1,1,1,1,1,1,1,394,0,2.611723308,2.611723308,2.611723308,2.611723308,2.611723308,2.611723308,CA209038-7-70,CA209038-7-70,70,CA209038,7,1,72,1,2,USA,NIV3-PROG,19-Mar-13,14-May-13,4-Jun-13,14-May-13,23-Jan-14,20-Dec-13,30-Jul-13,NA,NA,SD,SD,0,0,1,0,NA,NA,1,887,126.7142857,311,44.42857143,STABLE DISEASE,2-Jul-13,0,NA,NA,2-Jul-13,106,15.14285714,1,0,1,V600E,22-Aug-13,NA,PRCRSD,SDPD,1,0,Pt70,Jul-70,CA209038-7-70,72,MALE,19-Mar-13,14-May-13,NIV3-PROG,26-Feb-13,14-May-13,NA,NA,STABLE DISEASE,NA,SD,1,1-Jul-06,-2453,M1C WITH BRAIN METASTASES,M1C,Pt70,CA209038-7-70,CA209038,United States of America,7,70,CUTANEOUS,CUTANEOUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0.07039018,0.875212331,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.124787669,NA,NA,NA,NA,NA,NA,NAPt70_pre,Pt70,Pt70_pre,pre,428,2.631443769,612,2.787460475,1,1,1,0,0,NIV3-PROG,1,BRAF,275,0.642523364,0.7,2.3,0.685876284,2.250650527,-0.11896781,73,300,Pt70_pre,28,0.254342514,0.339379085,0.816326531,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt70_pre_S0101386,0,0.137180675,0.099294558,0.083126314,56277,9386,null,9.38698864,0.288664848,2666.56006,0,410240,67223,11486,null,9.7765379,0.27514562,0.837168826,"Melanoma, Biopsy, Tissue",0.137180675,Pt70_pre,pre,0.137,8835,0.291,9,0.7924,0.3934,Pt70_pre,0.963652689,57,3,0.923469388,0.928571429,0.943877551,0.62755102,0.808673469,0.87244898,392,0.477121255,2.430057767,2.443483501,2.4837607,1.651365221,2.127978761,2.295800432,CA209038-7-70,CA209038-7-70,70,CA209038,7,1,72,1,2,USA,NIV3-PROG,19-Mar-13,14-May-13,4-Jun-13,14-May-13,23-Jan-14,20-Dec-13,30-Jul-13,NA,NA,SD,SD,0,0,1,0,NA,NA,1,887,126.7142857,311,44.42857143,STABLE DISEASE,2-Jul-13,0,NA,NA,2-Jul-13,106,15.14285714,1,0,1,V600E,22-Aug-13,NA,PRCRSD,SDPD,1,0,Pt70,Jul-70,CA209038-7-70,72,MALE,19-Mar-13,14-May-13,NIV3-PROG,26-Feb-13,14-May-13,NA,NA,STABLE DISEASE,NA,SD,1,1-Jul-06,-2453,M1C WITH BRAIN METASTASES,M1C,Pt70,CA209038-7-70,CA209038,United States of America,7,70,CUTANEOUS,CUTANEOUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0.073834792,0.883332817,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.116667183,NA,NA,NA,NA,NA,NA,NAPt71_on,Pt71,Pt71_on,on,3,0.477121255,5,0.77815125,1,1,1,0,0,NIV3-NAIVE,4,TripleWt,1,0.333333333,0.5,2,NA,2,-0.002001843,23,300,Pt71_on,0,0,0.095652174,0.146341463,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt71_on_S0088556,0,0.076663019,0.032875877,0.026613342,16395,6792,null,11.0637808,0.130863309,1390.07996,0,213858,20253,8752,null,11.5609856,0.117171802,0.809509702,"Melanoma, Biopsy, Tissue",0.076663019,Pt71_on,on,0.077,6520,0.134,7,0.9132,0.7486,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-1-71,CA209038-1-71,71,CA209038,1,2,50,1,2,USA,NIV3-NAIVE,13-Mar-13,16-Sep-13,30-Sep-13,16-Sep-13,NA,13-Nov-13,1-Oct-13,NA,NA,SD,SD,-23.21428571,NA,1,1,NA,NA,1,995,142.1428571,246,35.14285714,STABLE DISEASE,4-Sep-13,-23.21428571,NA,NA,4-Sep-13,176,25.14285714,1,-23.21428571,97,NA,25-Dec-13,NA,PRCRSD,SDPD,0,0,Pt71,Jan-71,CA209038-1-71,50,FEMALE,13-Mar-13,16-Sep-13,NIV3-NAIVE,4-Mar-13,16-Sep-13,NA,NA,STABLE DISEASE,NA,SD,NA,4-Mar-13,-9,M1C WITH BRAIN METASTASES,M1C,Pt71,CA209038-1-71,CA209038,United States of America,1,71,OTHER: BRAIN METASTASIS,OTHER,13,NIVO 3 mg/kg Q2W,on,NA,12-Aug-13,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO DEFINITIVE TUMOR,NA,NA,NA,NA,NA,0.450627325,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.257067796,0,0.292304879,0,0.549372675,NA,NA,NA,Pt71_on,71,NA,NAPt71_pre,Pt71,Pt71_pre,pre,5,0.698970004,5,0.77815125,1,1,1,0,0,NIV3-NAIVE,4,TripleWt,2,0.4,0.4,2,NA,2,0.001320046,23,300,Pt71_pre,0,0,0.095419847,0.12,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt71_pre_S0088555,0,0.042795551,0.079260342,0.065917939,13033,4205,null,9.6800518,0.19586809,1979.52002,0,304541,15671,5391,null,10.2340603,0.174428716,0.831663582,"Melanoma, Biopsy, Tissue",0.042795551,Pt71_pre,pre,0.043,4018,0.198,5,0.8816,0.6757,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-1-71,CA209038-1-71,71,CA209038,1,2,50,1,2,USA,NIV3-NAIVE,13-Mar-13,16-Sep-13,30-Sep-13,16-Sep-13,NA,13-Nov-13,1-Oct-13,NA,NA,SD,SD,-23.21428571,NA,1,1,NA,NA,1,995,142.1428571,246,35.14285714,STABLE DISEASE,4-Sep-13,-23.21428571,NA,NA,4-Sep-13,176,25.14285714,1,-23.21428571,97,NA,25-Dec-13,NA,PRCRSD,SDPD,0,0,Pt71,Jan-71,CA209038-1-71,50,FEMALE,13-Mar-13,16-Sep-13,NIV3-NAIVE,4-Mar-13,16-Sep-13,NA,NA,STABLE DISEASE,NA,SD,NA,4-Mar-13,-9,M1C WITH BRAIN METASTASES,M1C,Pt71,CA209038-1-71,CA209038,United States of America,1,71,OTHER: BRAIN METASTASIS,OTHER,12,PRE-TREATMENT,pre,NA,31-Jul-13,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO DEFINITE TUMOR,NA,NA,NA,NA,NA,0,0,0,0,0,0.4875949,0,0,0.227208448,0,0,0,0,0,0,0,0,0,0,0.285196653,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,Pt71_pre,71,NA,NAPt72_pre,Pt72,Pt72_pre,pre,437,2.640481437,710,2.851869601,1,0,0,1,0,NIV3-NAIVE,1,BRAF,302,0.691075515,0.7,2.2,0.78574055,2.184923395,-0.101180626,46,300,Pt72_pre,5,0.043479107,0.381679389,0.846153846,-736.5288597,263.3259703,-473.2028894,0.860000075,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt72_pre,0.960990975,29,4,0.965601966,0.965601966,0.965601966,0.732186732,0.916461916,0.950859951,407,0.602059991,2.549654067,2.549654067,2.549654067,1.933325474,2.419900677,2.51072805,CA209038-6-72,CA209038-6-72,72,CA209038,6,2,43,1,2,USA,NIV3-NAIVE,18-Mar-13,3-Feb-14,17-Feb-14,3-Feb-14,26-Apr-15,3-Mar-15,NA,13-Feb-14,13-Feb-14,PR,PRCR,-72.4137931,0,0,0,222,31.71428571,0,112,16,770,110,PARTIAL RESPONSE,13-Feb-14,-72.4137931,7-Jul-13,112,13-Feb-14,333,47.57142857,1,-72.4137931,1,V600E,14-May-14,NA,PRCRSD,PRCR,1,1,Pt72,Jun-72,CA209038-6-72,43,FEMALE,18-Mar-13,3-Feb-14,NIV3-NAIVE,7-Mar-13,3-Feb-14,NA,13-Feb-14,PARTIAL RESPONSE,13-Feb-14,PR,NA,1-Feb-13,-45,M1B,M1B,Pt72,CA209038-6-72,CA209038,United States of America,6,72,CUTANEOUS,CUTANEOUS,106,PRE-TREATMENT,pre,29.59,18-Jun-13,1,1,1,EVALUABLE,3,MACROPHAGES ONLY,YES,NA,1256,1211,1248,1403,3.9,0.72,2.15,0.33,7.85,3.71,6.77,3.21,18.37,11.54,92.31,< 1% + PM TUMOR CELLS,NA,0.224299065,0.102803738,0.024332545,0.011152416,0.074836024,0,0,0,0.065646159,0,0.610538387,0,0,0,0.127914505,0,0,0,0,0,0,0,0,0,0,0,0.062170129,0,0,0,0,0,0,0,0.121064925,12,24,16.97056275,Pt72_pre,72,90,33Pt73_pre,Pt73,Pt73_pre,pre,14,1.146128036,21,1.342422681,1,0,0,0,0,NIV3-NAIVE,4,TripleWt,6,0.428571429,0.4,2,NA,2,0.065567927,36,300,Pt73_pre,14,0.218597044,0.072874494,0.222222222,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt73_pre,0.286348643,6,1,0.214285714,0.214285714,0.214285714,0,0,0,14,0,0.245598864,0.245598864,0.245598864,0,0,0,CA209038-1-73,CA209038-1-73,73,CA209038,1,1,60,1,1,USA,NIV3-NAIVE,25-Mar-13,16-Dec-13,30-Dec-13,16-Dec-13,NA,30-Dec-13,NA,8-Sep-13,8-Sep-13,SD,SD,0,NA,0,1,NA,NA,1,983,140.4285714,281,40.14285714,STABLE DISEASE,29-Dec-13,0,NA,NA,8-Sep-13,168,24,1,0,2,NA,26-Mar-14,NA,PRCRSD,SDPD,0,1,Pt73,Jan-73,CA209038-1-73,60,MALE,25-Mar-13,16-Dec-13,NIV3-NAIVE,13-Mar-13,16-Dec-13,NA,8-Sep-13,STABLE DISEASE,8-Sep-13,SD,NA,14-Jan-13,-70,M1C WITHOUT BRAIN METASTASES,M1C,Pt73,CA209038-1-73,CA209038,United States of America,1,73,OCULAR/UVEAL,OCULAR/UVEAL,14,PRE-TREATMENT,pre,NA,12-Aug-13,0,0,0,UNEVALUABLE,0,MACROPHAGES ONLY,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO DEFINITIVE TUMOR,NA,NA,NA,NA,NA,0,0,0.482397417,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.307050789,0,0,0,0,0,0.18969864,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NAPt74_pre,Pt74,Pt74_pre,pre,44,1.643452676,78,1.897627091,1,0,0,0,0,NIV3-NAIVE,4,TripleWt,30,0.681818182,0.7,2.4,0.601214182,3.28718768,-0.47190303,90,300,Pt74_pre,46,0.449082791,0.381575667,0.686956522,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt74_pre,0.925228771,3,2,0.928571429,0.928571429,0.928571429,0.285714286,0.714285714,0.880952381,42,0.301029996,1.5260632,1.5260632,1.5260632,0.469557908,1.173894768,1.447803548,CA209038-9-74,CA209038-9-74,74,CA209038,9,1,27,1,2,USA,NIV3-NAIVE,1-Apr-13,1-Apr-13,11-Apr-13,1-Apr-13,20-Apr-13,20-Apr-13,NA,8-Apr-13,NA,NE,PD,NA,1,0,0,NA,NA,1,976,139.4285714,20,2.857142857,DEATH PRIOR TO DISEASE ASSESSMENT,NA,NA,NA,NA,20-Apr-13,20,2.857142857,1,NA,2,NA,10-Jul-13,NA,PD,SDPD,1,1,Pt74,Sep-74,CA209038-9-74,27,MALE,1-Apr-13,1-Apr-13,NIV3-NAIVE,18-Mar-13,1-Apr-13,NA,8-Apr-13,DEATH PRIOR TO DISEASE ASSESSMENT,NA,NE,NA,2-Jan-13,-89,M1C WITHOUT BRAIN METASTASES,M1C,Pt74,CA209038-9-74,CA209038,United States of America,9,74,OTHER: METASATIC,OTHER,136,PRE-TREATMENT,pre,NA,13-Mar-14,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,< 1% + PM TUMOR CELLS,NA,NA,NA,NA,NA,0.203536469,0,0,0,0,0,0.337204624,0,0,0,0,0,0,0,0,0,0,0.110154578,0,0,0,0,0.224035693,0,0,0,0,0,0,0,0.459258907,NA,NA,NA,NA,NA,NA,NAPt76_pre,Pt76,Pt76_pre,pre,224,2.350248018,337,2.5289167,1,0,0,1,0,NIV3-NAIVE,2,RAS,141,0.629464286,0.5,2.1,0.551677294,2.095466942,-0.037499562,36,300,Pt76_pre,6,0.02131386,0.269888932,0.634615385,-776.727717,494.6288894,-282.0988275,0.845348912,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt76_pre,0.965990379,11,2,0.986046512,0.986046512,0.986046512,0.888372093,0.958139535,0.96744186,215,0.301029996,2.317453861,2.317453861,2.317453861,2.087894751,2.251865543,2.273728314,CA209038-3-76,CA209038-3-76,76,CA209038,3,1,60,1,2,USA,NIV3-NAIVE,22-Mar-13,22-Mar-13,29-Mar-13,22-Mar-13,31-Mar-13,31-Mar-13,NA,31-Mar-13,NA,NE,PD,NA,1,0,0,NA,NA,1,986,140.8571429,10,1.428571429,DEATH PRIOR TO DISEASE ASSESSMENT,NA,NA,NA,NA,31-Mar-13,10,1.428571429,1,NA,2,NA,30-Jun-13,NA,PD,SDPD,1,1,Pt76,Mar-76,CA209038-3-76,60,MALE,22-Mar-13,22-Mar-13,NIV3-NAIVE,19-Mar-13,22-Mar-13,NA,31-Mar-13,DEATH PRIOR TO DISEASE ASSESSMENT,NA,NE,NA,26-Feb-13,-24,M1C WITHOUT BRAIN METASTASES,M1C,Pt76,CA209038-3-76,CA209038,United States of America,3,76,CUTANEOUS,CUTANEOUS,52,PRE-TREATMENT,pre,2.38,28-Aug-13,10,20,30,EVALUABLE,60,MACROPHAGES ONLY,YES,NA,1511,1218,1622,1531,0.99,0.07,0.16,0.08,2.59,1.05,0.65,0.06,6.67,50,56.25,NA,NA,1.166666667,1.333333333,0.029411765,0.033613445,0.183633703,0,0.060156511,0,0,0,0.719698413,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.096667884,512,55,167.8094157,Pt76_pre,76,85,30Pt77_on,Pt77,Pt77_on,on,NA,NA,NA,NA,1,0,0,1,1,NIV3-NAIVE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1626.047441,3738.667645,5364.715087,0.177387468,0.182559006,0,0,0.06856053,0,0.073151225,0.116177387,0.102459639,0,0,0.021859545,0,0.004858142,0.045708992,0.038381787,0.137662625,0.018830651,0.065695006,0.124095465,0,0,0,0.360348781,0.182559006,0.021859545,0.221753404,0.124095465,0.089383799,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-5-77,CA209038-5-77,77,CA209038,5,2,56,1,2,USA,NIV3-NAIVE,26-Mar-13,27-Aug-13,10-Sep-13,27-Aug-13,9-Jul-14,28-Feb-14,17-Sep-13,4-Sep-13,4-Sep-13,SD,SD,-23.58490566,0,0,0,NA,NA,1,982,140.2857143,471,67.28571429,STABLE DISEASE,4-Sep-13,-23.58490566,NA,NA,4-Sep-13,163,23.28571429,1,-23.58490566,97,NA,5-Dec-13,NA,PRCRSD,SDPD,1,1,Pt77,May-77,CA209038-5-77,56,FEMALE,26-Mar-13,27-Aug-13,NIV3-NAIVE,20-Mar-13,27-Aug-13,NA,4-Sep-13,STABLE DISEASE,4-Sep-13,SD,NA,13-Feb-13,-41,M1A,M1A,Pt77,CA209038-5-77,CA209038,United States of America,5,77,CUTANEOUS,CUTANEOUS,78,NIVO 3 mg/kg Q2W,on,NA,8-Aug-13,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO DEFINITIVE VIABLE TUMOR,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2948,1295,1953.883313,Pt77_on,77,NA,NAPt77_pre,Pt77,Pt77_pre,pre,49,1.69019608,55,1.748188027,1,0,0,1,1,NIV3-NAIVE,1,BRAF,27,0.551020408,0.3,2,0.213275983,2.07064111,-0.01082713,73,300,Pt77_pre,20,0.101917754,0.075,0.266666667,871.6152438,3020.775749,3892.390993,0.384301663,0.044934521,0.14436998,0,0.128654391,0,0.069427565,0.093643685,0.103023253,0,0,0,0.022816426,0.0135524,0.066236596,0.086097422,0.140457328,0.005865369,0,0.069535594,0,0,0.011385472,0.394748894,0.189304501,0.022816426,0.292791346,0.069535594,0.030803241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt77_pre,0.685163768,3,3,0.5,0.659090909,0.909090909,0,0,0.068181818,44,0.477121255,0.84509804,1.113992871,1.536541891,0,0,0.115240642,CA209038-5-77,CA209038-5-77,77,CA209038,5,2,56,1,2,USA,NIV3-NAIVE,26-Mar-13,27-Aug-13,10-Sep-13,27-Aug-13,9-Jul-14,28-Feb-14,17-Sep-13,4-Sep-13,4-Sep-13,SD,SD,-23.58490566,0,0,0,NA,NA,1,982,140.2857143,471,67.28571429,STABLE DISEASE,4-Sep-13,-23.58490566,NA,NA,4-Sep-13,163,23.28571429,1,-23.58490566,97,NA,5-Dec-13,NA,PRCRSD,SDPD,1,1,Pt77,May-77,CA209038-5-77,56,FEMALE,26-Mar-13,27-Aug-13,NIV3-NAIVE,20-Mar-13,27-Aug-13,NA,4-Sep-13,STABLE DISEASE,4-Sep-13,SD,NA,13-Feb-13,-41,M1A,M1A,Pt77,CA209038-5-77,CA209038,United States of America,5,77,CUTANEOUS,CUTANEOUS,77,PRE-TREATMENT,pre,29.81,15-Jun-13,20,20,5,EVALUABLE,45,MACROPHAGES ONLY,YES,NA,1816,1647,1203,1196,48.29,4.96,30.97,18.58,26.77,13.8,6.77,9.14,10.26,51.96,49.09,NO DEFINITIVE TUMOR,NA,0.542669584,2.032822757,0.166387118,0.623280778,0.321147797,0,0,0,0,0.073223974,0.186037916,0,0,0,0,0,0,0,0,0,0,0.188064616,0,0.187327438,0,0,0,0,0,0,0,0,0,0,0.492814287,1064,713,870.9948335,Pt77_pre,77,5,8Pt78_on,Pt78,Pt78_on,on,NA,NA,NA,NA,0,0,0,1,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1121.415769,1749.481091,2870.896861,0.517900445,0,0,0,0.076986835,0,0.12591585,0,0,0,0,0.016269571,0.018202286,0.088108369,0.06250342,0.060181857,0.305188323,0,0,0.1025676,0,0.001062768,0.143013122,0.202902685,0,0.034471857,0.4278736,0.103630368,0.231121491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-7-78,CA209038-7-78,78,CA209038,7,1,33,1,2,USA,NIV3-PROG,16-Apr-13,28-May-13,11-Jun-13,28-May-13,2-Jul-13,2-Jul-13,NA,4-Jun-13,4-Jun-13,PD,PD,55.17241379,1,0,0,NA,NA,1,859,122.7142857,78,11.14285714,PROGRESSION,4-Jun-13,55.17241379,NA,NA,4-Jun-13,50,7.142857143,1,55.17241379,1,V600E,5-Sep-13,NA,PD,SDPD,1,1,Pt78,Jul-78,CA209038-7-78,33,MALE,16-Apr-13,28-May-13,NIV3-PROG,19-Mar-13,28-May-13,NA,4-Jun-13,PROGRESSION,4-Jun-13,PD,1,12-Jul-12,-278,M1C WITHOUT BRAIN METASTASES,M1C,Pt78,CA209038-7-78,CA209038,United States of America,7,78,CUTANEOUS,CUTANEOUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,248,357,297.5499958,NA,NA,NA,NAPt78_pre,Pt78,Pt78_pre,pre,NA,NA,NA,NA,0,0,0,1,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1045.176648,-809.6113348,-1854.787983,0.94515554,0.172591854,0,0,0.04378502,0,0.147843038,0,0.098404851,0,0,0,0.061073493,0.07234897,0.137680031,0.009552169,0.210156386,0,0,0.046564188,0,0,0,0.290032909,0.172591854,0.061073493,0.357388586,0.046564188,0.07234897,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-7-78,CA209038-7-78,78,CA209038,7,1,33,1,2,USA,NIV3-PROG,16-Apr-13,28-May-13,11-Jun-13,28-May-13,2-Jul-13,2-Jul-13,NA,4-Jun-13,4-Jun-13,PD,PD,55.17241379,1,0,0,NA,NA,1,859,122.7142857,78,11.14285714,PROGRESSION,4-Jun-13,55.17241379,NA,NA,4-Jun-13,50,7.142857143,1,55.17241379,1,V600E,5-Sep-13,NA,PD,SDPD,1,1,Pt78,Jul-78,CA209038-7-78,33,MALE,16-Apr-13,28-May-13,NIV3-PROG,19-Mar-13,28-May-13,NA,4-Jun-13,PROGRESSION,4-Jun-13,PD,1,12-Jul-12,-278,M1C WITHOUT BRAIN METASTASES,M1C,Pt78,CA209038-7-78,CA209038,United States of America,7,78,CUTANEOUS,CUTANEOUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,7,4.582575695,NA,NA,NA,NAPt79_on,Pt79,Pt79_on,on,NA,NA,NA,NA,1,0,0,1,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-150.657091,499.4353126,348.7782216,0.792326251,0,0,0.033547306,0.129729955,0,0.066261485,0.028341385,0.154572237,0,0,0,0.066400184,0.018869698,0.172165118,0.104581888,0.188791724,0,0,0.03673902,0,0,0,0.378905062,0.033547306,0.066400184,0.46553873,0.03673902,0.018869698,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-5-79,CA209038-5-79,79,CA209038,5,1,64,1,2,USA,NIV3-PROG,2-Apr-13,24-Sep-13,22-Oct-13,24-Sep-13,5-Nov-13,5-Nov-13,NA,19-Sep-13,19-Sep-13,SD,SD,13.75661376,1,0,0,NA,NA,1,873,124.7142857,218,31.14285714,STABLE DISEASE,19-Sep-13,13.75661376,NA,NA,19-Sep-13,171,24.42857143,1,13.75661376,2,NA,2-Jan-14,NA,PRCRSD,SDPD,1,1,Pt79,May-79,CA209038-5-79,64,MALE,2-Apr-13,24-Sep-13,NIV3-PROG,26-Mar-13,24-Sep-13,NA,19-Sep-13,STABLE DISEASE,19-Sep-13,SD,NA,1-Jul-12,-275,UNKNOWN,UNKNOWN,Pt79,CA209038-5-79,CA209038,United States of America,5,79,OTHER: SUBCUTANEOUS,OTHER,80,NIVO 3 mg/kg Q2W,on,14.08,18-Jun-13,0,0,0,EVALUABLE,0,MACROPHAGES ONLY,YES,NA,1954,1841,1753,2067,10.8,0.26,1.58,0.38,19.45,10.93,5.08,3.25,2.37,6.9,44.69,NA,NA,0.08,0.116923077,0.018465909,0.026988636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,366,176,253.8030733,Pt79_on,79,98,95Pt79_pre,Pt79,Pt79_pre,pre,544,2.7355989,668,2.825426118,1,0,0,1,1,NIV3-PROG,3,NF1,328,0.602941176,0.8,2.8,0.801648866,2.842432954,-0.419719782,124,300,Pt79_pre,26,0.270440907,0.404886934,0.963636364,-562.1703772,336.670932,-225.4994452,0.840881462,0.10918406,0,0.005110289,0.143250283,0,0,0.00782464,0.16139492,0,0,0,0.056988102,0,0.12499089,0.097759426,0.247750692,0,0,0.011689048,0,0,0.034057652,0.312469843,0.114294349,0.056988102,0.470501008,0.011689048,0.034057652,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt79_pre,0.988442794,12,2,0.964150943,0.964150943,0.964150943,0.91509434,0.935849057,0.945283019,530,0.301029996,2.637530259,2.637530259,2.637530259,2.50333107,2.560107651,2.585915187,CA209038-5-79,CA209038-5-79,79,CA209038,5,1,64,1,2,USA,NIV3-PROG,2-Apr-13,24-Sep-13,22-Oct-13,24-Sep-13,5-Nov-13,5-Nov-13,NA,19-Sep-13,19-Sep-13,SD,SD,13.75661376,1,0,0,NA,NA,1,873,124.7142857,218,31.14285714,STABLE DISEASE,19-Sep-13,13.75661376,NA,NA,19-Sep-13,171,24.42857143,1,13.75661376,2,NA,2-Jan-14,NA,PRCRSD,SDPD,1,1,Pt79,May-79,CA209038-5-79,64,MALE,2-Apr-13,24-Sep-13,NIV3-PROG,26-Mar-13,24-Sep-13,NA,19-Sep-13,STABLE DISEASE,19-Sep-13,SD,NA,1-Jul-12,-275,UNKNOWN,UNKNOWN,Pt79,CA209038-5-79,CA209038,United States of America,5,79,OTHER: SUBCUTANEOUS,OTHER,79,PRE-TREATMENT,pre,22.18,6-Jul-13,3,1,0,EVALUABLE,4,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,2580,2206,2291,2399,15.43,2.91,10.88,10.06,48.41,8.59,26.93,11.22,18.59,36.67,89.32,< 1% + PM TUMOR CELLS,NA,0.259358289,0.896613191,0.131199279,0.453561767,0.127945543,0,0,0,0,0,0.808754335,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.063300122,223,175,197.5474627,Pt79_pre,79,85,70Pt8_on,Pt8,Pt8_on,on,98,1.991226076,70,1.851258349,1,1,1,1,1,NIV3-NAIVE,4,TripleWt,45,0.459183673,0.7,2.3,0.810796198,1.827327999,0.104698776,61,300,Pt8_on,16,0.285333375,0.376973684,0.839622642,209.5681319,1292.522087,1502.090219,0.678206787,0.01368867,0,0,0.159454823,0,0.10083197,0.041043743,0.06484524,0,0,0.021264792,0.010843236,0.047630537,0.168461676,0.088345493,0.222865204,0,0,0.025236229,0,0,0.035488388,0.366175776,0.01368867,0.032108028,0.479672373,0.025236229,0.083118925,Pt8_on_S0087104,0,0.0618711,0.056220945,0.04641556,25382,6777,null,10.6721706,0.161416858,2666.56006,0,410240,30744,8531,null,11.0653124,0.152635202,0.825591985,"Melanoma, Biopsy, Tissue",0.0618711,Pt8_on,on,0.062,6528,0.166,7,0.8322,0.612,Pt8_on,0.953936584,22,2,0.846938776,0.846938776,0.857142857,0.520408163,0.663265306,0.724489796,98,0.301029996,1.686446575,1.686446575,1.706765207,1.036250304,1.320711172,1.442622973,CA209038-12-8,CA209038-12-8,8,CA209038,12,1,40,1,2,USA,NIV3-NAIVE,30-Oct-12,5-Feb-13,19-Feb-13,5-Feb-13,15-Jul-13,9-Apr-13,NA,19-Feb-13,20-Dec-12,PD,PD,25.10638298,0,0,0,NA,NA,1,1129,161.2857143,259,37,PROGRESSION,2-Feb-13,25.10638298,NA,NA,20-Dec-12,52,7.428571429,1,25.10638298,2,NA,16-May-13,NA,PD,SDPD,1,1,Pt8,8-Dec,CA209038-12-8,40,MALE,30-Oct-12,5-Feb-13,NIV3-NAIVE,22-Oct-12,5-Feb-13,NA,19-Feb-13,PROGRESSION,20-Dec-12,PD,NA,24-Jul-12,-98,M0,M0,Pt8,CA209038-12-8,CA209038,United States of America,12,8,MUCOSAL,MUCOSAL,40,NIVO 3 mg/kg Q2W,on,27.63,6-Jun-13,10,15,5,EVALUABLE,30,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,2764,2569,2716,2691,16.21,3.11,11.95,11.41,38.11,23.3,24.86,10.57,19.2,56.03,89.15,NA,NA,0.29422895,1.079470199,0.112558813,0.412956931,0,0,0,0.185228665,0,0,0.621959995,0,0,0,0,0,0,0.081349975,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.378040005,387,433,409.3543697,Pt8_on,8,80,90Pt8_pre,Pt8,Pt8_pre,pre,87,1.939519253,69,1.84509804,1,1,1,1,1,NIV3-NAIVE,4,TripleWt,44,0.505747126,0.3,2.1,0.401364702,1.823703922,0.051966641,39,300,Pt8_pre,10,0.27717932,0.191489362,0.406779661,1460.906158,1438.162072,2899.06823,0.514358582,0,0.040068559,0.01962171,0.121727956,0,0.159342563,0.034965261,0.011388702,0,0,0.005115129,0.014595889,0.033748636,0.098053078,0.090468185,0.245832809,0,0,0.078750423,0,0,0.0463211,0.327424482,0.059690269,0.019711018,0.434354072,0.078750423,0.080069736,Pt8_pre_S0087100,0,0.225065815,0.062005177,0.051837634,92331,17787,null,10.8888054,0.228758171,2666.56006,0,410240,110441,22301,null,11.3382139,0.215067163,0.836021043,"Melanoma, Biopsy, Tissue",0.225065815,Pt8_pre,pre,0.225,16889,0.232,15,0.808,0.4554,Pt8_pre,0.913775837,4,2,0.930232558,0.930232558,0.930232558,0,0.720930233,0.88372093,86,0.301029996,1.804203956,1.804203956,1.804203956,0,1.398258067,1.713993758,CA209038-12-8,CA209038-12-8,8,CA209038,12,1,40,1,2,USA,NIV3-NAIVE,30-Oct-12,5-Feb-13,19-Feb-13,5-Feb-13,15-Jul-13,9-Apr-13,NA,19-Feb-13,20-Dec-12,PD,PD,25.10638298,0,0,0,NA,NA,1,1129,161.2857143,259,37,PROGRESSION,2-Feb-13,25.10638298,NA,NA,20-Dec-12,52,7.428571429,1,25.10638298,2,NA,16-May-13,NA,PD,SDPD,1,1,Pt8,8-Dec,CA209038-12-8,40,MALE,30-Oct-12,5-Feb-13,NIV3-NAIVE,22-Oct-12,5-Feb-13,NA,19-Feb-13,PROGRESSION,20-Dec-12,PD,NA,24-Jul-12,-98,M0,M0,Pt8,CA209038-12-8,CA209038,United States of America,12,8,MUCOSAL,MUCOSAL,39,PRE-TREATMENT,pre,11.44,19-Dec-13,2,0,0,EVALUABLE,2,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,2382,2074,2516,2353,8.35,3.32,4.97,0.68,9.38,9.48,3.27,1.31,36.68,11.65,27.35,NO DEFINITIVE TUMOR,NA,2.534351145,0.519083969,0.29020979,0.059440559,0,0,0,0,0,0,0.665176805,0,0,0,0,0,0,0,0,0,0,0.084464983,0,0.168884809,0,0,0,0,0,0,0,0,0,0,0.334823195,503,416,457.4363344,Pt8_pre,8,99,100Pt80_on,Pt80,Pt80_on,on,NA,NA,NA,NA,0,0,0,0,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,257.0631667,2198.08033,2455.143497,0.569109565,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-7-80,CA209038-7-80,80,CA209038,7,2,35,1,2,USA,NIV3-PROG,2-Apr-13,14-May-13,28-May-13,14-May-13,5-Dec-14,11-Mar-14,5-Jun-13,25-May-13,25-May-13,PD,PD,0,0,0,0,NA,NA,1,873,124.7142857,613,87.57142857,PROGRESSION,25-May-13,0,NA,NA,25-May-13,54,7.714285714,1,0,1,V600E,22-Aug-13,NA,PD,SDPD,1,1,Pt80,Jul-80,CA209038-7-80,35,FEMALE,2-Apr-13,14-May-13,NIV3-PROG,12-Mar-13,14-May-13,NA,25-May-13,PROGRESSION,25-May-13,PD,NA,12-Mar-13,-21,M1C WITHOUT BRAIN METASTASES,M1C,Pt80,CA209038-7-80,CA209038,United States of America,7,80,CUTANEOUS,CUTANEOUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1331,838,1056.114577,NA,NA,NA,NAPt81_on,Pt81,Pt81_on,on,NA,NA,NA,NA,0,0,0,0,1,NIV3-NAIVE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,855.2361514,3115.324696,3970.560847,0.373683318,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-3-81,CA209038-3-81,81,CA209038,3,1,63,1,2,USA,NIV3-NAIVE,9-Apr-13,21-May-13,4-Jun-13,21-May-13,21-Jul-14,29-Apr-14,4-Jun-13,31-May-13,31-May-13,PD,PD,100,0,0,0,NA,NA,1,968,138.2857143,469,67,PROGRESSION,31-May-13,100,NA,NA,31-May-13,53,7.571428571,1,100,1,V600E,29-Aug-13,NA,PD,SDPD,1,1,Pt81,Mar-81,CA209038-3-81,63,MALE,9-Apr-13,21-May-13,NIV3-NAIVE,1-Apr-13,21-May-13,NA,31-May-13,PROGRESSION,31-May-13,PD,NA,16-Nov-05,-2701,M1B,M1B,Pt81,CA209038-3-81,CA209038,United States of America,3,81,CUTANEOUS,CUTANEOUS,54,NIVO 3 mg/kg Q2W,on,NA,28-Feb-14,30,20,20,EVALUABLE,70,LYMPHOCYTES ONLY,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3658,3277,3462.263133,NA,NA,NA,NAPt82_on,Pt82,Pt82_on,on,30,1.477121255,25,1.414973348,1,1,1,1,1,NIV3-PROG,4,TripleWt,14,0.466666667,0.3,2.1,0.352797803,2.20293726,-0.050742552,33,300,Pt82_on,4,0.064977861,0.122717336,0.195804196,223.109055,1899.676772,2122.785827,0.608531585,0.004092717,0,0.00285238,0.136979047,0,0.146587182,0.083413813,0.089642274,0,0,0,0.031631669,0.089070279,0.035734664,0.082368083,0.197845302,0,0.004703018,0.069295956,0,0.005011234,0.020772382,0.456622316,0.006945097,0.031631669,0.315948049,0.07430719,0.114545679,Pt82_on_S0088559,0,0.296170534,0.011053407,0.008896514,121501,43254,null,13.7354422,0.108119808,2666.56006,0,410240,150958,54791,null,14.0935516,0.104696766,0.804866254,"Melanoma, Biopsy, Tissue",0.296170534,Pt82_on,on,0.296,39423,0.112,31,0.8689,0.6924,Pt82_on,0.695350362,10,1,0.222222222,0.592592593,0.962962963,0,0,0,27,0,0.328249167,0.875331115,1.42241306,0,0,0,CA209038-1-82,CA209038-1-82,82,CA209038,1,2,60,1,2,USA,NIV3-PROG,8-Apr-13,4-Nov-13,18-Nov-13,4-Nov-13,10-Jun-14,24-Feb-14,16-Jan-14,13-Nov-13,13-Nov-13,SD,SD,-4.605263158,0,0,0,NA,NA,1,867,123.8571429,429,61.28571429,STABLE DISEASE,13-Nov-13,-4.605263158,NA,NA,13-Nov-13,220,31.42857143,1,-4.605263158,2,NA,12-Feb-14,NA,PRCRSD,SDPD,1,1,Pt82,Jan-82,CA209038-1-82,60,FEMALE,8-Apr-13,4-Nov-13,NIV3-PROG,20-Mar-13,4-Nov-13,NA,13-Nov-13,STABLE DISEASE,13-Nov-13,SD,NA,22-Nov-11,-503,M1C WITHOUT BRAIN METASTASES,M1C,Pt82,CA209038-1-82,CA209038,United States of America,1,82,OCULAR/UVEAL,OCULAR/UVEAL,16,NIVO 3 mg/kg Q2W,on,NA,13-Mar-14,4,2,0,EVALUABLE,6,MACROPHAGES ONLY,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0.187725882,0,0.375539007,0,0,0,0,0,0,0,0,0,0.436735111,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.624460993,999,782,883.8653744,Pt82_on,82,80,50Pt82_pre,Pt82,Pt82_pre,pre,33,1.51851394,25,1.414973348,1,1,1,1,1,NIV3-PROG,4,TripleWt,14,0.424242424,0.3,2.1,0.349447907,2.243589172,-0.060131609,34,300,Pt82_pre,6,0.086426034,0.170909091,0.299212598,425.0459161,1311.269695,1736.315611,0.65254493,0,0,0.00803874,0.105151218,0,0.181309586,0.049382087,0.03418653,0,0,0,0.015069693,0.088895852,0.033128915,0.088115951,0.268641773,0.07482726,0,0.044048125,0,0.009204271,0,0.370029421,0.00803874,0.015069693,0.389886639,0.053252396,0.163723112,Pt82_pre_S0088558,0,0.166370905,0.014094825,0.011308999,68252,23624,null,12.9992838,0.10522338,2666.56006,0,410240,85065,29824,null,13.3399839,0.102541946,0.802351143,"Melanoma, Biopsy, Tissue",0.166370905,Pt82_pre,pre,0.166,22630,0.108,18,0.865,0.6991,Pt82_pre,0.935513335,8,1,0.875,0.9375,0.9375,0.34375,0.625,0.71875,32,0,1.328699697,1.423606819,1.423606819,0.521989167,0.949071212,1.091431894,CA209038-1-82,CA209038-1-82,82,CA209038,1,2,60,1,2,USA,NIV3-PROG,8-Apr-13,4-Nov-13,18-Nov-13,4-Nov-13,10-Jun-14,24-Feb-14,16-Jan-14,13-Nov-13,13-Nov-13,SD,SD,-4.605263158,0,0,0,NA,NA,1,867,123.8571429,429,61.28571429,STABLE DISEASE,13-Nov-13,-4.605263158,NA,NA,13-Nov-13,220,31.42857143,1,-4.605263158,2,NA,12-Feb-14,NA,PRCRSD,SDPD,1,1,Pt82,Jan-82,CA209038-1-82,60,FEMALE,8-Apr-13,4-Nov-13,NIV3-PROG,20-Mar-13,4-Nov-13,NA,13-Nov-13,STABLE DISEASE,13-Nov-13,SD,NA,22-Nov-11,-503,M1C WITHOUT BRAIN METASTASES,M1C,Pt82,CA209038-1-82,CA209038,United States of America,1,82,OCULAR/UVEAL,OCULAR/UVEAL,15,PRE-TREATMENT,pre,29.76,4-Dec-13,1,0,0,EVALUABLE,1,MACROPHAGES ONLY,YES,MACROPHAGES,2309,2378,2373,2293,8.45,0.04,2.57,0.84,3.54,4.8,7.98,7.29,0.51,13.11,79.09,NA,NA,0.005486968,0.115226337,0.001344086,0.028225806,0,0,0.189024514,0,0.390557422,0,0,0,0,0,0,0,0,0,0.420418063,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.609442578,376,139,228.6132105,Pt82_pre,82,60,15Pt83_on,Pt83,Pt83_on,on,99,1.995635195,223,2.350248018,1,1,0,0,0,NIV3-PROG,1,BRAF,66,0.666666667,0.4,2,NA,2,-0.019701459,45,300,Pt83_on,8,0.05309765,0.060465116,0.153846154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt83_on,0.236844338,4,1,0,0,0,0,0,0,91,0,0,0,0,0,0,0,CA209038-5-83,CA209038-5-83,83,CA209038,5,2,39,1,2,USA,NIV3-PROG,16-Apr-13,28-May-13,19-Jul-13,28-May-13,NA,21-Jul-14,NA,NA,NA,SD,SD,0,NA,1,1,NA,NA,1,859,122.7142857,462,66,STABLE DISEASE,1-Apr-14,0,NA,NA,1-Apr-14,351,50.14285714,1,0,1,V600E,5-Sep-13,NA,PRCRSD,SDPD,0,0,Pt83,May-83,CA209038-5-83,39,FEMALE,16-Apr-13,28-May-13,NIV3-PROG,2-Apr-13,28-May-13,NA,NA,STABLE DISEASE,NA,SD,NA,1-Jul-11,-655,M1C WITHOUT BRAIN METASTASES,M1C,Pt83,CA209038-5-83,CA209038,United States of America,5,83,CUTANEOUS,CUTANEOUS,82,NIVO 3 mg/kg Q2W,on,70.45,28-Aug-13,10,40,20,EVALUABLE,70,LYMPHOCYTES AND MACROPHAGES,YES,LYMPHOCYTES,2466,2834,3195,1816,96.59,76.4,75.69,86.94,97.12,97.58,96.7,69.8,79.05,95.94,98.81,NA,NA,1.094555874,1.245558739,1.084457062,1.234066714,0,0,0,0,0,0,0.895070596,0,0,0,0,0,0,0,0.065521984,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.104929404,NA,NA,NA,NA,NA,NA,NAPt83_pre,Pt83,Pt83_pre,pre,339,2.530199698,700,2.845718018,1,1,0,0,0,NIV3-PROG,1,BRAF,214,0.631268437,0.3,2,0.474934466,3.079851738,-0.329329612,40,300,Pt83_pre,8,0.145275226,0.216216216,0.605072464,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt83_pre,0.976312483,16,2,0.958466454,0.961661342,0.961661342,0.773162939,0.897763578,0.920127796,313,0.301029996,2.425111533,2.433195237,2.433195237,1.956256635,2.271521134,2.328107072,CA209038-5-83,CA209038-5-83,83,CA209038,5,2,39,1,2,USA,NIV3-PROG,16-Apr-13,28-May-13,19-Jul-13,28-May-13,NA,21-Jul-14,NA,NA,NA,SD,SD,0,NA,1,1,NA,NA,1,859,122.7142857,462,66,STABLE DISEASE,1-Apr-14,0,NA,NA,1-Apr-14,351,50.14285714,1,0,1,V600E,5-Sep-13,NA,PRCRSD,SDPD,0,0,Pt83,May-83,CA209038-5-83,39,FEMALE,16-Apr-13,28-May-13,NIV3-PROG,2-Apr-13,28-May-13,NA,NA,STABLE DISEASE,NA,SD,NA,1-Jul-11,-655,M1C WITHOUT BRAIN METASTASES,M1C,Pt83,CA209038-5-83,CA209038,United States of America,5,83,CUTANEOUS,CUTANEOUS,81,PRE-TREATMENT,pre,28.67,28-Aug-13,10,5,0,EVALUABLE,15,LYMPHOCYTES ONLY,YES,MACROPHAGES,1863,2006,1958,1867,36.77,8.48,7.83,15.5,60.93,50.03,51.9,17.93,23.07,59.87,93.36,NA,NA,0.472950363,0.86447295,0.295779561,0.54063481,0.065157662,0,0,0,0,0.096270173,0.758570733,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.176271604,NA,NA,NA,NA,NA,NA,NAPt84_on,Pt84,Pt84_on,on,NA,NA,NA,NA,1,0,1,1,1,NIV3-NAIVE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5.134781919,-592.0679092,-586.9331273,0.868398831,0,0.038521577,0.033212951,0,0,0.266661669,0,0,0,0,0,0.019031593,0.019153891,0.117283438,0.022646174,0.359876324,0,0,0.110842693,0,0,0.012769692,0.266661669,0.071734528,0.019031593,0.499805936,0.110842693,0.031923583,Pt84_on_S0096364,0,0.002391283,0.061162081,0.065406978,981,685,null,8.88377285,0.056920387,2666.56006,0,410240,1376,943,null,9.1639452,0.072579756,0.712936047,"Melanoma, Biopsy, Tissue, Tumor",0.002391283,Pt84_on,on,0.002,655,0.06,1,0,0.8504,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-5-84,CA209038-5-84,84,CA209038,5,2,48,1,2,USA,NIV3-NAIVE,9-Apr-13,21-May-13,31-May-13,21-May-13,6-Sep-13,11-Jul-13,4-Jun-13,28-May-13,28-May-13,PD,PD,13.04347826,0,0,0,NA,NA,1,968,138.2857143,151,21.57142857,PROGRESSION,28-May-13,13.04347826,NA,NA,28-May-13,50,7.142857143,1,13.04347826,2,NA,29-Aug-13,NA,PD,SDPD,1,1,Pt84,May-84,CA209038-5-84,48,FEMALE,9-Apr-13,21-May-13,NIV3-NAIVE,2-Apr-13,21-May-13,NA,28-May-13,PROGRESSION,28-May-13,PD,NA,1-Jul-13,84,M1C WITHOUT BRAIN METASTASES,M1C,Pt84,CA209038-5-84,CA209038,United States of America,5,84,OTHER: SOFT TISSUE-ORAL,OTHER,84,NIVO 3 mg/kg Q2W,on,20,18-Jun-13,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,2152,2118,2237,2476,0.6,0.14,0.09,0.05,0.45,0.16,0.2,0.4,23.08,0,100,NA,NA,0.35,0.125,0.007,0.0025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,14,10.58300524,Pt84_on,84,99,78Pt84_pre,Pt84,Pt84_pre,pre,11,1.041392685,41,1.62324929,1,0,1,1,1,NIV3-NAIVE,4,TripleWt,10,0.909090909,0.8,2.7,0.794248125,2.553883654,-0.286834469,30,300,Pt84_pre,4,0.098721975,0.267281106,0.5875,-250.9372515,-725.6212391,-976.5584906,0.895323332,0.099605545,0,0.070124333,0,0,0.172092441,0,0.003054741,0,0,0,0.075143268,0,0.120623432,0.00756569,0.313865545,0,0,0.126661471,0,0,0.011263533,0.175147182,0.169729878,0.075143268,0.442054667,0.126661471,0.011263533,Pt84_pre_S0096386,0,0.001970616,0.018218624,0.012211669,494,395,null,8.43652725,0.02193233,1629.43994,0,250683,737,615,null,9.11900234,0.015698742,0.670284939,"Melanoma, Biopsy, Tissue, Tumor",0.001970616,Pt84_pre,pre,0.002,384,0.024,1,0,0.8698,Pt84_pre,0.749326673,7,1,0.9,0.9,0.9,0,0.2,0.3,10,0,0.937253417,0.937253417,0.937253417,0,0.208278537,0.312417806,CA209038-5-84,CA209038-5-84,84,CA209038,5,2,48,1,2,USA,NIV3-NAIVE,9-Apr-13,21-May-13,31-May-13,21-May-13,6-Sep-13,11-Jul-13,4-Jun-13,28-May-13,28-May-13,PD,PD,13.04347826,0,0,0,NA,NA,1,968,138.2857143,151,21.57142857,PROGRESSION,28-May-13,13.04347826,NA,NA,28-May-13,50,7.142857143,1,13.04347826,2,NA,29-Aug-13,NA,PD,SDPD,1,1,Pt84,May-84,CA209038-5-84,48,FEMALE,9-Apr-13,21-May-13,NIV3-NAIVE,2-Apr-13,21-May-13,NA,28-May-13,PROGRESSION,28-May-13,PD,NA,1-Jul-13,84,M1C WITHOUT BRAIN METASTASES,M1C,Pt84,CA209038-5-84,CA209038,United States of America,5,84,OTHER: SOFT TISSUE-ORAL,OTHER,83,PRE-TREATMENT,pre,14.29,15-Jun-13,0,0,0,EVALUABLE,0,MACROPHAGES ONLY,YES,NA,2635,2657,2733,2626,0.15,0.04,0.11,0,0.26,0.04,0.11,0.4,25,0,100,< 1% + PM TUMOR CELLS,NA,0.1,0,0.00279916,0,0.553814447,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.064281633,0,0.157719902,0,0.224184018,0,0,0,0,0,0,0.446185553,8,11,9.38083152,Pt84_pre,84,98,60Pt85_on,Pt85,Pt85_on,on,NA,NA,NA,NA,1,0,0,1,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-412.3680028,292.1747046,-120.1932982,0.83241532,0.112057489,0,0.023308291,0.004526266,0,0.181639809,0.006579289,0.038205951,0,0,0.029479196,0,0.037818323,0.146573914,0.058641269,0.243294401,0,0,0.084150025,0,0,0.033725778,0.230951315,0.13536578,0.029479196,0.448509584,0.084150025,0.071544101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-3-85,CA209038-3-85,85,CA209038,3,1,66,1,2,USA,NIV3-PROG,16-Apr-13,9-Jul-13,23-Jul-13,9-Jul-13,NA,6-Oct-15,12-Aug-13,3-Jun-13,3-Jun-13,PD,PD,56.25,NA,0,1,NA,NA,1,859,122.7142857,904,129.1428571,PROGRESSION,18-Jul-13,56.25,NA,NA,3-Jun-13,49,7,1,56.25,2,NA,17-Oct-13,NA,PD,SDPD,0,1,Pt85,Mar-85,CA209038-3-85,66,MALE,16-Apr-13,9-Jul-13,NIV3-PROG,2-Apr-13,9-Jul-13,NA,3-Jun-13,PROGRESSION,3-Jun-13,PD,NA,8-Oct-12,-190,M1A,M1A,Pt85,CA209038-3-85,CA209038,United States of America,3,85,CUTANEOUS,CUTANEOUS,56,NIVO 3 mg/kg Q2W,on,NA,13-Mar-14,0,0,0,EVALUABLE,0,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,< 1% + PM TUMOR CELLS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,82,35,53.57238094,Pt85_on,85,83,55Pt85_pre,Pt85,Pt85_pre,pre,129,2.11058971,180,2.257678575,1,0,0,1,1,NIV3-PROG,2,RAS,85,0.658914729,0.9,3.1,0.943669374,1.671800061,0.242731116,54,300,Pt85_pre,23,0.415277986,0.439834025,0.974358974,-1141.662124,43.52488363,-1098.13724,0.903129402,0,0.110910957,0,0,0,0.109161433,0,0.07392486,0,0,0,0.027006045,0.038520323,0.218092911,0.046398777,0.294515045,0,0,0.023207885,0,0,0.058261765,0.183086293,0.110910957,0.027006045,0.559006733,0.023207885,0.096782088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt85_pre,0.963949203,12,4,0.722222222,0.753968254,0.761904762,0.555555556,0.69047619,0.706349206,126,0.602059991,1.52431479,1.591317639,1.608068351,1.17254984,1.457311942,1.490813366,CA209038-3-85,CA209038-3-85,85,CA209038,3,1,66,1,2,USA,NIV3-PROG,16-Apr-13,9-Jul-13,23-Jul-13,9-Jul-13,NA,6-Oct-15,12-Aug-13,3-Jun-13,3-Jun-13,PD,PD,56.25,NA,0,1,NA,NA,1,859,122.7142857,904,129.1428571,PROGRESSION,18-Jul-13,56.25,NA,NA,3-Jun-13,49,7,1,56.25,2,NA,17-Oct-13,NA,PD,SDPD,0,1,Pt85,Mar-85,CA209038-3-85,66,MALE,16-Apr-13,9-Jul-13,NIV3-PROG,2-Apr-13,9-Jul-13,NA,3-Jun-13,PROGRESSION,3-Jun-13,PD,NA,8-Oct-12,-190,M1A,M1A,Pt85,CA209038-3-85,CA209038,United States of America,3,85,CUTANEOUS,CUTANEOUS,55,PRE-TREATMENT,pre,NA,28-Feb-14,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.093626433,0,0,0,0.228726611,0,0.599719743,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.060953703,0,0,0,0,0,0,0,0.077927214,3,10,5.477225575,NA,NA,NA,NAPt86_on,Pt86,Pt86_on,on,526,2.720985744,1169,3.068185862,1,1,0,0,0,NIV3-PROG,4,TripleWt,363,0.690114068,0.4,2.4,0.583093566,1.75110948,0.108679169,41,300,Pt86_on,16,0.433052403,0.250426621,0.780487805,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt86_on,0.791081701,110,10,0.650306748,0.668711656,0.695296524,0.08997955,0.265848671,0.370143149,489,1,1.769475391,1.819554883,1.89189193,0.244833073,0.723370444,1.007154232,CA209038-6-86,CA209038-6-86,86,CA209038,6,2,50,1,2,USA,NIV3-PROG,2-May-13,13-Jun-13,22-Aug-13,13-Jun-13,28-Jan-14,26-Aug-13,NA,21-Aug-13,17-Jul-13,PD,PD,NA,0,0,0,NA,NA,1,843,120.4285714,272,38.85714286,PROGRESSION,21-Aug-13,NA,NA,NA,17-Jul-13,77,11,1,-34.22053232,2,NA,21-Sep-13,NA,PD,SDPD,1,1,Pt86,Jun-86,CA209038-6-86,50,FEMALE,2-May-13,13-Jun-13,NIV3-PROG,18-Apr-13,13-Jun-13,NA,21-Aug-13,PROGRESSION,17-Jul-13,PD,NA,1-Apr-13,-31,M1C WITH BRAIN METASTASES,M1C,Pt86,CA209038-6-86,CA209038,United States of America,6,86,OTHER: UNKNOWN PRIMARY,OTHER,109,NIVO 3 mg/kg Q2W,on,NA,28-Feb-14,1,0,0,EVALUABLE,1,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0.068237532,0,0,0.676687583,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.095947997,0,0,0,0,0,0,0,0.323312417,NA,NA,NA,NA,NA,NA,NAPt86_pre,Pt86,Pt86_pre,pre,562,2.749736316,1237,3.092720645,1,1,0,0,0,NIV3-PROG,4,TripleWt,396,0.704626335,0.8,2.3,0.512393996,4.642021064,-0.745777614,38,300,Pt86_pre,17,0.553258318,0.351245211,0.854368932,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt86_pre,0.995926909,6,1,1,1,1,1,1,1,540,0,2.749736316,2.749736316,2.749736316,2.749736316,2.749736316,2.749736316,CA209038-6-86,CA209038-6-86,86,CA209038,6,2,50,1,2,USA,NIV3-PROG,2-May-13,13-Jun-13,22-Aug-13,13-Jun-13,28-Jan-14,26-Aug-13,NA,21-Aug-13,17-Jul-13,PD,PD,NA,0,0,0,NA,NA,1,843,120.4285714,272,38.85714286,PROGRESSION,21-Aug-13,NA,NA,NA,17-Jul-13,77,11,1,-34.22053232,2,NA,21-Sep-13,NA,PD,SDPD,1,1,Pt86,Jun-86,CA209038-6-86,50,FEMALE,2-May-13,13-Jun-13,NIV3-PROG,18-Apr-13,13-Jun-13,NA,21-Aug-13,PROGRESSION,17-Jul-13,PD,NA,1-Apr-13,-31,M1C WITH BRAIN METASTASES,M1C,Pt86,CA209038-6-86,CA209038,United States of America,6,86,OTHER: UNKNOWN PRIMARY,OTHER,108,PRE-TREATMENT,pre,0,4-Dec-13,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,1352,1393,1558,1558,0.37,0,0.14,0.07,15.6,0.39,0.39,0.06,0,0,83.33,< 1% + PM TUMOR CELLS,NA,0,1.166666667,NA,NA,0,0,0,0.09082196,0,0,0.604971915,0,0,0,0.106828201,0,0,0,0,0,0,0,0,0.081282338,0,0,0,0,0,0,0,0,0,0,0.288199884,NA,NA,NA,NA,NA,NA,NAPt87_on,Pt87,Pt87_on,on,NA,NA,NA,NA,1,0,0,0,1,NIV3-NAIVE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1170.329044,3772.456787,4942.785831,0.23796051,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-5-87,CA209038-5-87,87,CA209038,5,1,68,1,2,USA,NIV3-NAIVE,23-Apr-13,13-May-14,27-May-14,13-May-14,NA,22-Dec-15,5-Jun-14,22-May-14,8-Aug-13,SD,SD,-20.77922078,NA,0,1,NA,NA,1,954,136.2857143,974,139.1428571,PARTIAL RESPONSE,22-May-14,-38.96103896,NA,NA,8-Aug-13,108,15.42857143,1,-55.84415584,2,NA,21-Aug-14,NA,PRCRSD,SDPD,0,1,Pt87,May-87,CA209038-5-87,68,MALE,23-Apr-13,13-May-14,NIV3-NAIVE,16-Apr-13,13-May-14,NA,22-May-14,PARTIAL RESPONSE,8-Aug-13,SD,NA,28-Mar-13,-26,UNKNOWN,UNKNOWN,Pt87,CA209038-5-87,CA209038,United States of America,5,87,CUTANEOUS,CUTANEOUS,86,NIVO 3 mg/kg Q2W,on,34.78,4-Dec-13,20,20,30,EVALUABLE,70,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,2688,2784,2739,2669,82.66,0,55.57,41.95,95.22,87.41,75.8,33.95,0,53.59,84.61,NA,NA,0,1.235640648,0,1.206152961,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5160,3101,4000.144997,Pt87_on,87,80,80Pt87_pre,Pt87,Pt87_pre,pre,677,2.830588669,1180,3.072249898,1,0,0,0,1,NIV3-NAIVE,2,RAS,431,0.636632201,0.5,2.6,0.537518755,3.175458869,-0.396066954,80,300,Pt87_pre,21,0.326961612,0.255813953,0.714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt87_pre,0.889549046,34,3,0.99391172,0.99391172,0.99391172,0,0.147640791,0.949771689,657,0.477121255,2.813355252,2.813355252,2.813355252,0,0.41791035,2.688412981,CA209038-5-87,CA209038-5-87,87,CA209038,5,1,68,1,2,USA,NIV3-NAIVE,23-Apr-13,13-May-14,27-May-14,13-May-14,NA,22-Dec-15,5-Jun-14,22-May-14,8-Aug-13,SD,SD,-20.77922078,NA,0,1,NA,NA,1,954,136.2857143,974,139.1428571,PARTIAL RESPONSE,22-May-14,-38.96103896,NA,NA,8-Aug-13,108,15.42857143,1,-55.84415584,2,NA,21-Aug-14,NA,PRCRSD,SDPD,0,1,Pt87,May-87,CA209038-5-87,68,MALE,23-Apr-13,13-May-14,NIV3-NAIVE,16-Apr-13,13-May-14,NA,22-May-14,PARTIAL RESPONSE,8-Aug-13,SD,NA,28-Mar-13,-26,UNKNOWN,UNKNOWN,Pt87,CA209038-5-87,CA209038,United States of America,5,87,CUTANEOUS,CUTANEOUS,85,PRE-TREATMENT,pre,17.27,28-Aug-13,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,MACROPHAGES,2634,1490,1732,1748,4.1,0.19,6.38,5.44,14.38,13.84,0.51,3.81,4.63,27.37,3.31,< 1% + PM TUMOR CELLS,NA,0.049868766,1.427821522,0.011001737,0.314997105,0,0,0,0,0,0.100801579,0.865395053,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.134604947,NA,NA,NA,Pt87_pre,87,55,55Pt89_on,Pt89,Pt89_on,on,219,2.340444115,195,2.292256071,1,1,1,1,1,NIV3-NAIVE,4,TripleWt,112,0.511415525,0.3,2,0.380791035,1.898685939,0.028101128,47,300,Pt89_on,13,0.258127018,0.176470588,0.379032258,697.8542383,1630.01298,2327.867218,0.584371406,0,0,0,0.124658783,0,0.105375818,0.04217555,0.110103117,0,0,0,0.026845729,0.036399719,0.055541811,0.109642578,0.231543752,0.011604525,0,0.115934861,0,0,0.030173757,0.382313268,0,0.026845729,0.396728141,0.115934861,0.078178001,Pt89_on_S0106604,0,0.177764236,0.222993165,0.191895589,72926,17067,null,9.68593311,0.311047256,2666.56006,0,410240,84744,21451,null,10.3567791,0.28021729,0.860544699,"Melanoma, Biopsy, Tissue",0.177764236,Pt89_on,on,0.178,16452,0.315,15,0.88,0.5569,Pt89_on,0.930695525,41,2,0.986111111,0.990740741,0.99537037,0.023148148,0.689814815,0.796296296,216,0.301029996,2.307937946,2.318773337,2.329608725,0.054176947,1.614473024,1.86368698,CA209038-3-89,CA209038-3-89,89,CA209038,3,1,56,1,2,USA,NIV3-NAIVE,23-Apr-13,19-Nov-13,3-Dec-13,19-Nov-13,14-Aug-15,5-May-15,17-Dec-13,27-Nov-13,27-Nov-13,SD,SD,-18.18181818,0,0,0,NA,NA,1,954,136.2857143,844,120.5714286,STABLE DISEASE,27-Nov-13,-18.18181818,NA,NA,27-Nov-13,219,31.28571429,1,-18.18181818,2,NA,27-Feb-14,NA,PRCRSD,SDPD,1,1,Pt89,Mar-89,CA209038-3-89,56,MALE,23-Apr-13,19-Nov-13,NIV3-NAIVE,16-Apr-13,19-Nov-13,NA,27-Nov-13,STABLE DISEASE,27-Nov-13,SD,NA,20-Mar-13,-34,M1A,M1A,Pt89,CA209038-3-89,CA209038,United States of America,3,89,CUTANEOUS,CUTANEOUS,58,NIVO 3 mg/kg Q2W,on,3.45,28-Aug-13,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,1490,1451,1502,1412,1.21,0.13,0.07,0.41,1.93,1.13,1.35,0.13,11.11,100,81.25,NO DEFINITE TUMOR,NA,1,3.153846154,0.037681159,0.11884058,0,0,0,0,0.168326956,0,0.730433794,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.10123925,506,418,459.8999891,Pt89_on,89,80,80Pt89_pre,Pt89,Pt89_pre,pre,214,2.330413773,199,2.301029996,1,1,1,1,1,NIV3-NAIVE,4,TripleWt,115,0.537383178,0.3,2,0.296202276,2.553173542,-0.113601335,64,300,Pt89_pre,16,0.224995203,0.161584107,0.692307692,506.5713905,669.7969791,1176.36837,0.712554154,0.02809726,0,0,0,0,0.168091147,0.036725461,0.07799485,0,0.003465169,0,0.034216458,0,0.107364752,0.060369232,0.18684691,0.028721564,3.00E-04,0.204881603,0,0,0.062888242,0.286276627,0.02809726,0.034216458,0.354580894,0.204881603,0.091909806,Pt89_pre_S0101370,0,0.069032761,0.036617231,0.029525653,28320,10363,null,11.394846,0.145759463,2666.56006,0,410240,35122,13211,null,11.8189411,0.136638865,0.806332213,"Melanoma, Biopsy, Tissue",0.069032761,Pt89_pre,pre,0.069,10090,0.147,10,0.8962,0.7193,Pt89_pre,0.985532397,9,1,1,1,1,1,1,1,212,0,2.330413773,2.330413773,2.330413773,2.330413773,2.330413773,2.330413773,CA209038-3-89,CA209038-3-89,89,CA209038,3,1,56,1,2,USA,NIV3-NAIVE,23-Apr-13,19-Nov-13,3-Dec-13,19-Nov-13,14-Aug-15,5-May-15,17-Dec-13,27-Nov-13,27-Nov-13,SD,SD,-18.18181818,0,0,0,NA,NA,1,954,136.2857143,844,120.5714286,STABLE DISEASE,27-Nov-13,-18.18181818,NA,NA,27-Nov-13,219,31.28571429,1,-18.18181818,2,NA,27-Feb-14,NA,PRCRSD,SDPD,1,1,Pt89,Mar-89,CA209038-3-89,56,MALE,23-Apr-13,19-Nov-13,NIV3-NAIVE,16-Apr-13,19-Nov-13,NA,27-Nov-13,STABLE DISEASE,27-Nov-13,SD,NA,20-Mar-13,-34,M1A,M1A,Pt89,CA209038-3-89,CA209038,United States of America,3,89,CUTANEOUS,CUTANEOUS,57,PRE-TREATMENT,pre,NA,13-Mar-14,4,1,0,EVALUABLE,5,LYMPHOCYTES AND MACROPHAGES,YES,LYMPHOCYTES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0.10593591,0,0,0,0.74723807,0,0,0,0.075130822,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.177631108,188,149,167.3678583,NA,NA,NA,NAPt9_on,Pt9,Pt9_on,on,413,2.615950052,635,2.803457116,1,1,1,1,1,NIV3-NAIVE,1,BRAF,250,0.605326877,0.8,3.2,0.828513049,3.480932592,-0.69018105,50,300,Pt9_on,23,0.615552091,0.373563218,0.947368421,196.8078585,194.455759,391.2636175,0.788506077,0,0.06629287,0,0.046911212,0.003828454,0.206740177,0.061388156,0,0,0,0.033608426,0,0.062951384,0.123866076,0.025608619,0.287963951,0.037548994,0,0.02822842,0,0,0.015063261,0.318867999,0.06629287,0.033608426,0.437438646,0.02822842,0.115563639,Pt9_on_S0089496,0,0.010566985,0.021914648,0.018543823,4335,1563,null,9.24360657,0.128791928,2666.56006,0,410240,5123,2025,null,9.71999359,0.115053348,0.846183877,"Melanoma, Biopsy, Tissue",0.010566985,Pt9_on,on,0.011,1494,0.131,3,0.8314,0.7115,Pt9_on,0.943514802,7,2,0.977722772,0.98019802,0.98019802,0,0.940594059,0.962871287,404,0.301029996,2.557673936,2.564149061,2.564149061,0,2.460547077,2.518823193,CA209038-8-9,CA209038-8-9,9,CA209038,8,1,46,1,NA,SPAIN,NIV3-NAIVE,29-Oct-12,26-Nov-12,2-Jan-13,26-Nov-12,28-Jan-13,10-Jan-13,NA,2-Jan-13,2-Jan-13,PD,PD,45.16129032,1,0,0,NA,NA,1,1130,161.4285714,92,13.14285714,PROGRESSION,2-Jan-13,45.16129032,NA,NA,2-Jan-13,66,9.428571429,1,45.16129032,1,V600E,6-Mar-13,NA,PD,SDPD,1,1,Pt9,9-Aug,CA209038-8-9,46,MALE,29-Oct-12,26-Nov-12,NIV3-NAIVE,24-Oct-12,26-Nov-12,NA,2-Jan-13,PROGRESSION,2-Jan-13,PD,NA,9-Oct-12,-20,M1C WITHOUT BRAIN METASTASES,M1C,Pt9,CA209038-8-9,CA209038,SPAIN,8,9,CUTANEOUS,CUTANEOUS,130,NIVO 3 mg/kg Q2W,on,7.59,6-Jul-13,1,1,0,EVALUABLE,2,MACROPHAGES ONLY,YES,NA,2568,2357,2376,2261,1.01,0.19,1.36,0.21,6.1,1.46,0.44,0.59,19.23,12.5,24.24,NA,NA,0.322033898,0.355932203,0.025032938,0.027667984,0.133605168,0,0,0,0,0,0.825594882,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.040799951,89,29,50.80354318,NA,NA,NA,NAPt9_pre,Pt9,Pt9_pre,pre,409,2.611723308,615,2.789580712,1,1,1,1,1,NIV3-NAIVE,1,BRAF,246,0.601466993,0.8,2.9,0.828598962,1.72494115,0.174550954,48,300,Pt9_pre,23,0.618047407,0.378787879,0.896551724,518.6266695,540.5335405,1059.16021,0.724519282,0,0.016341999,0,0.071924867,0,0.231443562,0.007175534,0,0,0,0,0.020034463,0.047257261,0.191860007,0.004607072,0.287671477,0.010724866,0.035119274,0.03187712,0,0,0.043962499,0.310543963,0.016341999,0.020034463,0.484138556,0.03187712,0.1370639,Pt9_pre_S0089488,0,0.009019111,0.050270271,0.04060249,3700,1692,null,9.48275948,0.115786515,2666.56006,0,410240,4581,2177,null,9.92976093,0.104468957,0.807683912,"Melanoma, Biopsy, Tissue",0.009019111,Pt9_pre,pre,0.009,1650,0.118,3,0.9183,0.777,Pt9_pre,0.77562756,31,5,0.410447761,0.470149254,0.549751244,0.109452736,0.208955224,0.256218905,402,0.698970004,1.071975984,1.227899765,1.435798138,0.285860262,0.545733229,0.669172886,CA209038-8-9,CA209038-8-9,9,CA209038,8,1,46,1,NA,SPAIN,NIV3-NAIVE,29-Oct-12,26-Nov-12,2-Jan-13,26-Nov-12,28-Jan-13,10-Jan-13,NA,2-Jan-13,2-Jan-13,PD,PD,45.16129032,1,0,0,NA,NA,1,1130,161.4285714,92,13.14285714,PROGRESSION,2-Jan-13,45.16129032,NA,NA,2-Jan-13,66,9.428571429,1,45.16129032,1,V600E,6-Mar-13,NA,PD,SDPD,1,1,Pt9,9-Aug,CA209038-8-9,46,MALE,29-Oct-12,26-Nov-12,NIV3-NAIVE,24-Oct-12,26-Nov-12,NA,2-Jan-13,PROGRESSION,2-Jan-13,PD,NA,9-Oct-12,-20,M1C WITHOUT BRAIN METASTASES,M1C,Pt9,CA209038-8-9,CA209038,SPAIN,8,9,CUTANEOUS,CUTANEOUS,129,PRE-TREATMENT,pre,7.69,8-Jun-13,0,0,0,EVALUABLE,0,MACROPHAGES ONLY,YES,MACROPHAGES,2451,2115,2397,2300,1.31,0.49,0.52,0,0.54,0.39,1,0.04,37.5,0,88.89,< 1% + PM TUMOR CELLS,NA,12.25,0,0.063719116,0,0.135316405,0,0,0,0,0,0.821117436,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.04356616,76,45,58.48076607,NA,NA,NA,NAPt90_pre,Pt90,Pt90_pre,pre,283,2.451786436,302,2.481442629,1,0,0,1,0,NIV3-PROG,4,TripleWt,162,0.572438163,0.3,2.3,0.226284779,3.92108315,-0.283751054,91,300,Pt90_pre,26,0.246924934,0.060606061,0.454545455,-69.26480482,2235.623549,2166.358744,0.603443758,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt90_pre,0.507543106,28,2,0.22826087,0.286231884,0.362318841,0.039855072,0.050724638,0.061594203,276,0.301029996,0.559646905,0.701779451,0.88832842,0.097716125,0.124365979,0.151015831,CA209038-7-90,CA209038-7-90,90,CA209038,7,2,60,1,2,USA,NIV3-PROG,14-May-13,11-Jun-13,25-Jun-13,11-Jun-13,3-Nov-13,2-Jul-13,NA,25-Jun-13,26-Jun-13,PD,PD,22.02643172,0,0,0,NA,NA,1,831,118.7142857,174,24.85714286,PROGRESSION,26-Jun-13,22.02643172,NA,NA,26-Jun-13,44,6.285714286,1,22.02643172,97,NA,19-Sep-13,NA,PD,SDPD,1,1,Pt90,Jul-90,CA209038-7-90,60,FEMALE,14-May-13,11-Jun-13,NIV3-PROG,29-Mar-13,11-Jun-13,NA,25-Jun-13,PROGRESSION,26-Jun-13,PD,NA,29-Mar-13,-46,M1C WITHOUT BRAIN METASTASES,M1C,Pt90,CA209038-7-90,CA209038,United States of America,7,90,MUCOSAL,MUCOSAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.11002949,0,0,0,0.114098931,0,0,0,0,0,0.529367847,0,0,0,0,0,0,0,0,0,0,0,0.09613637,0,0,0,0,0,0,0,0.246503732,1178,860,1006.518753,NA,NA,NA,NAPt92_on,Pt92,Pt92_on,on,631,2.800029359,1071,3.030194785,1,1,1,1,1,NIV3-PROG,2,RAS,380,0.6022187,0.3,2.1,0.314187971,2.034520712,-0.007802592,43,300,Pt92_on,6,0.052035613,0.141176471,0.41025641,666.9045747,3513.596997,4180.501572,0.34492604,0.118536677,0,0,0.157906686,0,0.037701992,0.152064616,0.12347959,0,0,0.024519052,0,0.067561785,0.021912164,0.09251287,0.173951059,0,0.015944278,0.01390923,0,0,0,0.471152884,0.118536677,0.024519052,0.288376093,0.01390923,0.083506063,Pt92_on_S0101379,0,0.638791927,0.010322142,0.008736487,262058,41822,null,12.6052656,0.178915665,2666.56006,0,410240,309621,50778,null,12.8901415,0.175395936,0.846383159,"Melanoma, Biopsy, Tissue",0.638791927,Pt92_on,on,0.639,37656,0.182,31,0.7232,0.3875,Pt92_on,0.882434723,69,2,0.983606557,0.986885246,0.98852459,0,0.047540984,0.816393443,610,0.301029996,2.754127238,2.763307663,2.767897874,0,0.133116151,2.285925609,CA209038-7-92,CA209038-7-92,92,CA209038,7,1,58,1,2,USA,NIV3-PROG,7-May-13,19-Nov-13,20-Nov-13,19-Nov-13,4-Apr-14,19-Nov-13,NA,19-Nov-13,12-Nov-13,SD,SD,-4.975124378,0,0,0,NA,NA,1,838,119.7142857,333,47.57142857,STABLE DISEASE,12-Nov-13,-4.975124378,NA,NA,12-Nov-13,190,27.14285714,1,-4.975124378,2,NA,27-Feb-14,NA,PRCRSD,SDPD,1,1,Pt92,Jul-92,CA209038-7-92,58,MALE,7-May-13,19-Nov-13,NIV3-PROG,12-Apr-13,19-Nov-13,NA,19-Nov-13,STABLE DISEASE,12-Nov-13,SD,NA,9-May-10,-1094,UNKNOWN,UNKNOWN,Pt92,CA209038-7-92,CA209038,United States of America,7,92,CUTANEOUS,CUTANEOUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.078148431,0,0,0,0,0,0.897784848,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.024066721,6013,8607,7194.017723,NA,NA,NA,NAPt92_pre,Pt92,Pt92_pre,pre,642,2.807535028,1086,3.036229544,1,1,1,1,1,NIV3-PROG,2,RAS,388,0.604361371,0.5,2.1,0.449560954,1.987904014,0.003927946,37,300,Pt92_pre,4,0.028296934,0.225352113,0.603053435,672.3422595,2330.30436,3002.646619,0.501260971,0.015058202,0.050279606,0,0.072369245,0,0.143057578,0.154659409,0.069430823,0,0,0.021469311,0.006467941,0.038883541,0.004206691,0.090411904,0.26974649,0,0.006179222,0.05487208,0,0,0.002907959,0.439517055,0.065337808,0.027937252,0.364365085,0.05487208,0.047970722,Pt92_pre_S0101401,0,0.375504583,0.025245542,0.020845616,154047,42411,null,12.7737246,0.169034675,2666.56006,0,410240,186562,51771,null,12.969202,0.171818614,0.825714776,"Melanoma, Biopsy, Tissue",0.375504583,Pt92_pre,pre,0.376,38597,0.173,31,0.8436,0.6012,Pt92_pre,0.984225129,37,2,0.977419355,0.979032258,0.979032258,0.890322581,0.938709677,0.95483871,620,0.301029996,2.744139076,2.748667358,2.748667358,2.499611832,2.635460299,2.680743124,CA209038-7-92,CA209038-7-92,92,CA209038,7,1,58,1,2,USA,NIV3-PROG,7-May-13,19-Nov-13,20-Nov-13,19-Nov-13,4-Apr-14,19-Nov-13,NA,19-Nov-13,12-Nov-13,SD,SD,-4.975124378,0,0,0,NA,NA,1,838,119.7142857,333,47.57142857,STABLE DISEASE,12-Nov-13,-4.975124378,NA,NA,12-Nov-13,190,27.14285714,1,-4.975124378,2,NA,27-Feb-14,NA,PRCRSD,SDPD,1,1,Pt92,Jul-92,CA209038-7-92,58,MALE,7-May-13,19-Nov-13,NIV3-PROG,12-Apr-13,19-Nov-13,NA,19-Nov-13,STABLE DISEASE,12-Nov-13,SD,NA,9-May-10,-1094,UNKNOWN,UNKNOWN,Pt92,CA209038-7-92,CA209038,United States of America,7,92,CUTANEOUS,CUTANEOUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0.07003626,0.918137021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.081862979,1408,1735,1562.971529,NA,NA,NA,NAPt93_on,Pt93,Pt93_on,on,407,2.609594409,227,2.357934847,1,1,1,0,1,NIV3-PROG,2,RAS,146,0.358722359,0.9,2,0.900699638,1.940470711,0.039205123,72,300,Pt93_on,8,0.105718058,0.43315508,0.972972973,-446.1968035,217.8481511,-228.3486525,0.841107743,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt93_on_S0106607,0,0.015100917,0.044067796,0.033595864,6195,2025,null,9.23251915,0.159434974,2666.56006,0,410240,8126,2503,null,9.36015415,0.170893148,0.762367709,"Melanoma, Biopsy, Tissue",0.015100917,Pt93_on,on,0.015,1962,0.16,3,0.8699,0.685,Pt93_on,0.966344951,11,3,0.944584383,0.944584383,0.944584383,0.914357683,0.929471033,0.931989924,397,0.477121255,2.464982125,2.464982125,2.464982125,2.386102698,2.425542411,2.432115695,CA209038-3-93,CA209038-3-93,93,CA209038,3,1,52,1,2,USA,NIV3-PROG,7-May-13,30-Dec-14,13-Jan-15,30-Dec-14,NA,2-Sep-15,6-Apr-15,26-Jun-13,26-Jun-13,PD,PD,27.45098039,NA,0,1,NA,NA,1,838,119.7142857,849,121.2857143,PROGRESSION,9-Jan-15,27.45098039,NA,NA,26-Jun-13,51,7.285714286,1,-11.76470588,2,NA,9-Apr-15,NA,PD,SDPD,0,1,Pt93,Mar-93,CA209038-3-93,52,MALE,7-May-13,30-Dec-14,NIV3-PROG,24-Apr-13,30-Dec-14,NA,26-Jun-13,PROGRESSION,26-Jun-13,PD,NA,24-Apr-13,-13,M1C WITHOUT BRAIN METASTASES,M1C,Pt93,CA209038-3-93,CA209038,United States of America,3,93,CUTANEOUS,CUTANEOUS,60,NIVO 3 mg/kg Q2W,on,NA,28-Feb-14,0,1,0,EVALUABLE,1,MACROPHAGES ONLY,YES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0.085568157,0,0.773843583,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.079858695,0,0,0,0,0,0,0,0.140588259,96,201,138.9100428,Pt93_on,93,95,60Pt93_pre,Pt93,Pt93_pre,pre,7,0.84509804,1,0.301029996,1,1,1,0,1,NIV3-PROG,4,TripleWt,1,0.142857143,0.5,2,NA,2,0.007340933,25,300,Pt93_pre,0,0,0.051948052,0.113636364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt93_pre_S0101368,0,0.043834757,0.016552111,0.013288288,14258,4691,null,10.8627176,0.109297872,2114.23999,0,325267,17760,5850,null,11.1446562,0.10944064,0.802815315,"Melanoma, Biopsy, Tissue",0.043834757,Pt93_pre,pre,0.044,4479,0.111,6,0.8554,0.6821,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-3-93,CA209038-3-93,93,CA209038,3,1,52,1,2,USA,NIV3-PROG,7-May-13,30-Dec-14,13-Jan-15,30-Dec-14,NA,2-Sep-15,6-Apr-15,26-Jun-13,26-Jun-13,PD,PD,27.45098039,NA,0,1,NA,NA,1,838,119.7142857,849,121.2857143,PROGRESSION,9-Jan-15,27.45098039,NA,NA,26-Jun-13,51,7.285714286,1,-11.76470588,2,NA,9-Apr-15,NA,PD,SDPD,0,1,Pt93,Mar-93,CA209038-3-93,52,MALE,7-May-13,30-Dec-14,NIV3-PROG,24-Apr-13,30-Dec-14,NA,26-Jun-13,PROGRESSION,26-Jun-13,PD,NA,24-Apr-13,-13,M1C WITHOUT BRAIN METASTASES,M1C,Pt93,CA209038-3-93,CA209038,United States of America,3,93,CUTANEOUS,CUTANEOUS,59,PRE-TREATMENT,pre,NA,12-Aug-13,NA,NA,NA,UNEVALUABLE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO DEFINITIVE TUMOR,HIGH MELANIN CONTENT,NA,NA,NA,NA,0.063035501,0,0,0,0,0,0,0,0,0,0.221266932,0,0,0,0,0,0,0,0,0.455441449,0,0,0,0,0,0,0,0,0.200373752,0,0.715697567,NA,NA,NA,NA,NA,NA,NAPt94_on,Pt94,Pt94_on,on,NA,NA,NA,NA,1,0,1,1,1,NIV3-NAIVE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,328.0236956,1600.260024,1928.28372,0.630936295,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt94_on_S0096357,0,0.096943503,0.125919774,0.108441241,27724,7469,null,10.0786409,0.216687933,1858.88,0,285981,36914,9468,null,9.95626259,0.246242687,0.751042965,"Melanoma, Biopsy, Tissue, Tumor",0.096943503,Pt94_on,on,0.097,6794,0.224,7,0.8477,0.593,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-4-94,CA209038-4-94,94,CA209038,4,1,41,1,2,USA,NIV3-NAIVE,20-May-13,11-May-15,18-May-15,11-May-15,NA,25-Jan-16,27-May-15,NA,NA,CR,PRCR,-100,NA,1,1,673,96.14285714,0,57,8.142857143,981,140.1428571,COMPLETE RESPONSE,18-May-15,-100,15-Jul-13,57,18-May-15,729,104.1428571,1,-100,1,V600,19-Aug-15,NA,PRCRSD,PRCR,0,0,Pt94,Apr-94,CA209038-4-94,41,MALE,20-May-13,11-May-15,NIV3-NAIVE,6-May-13,11-May-15,NA,NA,COMPLETE RESPONSE,NA,CR,NA,10-Apr-13,-40,M1C WITHOUT BRAIN METASTASES,M1C,Pt94,CA209038-4-94,CA209038,United States of America,4,94,CUTANEOUS,CUTANEOUS,72,NIVO 3 mg/kg Q2W,on,22.34,4-Dec-13,1,5,5,EVALUABLE,11,LYMPHOCYTES AND MACROPHAGES,YES,MACROPHAGES,1310,1285,1166,1235,9.16,1.83,3.5,0.78,16.9,7.53,6.88,5.15,20,4.44,61.29,NA,HIGH MELANIN CONTENT,0.355339806,0.151456311,0.081915846,0.034914951,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,517,525,520.9846447,Pt94_on,94,35,40Pt94_pre,Pt94,Pt94_pre,pre,405,2.607455023,544,2.736396502,1,0,1,1,1,NIV3-NAIVE,1,BRAF,239,0.590123457,0.4,2.1,0.330354159,3.337442628,-0.287962607,62,300,Pt94_pre,22,0.481413971,0.188741722,0.757142857,441.2713265,1663.605668,2104.876994,0.610615518,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt94_pre_S0096358,0,0.227718023,0.012187949,0.009958645,73105,40530,null,14.0234928,0.083833203,2086.71997,0,321033,89470,49959,null,14.3539753,0.080371946,0.817089527,"Melanoma, Biopsy, Tissue, Tumor",0.227718023,Pt94_pre,pre,0.228,38503,0.087,31,0.9567,0.8106,Pt94_pre,0.860180265,9,5,0.994936709,1,1,0,0,1,395,0.698970004,2.59425272,2.607455023,2.607455023,0,0,2.607455023,CA209038-4-94,CA209038-4-94,94,CA209038,4,1,41,1,2,USA,NIV3-NAIVE,20-May-13,11-May-15,18-May-15,11-May-15,NA,25-Jan-16,27-May-15,NA,NA,CR,PRCR,-100,NA,1,1,673,96.14285714,0,57,8.142857143,981,140.1428571,COMPLETE RESPONSE,18-May-15,-100,15-Jul-13,57,18-May-15,729,104.1428571,1,-100,1,V600,19-Aug-15,NA,PRCRSD,PRCR,0,0,Pt94,Apr-94,CA209038-4-94,41,MALE,20-May-13,11-May-15,NIV3-NAIVE,6-May-13,11-May-15,NA,NA,COMPLETE RESPONSE,NA,CR,NA,10-Apr-13,-40,M1C WITHOUT BRAIN METASTASES,M1C,Pt94,CA209038-4-94,CA209038,United States of America,4,94,CUTANEOUS,CUTANEOUS,71,PRE-TREATMENT,pre,7.84,4-Dec-13,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,1170,1171,1139,1212,1.11,0.51,2.73,0.43,4.48,2.97,2.39,2.02,46.15,9.38,63.89,NA,NA,0.252475248,0.212871287,0.06505102,0.054846939,0,0,0,0,0,0.068836991,0.734298506,0,0,0,0.085841216,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.179860278,445,308,370.2161531,Pt94_pre,94,50,85Pt98_on,Pt98,Pt98_on,on,NA,NA,NA,NA,1,0,0,1,1,NIV3-PROG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-24.64445435,1651.756463,1627.112008,0.664607172,0.029433422,0,0.030722795,0.096464954,0,0.127319135,0.064758442,0.059013166,0,0,0,0.072416667,0.043761489,0.115783913,0.053019706,0.220278264,0,0.007932072,0.059157354,0,0,0.019938623,0.347555697,0.060156217,0.072416667,0.389081883,0.059157354,0.071632184,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CA209038-5-98,CA209038-5-98,98,CA209038,5,1,74,1,2,USA,NIV3-PROG,7-May-13,6-Jun-14,18-Jun-14,6-Jun-14,23-May-15,28-Apr-15,28-Aug-14,18-Jun-14,18-Jun-14,SD,SD,4.430379747,0,0,0,NA,NA,1,838,119.7142857,747,106.7142857,STABLE DISEASE,18-Jun-14,4.430379747,NA,NA,18-Jun-14,408,58.28571429,1,4.430379747,2,NA,14-Sep-14,NA,PRCRSD,SDPD,1,1,Pt98,May-98,CA209038-5-98,74,MALE,7-May-13,6-Jun-14,NIV3-PROG,30-Apr-13,6-Jun-14,NA,18-Jun-14,STABLE DISEASE,18-Jun-14,SD,NA,5-Oct-12,-214,M1C WITHOUT BRAIN METASTASES,M1C,Pt98,CA209038-5-98,CA209038,United States of America,5,98,OCULAR/UVEAL,OCULAR/UVEAL,90,NIVO 3 mg/kg Q2W,on,25.12,4-Dec-13,1,1,3,EVALUABLE,5,MACROPHAGES ONLY,YES,NA,2037,2037,2035,2165,16.3,2.41,5.65,1.91,21.13,17.32,23.56,10.66,13.86,8.7,74.13,NA,NA,0.226078799,0.179174484,0.09593949,0.076035032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,769,849,808.0105197,Pt98_on,98,90,90Pt98_pre,Pt98,Pt98_pre,pre,20,1.301029996,23,1.380211242,1,0,0,1,1,NIV3-PROG,4,TripleWt,13,0.65,0.8,2.1,0.828061053,1.981969297,0.010810498,46,300,Pt98_pre,8,0.115852489,0.395338159,0.856321839,-668.94674,149.8792936,-519.0674464,0.863416055,0.032719116,0,0.06151566,0.050983296,0,0.181708854,0,0.022207389,0,0,0,0.064062528,0.004526881,0.162756825,0.045990129,0.373529323,0,0,0,0,0,0,0.254899539,0.094234776,0.064062528,0.582276277,0,0.004526881,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pt98_pre,0.959354335,2,2,0.631578947,0.631578947,0.631578947,0.526315789,0.578947368,0.578947368,19,0.301029996,0.821703155,0.821703155,0.821703155,0.684752629,0.753227892,0.753227892,CA209038-5-98,CA209038-5-98,98,CA209038,5,1,74,1,2,USA,NIV3-PROG,7-May-13,6-Jun-14,18-Jun-14,6-Jun-14,23-May-15,28-Apr-15,28-Aug-14,18-Jun-14,18-Jun-14,SD,SD,4.430379747,0,0,0,NA,NA,1,838,119.7142857,747,106.7142857,STABLE DISEASE,18-Jun-14,4.430379747,NA,NA,18-Jun-14,408,58.28571429,1,4.430379747,2,NA,14-Sep-14,NA,PRCRSD,SDPD,1,1,Pt98,May-98,CA209038-5-98,74,MALE,7-May-13,6-Jun-14,NIV3-PROG,30-Apr-13,6-Jun-14,NA,18-Jun-14,STABLE DISEASE,18-Jun-14,SD,NA,5-Oct-12,-214,M1C WITHOUT BRAIN METASTASES,M1C,Pt98,CA209038-5-98,CA209038,United States of America,5,98,OCULAR/UVEAL,OCULAR/UVEAL,89,PRE-TREATMENT,pre,27.43,28-Aug-13,0,0,0,EVALUABLE,0,NEITHER LYMPHOCYTES OR MACROPHAGES,YES,NA,1500,1850,1806,1759,9,3.2,6.32,2.7,9.69,9.78,19.1,24.36,35.56,24.79,86.05,NA,NA,0.13136289,0.110837438,0.116660591,0.098432373,0.478967068,0,0,0,0,0,0.131946542,0,0,0.124107921,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.185667255,0,0,0,0,0,0.389086389,125,77,98.10708435,Pt98_pre,98,100,100